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Abstract
In animals, tissue maintenance, plasticity and repair rely on adult stem cells which have 
been identi!ed in nearly all tissues.  Many adult stem cells are typically quiescent and only 
activate when required for maintenance and repair of adult tissues.  Within hours of activation 
skeletal muscle stem cells called satellite cells begin to express MyoD, a muscle-speci!c 
transcription factor that functions as a master regulator, committing satellite cells to myogenesis.  
e earliest detectable event in satellite cells following muscle injury is phosphorylation of p38α/β 
MAPKs, which is required for MyoD induction and cell-cycle entry.  Loss of Syndecan-4, a 
component of the satellite cell niche disrupts p38α/β MAPK activation and severely delays MyoD 
induction.  We performed a microarray gene chip experiment to identify genes expressed during 
satellite cell activation.  We identi!ed diﬀerentially expressed genes by subtracting genes changing 
in Sdc4-/- satellite cells from those changing in WT satellite cells following 12h of muscle injury.  
Unexpectedly, we observed that 70% of RNA-binding proteins (RNA-BPs) decreased in activated 
satellite cells.  Expression levels of the Tristetraprolin (TTP) family of RNA-BPs declined 
dramatically as satellite cells activated.  e TTP family is known to direct mRNA decay and we 
identi!ed the 3‘UTR of MyoD as a direct TTP target.  Furthermore, p38α/β MAPK signaling 
inhibits TTP-mediated mRNA decay in satellite cells.  HuR, an RNA-BP that is induced during 
satellite cell activation is known to stabilize MyoD mRNA.  e coordinate inhibition of TTP and 
induction of HuR may together function as a feed-forward loop to commit satellite cells to 
myogenesis by rapid induction of MyoD.  A similar feed-forward circuit could operate in other 
iii
stem cell systems, implicating that post-transcriptional regulation of mRNA could play a major 
role in regulating adult stem cells to maintain and repair adult tissues.
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Chapter 1:  Introduction
Nearly all tissues in vertebrates are thought to harbor adult stem cells.  Populations of well 
characterized adult stem cells reside within bone marrow, skin, intestine and muscle 1,2.  
Maintenance, homeostasis, plasticity, and repair of these tissues rely heavily on resident adult 
stem cells 3.  Although they reside within distinct tissues, adult stem cells have a number of 
important commonalities, 1) long-term maintenance of genomic stability 2) response to the 
micro-environment and 3) self-renewal of the stem cell population 3,4.  To maintain long-term 
genomic stability, most adult stem cells divide infrequently and can remain in a mitotically 
quiescent state for years 5.  When a tissue requires maintenance or repair, quiescent adult stem 
cells receive signals from their micro-environment or niche resulting in exit from quiescence and 
entry into the cell cycle 3.  Renewal of adult stem cell populations is not well understood.  One 
hypothesis is that adult stem cells divide asymmetrically; where one daughter cell exits the cell 
cycle to renew the stem cell population while the other continues to proliferate generating enough 
cells appropriate for the response 6.  e mechanisms regulating adult stem cell quiescence are 
poorly understood; however, maintenance and exit from quiescence are absolutely critical aspects 
of adult stem cell function.  Skeletal muscle regeneration provides an opportunity to study these 
important aspects of adult stem cells within the same tissue and oen within the same individual 
over its lifetime 7.  Fully regenerated muscle contains a similar number of quiescent satellite cells 
compared to uninjured muscle and appears phenotypically normal illustrating the impressive 
ability of skeletal muscle to regenerate.
Skeletal Muscle 
Skeletal muscles interconnect bones via tendons providing support and movement of the 
skeleton8.  Each muscle contains fascicles, which are bundles of myo!bers.  Myo!bers are 
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syncytial cells formed by the fusion of myoblasts during development.  Myo!bers contain the 
contractile subunits called myo!brils, comprising of actin and myosin !laments.  Contraction of 
skeletal muscle is voluntary and each individual myo!ber is innervated by a single branching 
axon of a motor neuron.  Upon excitation of the nerve, actin and myosin !laments within 
myo!brils slide in opposing directions, functionally shortening the muscle resulting in movement 
of the bone 8.  
Vertebrate survival depends on normal skeletal muscle function and skeletal muscle 
diseases are debilitating and cause mortality of the animal.  Muscular dystrophies comprise a 
group of muscle diseases that cause progressive muscle weakness.  Several genetic mutations 
cause muscular dystrophies but the most common is Duchenne’s Muscular Dystrophy (DMD) 9.  
DMD aﬀects approximately 1:3,500 boys born in the United States 10.  Currently, there is no 
treatment for DMD and on average, people with this disease die in their thirties 10.  Treatment of 
muscular dystrophies like DMD may be made possible through our understanding of muscle 
development and adult muscle stem cells called satellite cells.
Skeletal Muscle Development
In amniotes, all skeletal muscle of the trunk and limbs originate from somites, segments 
of paraxial mesoderm that form on either side of the neural tube and notochord during 
embryogenesis 11.  Multi-potent progenitor cells located in the dermomyotome are the source of 
muscle precursor cells.  From limb level somites, migration of muscle precursor cells into the limb 
buds requires c-met, the receptor for HGF.  Once in the limb, muscle precursor cells commit to 
the myogenic lineage and become myoblasts, which are cycling muscle cells that express muscle 
speci!c transcription factors 11.  Upon induction of muscle diﬀerentiation, myoblasts exit the cell 
cycle to form myocytes, non-cycling mono-nucleated muscle cells.  Diﬀerentiating myocytes align 
and fuse to form multi-nucleate myo!bers.  Myonuclei within myo!bers are terminally 
diﬀerentiated and under normal physiological conditions do not re-enter into the cell-cycle 12.
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Amniote limb muscle development is characterized by two waves of muscle 
diﬀerentiation, primary and secondary myogenesis 11.  Following a proliferation phase, 
embryonic myoblasts exit the cell cycle and fuse to form primary myotubes.  Subsequently fetal 
myoblasts proliferate and execute myogenic diﬀerentiation.  Secondary myotubes use primary 
myotubes as scaﬀolds and form the bulk of the limb musculature.  During the late fetal stage, 
satellite cells are seen associated with myo!bers sandwiched between the plasma membrane of the 
myo!ber and the basal lamina 13.  Postnatal myogenesis is attributed to sustained satellite cell 
fusion with existing myo!bers 14.  Insight into the mechanistic details of myogenesis began with 
the in vitro transcriptional characterization of myogenesis.
Muscle Transcription Factors
Myogenesis collectively refers to the process of forming multi-nucleated myo!bers from 
non-committed mono-nucleated cells.  A network of muscle regulatory transcription factors 
(MRFs) induce a suite of muscle speci!c genes suﬃcient to drive myogenesis 11.  e MRFs 
contain a basic helix-loop-helix domain required for DNA binding and heterodimerization 15.  
Currently, four MRFs have been identi!ed: MyoD, Myf5, MRF4, and Myogenin.   
MyoD has been referred to as a master regulator of myogenesis 16.  All four MRFs are 
suﬃcient to convert cells into muscle in vitro; however, MRF regulation of embryonic and adult 
myogenesis in vivo is much more complicated.
e MRFs were systematically targeted for knockout or reporter knock-in in mice.  e 
phenotypes of single, double and triple knock-out mice aided in de!ning the complex regulatory 
and compensatory relationships between the MRFs.  In summary, Myf5 and MyoD commit 
multi-potent precursor cells to myoblasts and are overall functionally redundant during 
development 17-21.  In a subset of precursor cells in the myotome, MRF4 regulates commitment to 
the myogenic lineage and diﬀerentiation 21,22.  Myogenin is required for muscle diﬀerentiation; 
thus, Myogenin null neonates display only residual muscle formation 23-26.  However, Myf5 and 
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Myogenin expression alone is insuﬃcient to support muscle diﬀerentiation in the absence of 
MyoD and MRF4 27.  Further, Myf5 expression alone is not suﬃcient for muscle formation in 
vitro or in vivo 28, whereas cells isolated from all the other single and double MRF knockout mice 
are able to form muscle in vitro 17-21,23-26.  Embryonic myogenesis is one of the most understood 
processes of cell fate decisions and cellular diﬀerentiation because of the analysis of MRF 
knockout mice.  
Adult Myogenesis - Maintenance and Repair of Adult Muscle Tissue
Adult myogenesis collectively refers to the process of satellite cell mediated muscle 
formation.  In humans, satellite cell nuclei comprise 4-6% of all basal lamina incapsulated nuclei 
within muscle 29, and are able to remain quiescent for years 5.  Satellite cells based on their 
physiology during the adult myogenic process are grouped into four classes, 1) quiescent, 2) 
activated, 3) proliferating and 4) diﬀerentiating.
Quiescent Satellite Cells
e “satellite cell” was !rst described by Mauro in 1961 as cells “satellite” to the myo!ber, 
anatomically de!ning this cell 30.  Satellite cells are sandwiched between the myo!ber plasma 
membrane and the basement membrane 30.  e quiescent satellite cell is in(uenced by both the 
myo!ber and the extracellular space and are anatomically polarized 31.  Satellite cell nuclei and the 
myonuclei of the myo!ber are nearly indistinguishable because 1) myonuclei are located at the 
periphery of the myo!ber and 2) satellite cells distort the sarcomere of myo!bers 30.  Satellite cells 
were only distinguishable from myonuclei by electron microscopy until methods of immuno-
detection by light microscopy were developed.
Early descriptions of satellite cell morphology by electron microscopy provided insights 
into satellite cell quiescence under normal physiological conditions.  Comparison of satellite cells 
associated with muscle from young mice (1 -2 weeks old) to those associated with older muscle (5 
- 50 weeks old) reveals several anatomical diﬀerences.  Young mouse muscle contains satellite 
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cells characterized by more dispersed chromatin, many polysomes each containing 4-5 
ribosomes, readily identi!able rough endoplasmic reticulum, Golgi cisternae, and mitochondria 
32.  Human fetal satellite cells observed from 10 to 23 weeks gestation by electron microscopy 
displayed many common features as described in young murine muscle 33.  However, the 
morphological characteristics of satellite cells in young muscle dramatically change in adult 
muscle tissue implying that satellite cells enter into long-term quiescence in adult resting muscle.
In normal murine adult muscle, satellite cell nuclei are not radioactive aer continuous 
perfusion of titrated thymidine over nine days, indicating that they are not entering into S-phase 
and are mitotically quiescent 34.  Satellite cell nuclei observed in adult mice have a lower ratio of 
dispersed to condensed chromatin compared to young satellite cells, indicating a shi towards 
more condensed chromatin in adult satellite cell nuclei 32.  Cytoplasmic anatomical changes in 
adult satellite cells include the absence of polysome structures and further, ribosomes are rarely 
found 32.  In addition, rough endoplasmic reticulum is considerably diminished and ordered 
Golgi cisternae are not identi!able 32.  Based on these early electron microscopy studies, quiescent 
adult satellite cells in resting muscle were thought to be both mitotically and metabolically 
inactive with low transcriptional and translational pro!les.
Satellite cells appear metabolically inactive but express proteins involved in maintaining 
satellite cell quiescence such as Pax7, a paired-box transcription factor, expressed in quiescent 
satellite cells 35,36.  In Pax7 null mice, satellite cells are present at birth; however, they undergo 
apoptosis resulting in ablation of adult satellite cells 35,36.  e importance of Pax7 expression in 
satellite cells appears to be during early post-natal growth prior to post-natal day 21 (P21).  
During post-natal growth up until approximately P21, satellite cells are actively fusing to existing 
myo!bers, and thus have not entered into long-term quiescence 37.  If Pax7 is conditionally 
deleted between P7 and P18, adult muscle repair is severely defective 37.  In contrast, normal adult 
muscle regeneration proceeds if Pax7 expression is conditionally knocked out aer P21 37.  ese 
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data suggest that Pax7 may not required for satellite cell mediated adult muscle regeneration but 
for satellite cell entry into long-term quiescence aer juvenile growth.  
Quiescent satellite cells do not express detectable levels of the four MRFs when assayed by 
RT-PCR 38,39.  In disagreement, Cre-mediated lineage tracing suggests that progenitor cells 
contributing to adult satellite cells have expressed MyoD mRNA before entering into quiescence 
40.  However, other alternative explanations are possible since entry of satellite cells into 
quiescence and maintenance of the quiescent state are poorly understood.  Nevertheless, a 
fundamental cellular change occurs during the transition from a quiescent to activated satellite 
cell.
Activated Satellite Cells
Descriptive studies of satellite cells by electron microscopy implied that exit from 
quiescence results in a fundamental cellular change in satellite cells.  In response to exercise, 
injury, disease or denervation of the muscle, satellite cells appear “activated” and display 
morphological characteristics divergent of satellite cells from uninjured muscle.  As described by 
electron microscopy, activated satellite cells contain less condensed chromatin, increased 
cytoplasmic volume and ribosomal number, organization of ribosomes into polysomes, and 
increased rough ER and Golgi cisternae 41-46.  Pinpointing exactly when a satellite cell becomes 
“activated” is still under revision as the exit from quiescence continues to be molecularly de!ned.  
Perturbation of the muscle tissue inevitably activates satellite cells, thus “freshly isolated” satellite 
cells are activated.  For the purpose of this thesis, I will de!ne an “activated satellite cell” within 
the time frame of the initial signaling event occurring immediately aer muscle damage up until 
cell-cycle entry.  Currently, three major events have been described in activated satellite cells 
before cell cycle entry 1) extracellular receptor activation as identi!ed by autophosphorylation of 
FGF receptor tyrosine kinases, 2) p38α/β MAPK activation and 3) induction of MyoD mRNA 
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leading to myogenic commitment.  At the time of cell-cycle entry satellite cells are committed to 
the muscle lineage and I will refer to these cells as proliferating myoblasts.  
Molecular changes occurring rapidly upon muscle damage that are mediated by receptors 
expressed by quiescent satellite cells.  Proteins released by damaged muscle tissue bind to 
extracellular receptors on the surface of quiescent satellite cells which activates intracellular 
signaling 47.  Stretch-mediated activation of satellite cells has been shown to occur through HGF 
release which binds to the HGF receptor, c-met on the surface of satellite cells 48.  c-met mRNA is 
detected in 100% of freshly isolated satellite cells by single cell RT-PCR and c-met protein is 
detected in quiescent satellite cells in uninjured muscle sections 39.  In mice, knockout of c-met 
inhibits migration of muscle precursor cells into the limb and results in embryonic death 49.  An 
adult conditional c-met knockout has not been studied in the context of muscle regeneration.
Fibroblast Growth Factor Receptors (FGFRs) also play a role in satellite cell activation.  
Freshly isolated satellite cells express FGFR1 and FGFR4 at levels detectable by RT-PCR 50.  
Conditional knockout of FGFR1 (Olwin lab, unpublished) and FGFR4 knockout results in muscle 
regeneration defects 51.  FGF receptors require Heparan Sulfate Proteoglycans (HSPGs) located on 
the cell surface for signaling 52.  Two HSPGs, Syndecan-3 and Syndecan-4 are expressed by 
satellite cells 53.  With respect to satellite cell activation, Sdc4-/- satellite cells delay satellite cell 
activation as de!ned by MyoD expression, and cell cycle entry 54.  While several FGFs have been 
shown to in(uence proliferation of cultured satellite cells 55, it appears that in vivo FGF-6 and 
FGF-2 are particularily important to satellite cell mediated muscle regeneration 56,57.  Likely a 
complex interplay between FGF receptors, FGFs and Heparan Sulfate Proteoglycans regulate 
satellite cell activation.
Another signaling molecule that has been demonstrated to play an important role in 
satellite cell activation is TNF-α.  Intraperitoneal injection of TNF-α results in satellite cell 
activation in the absence of muscle injury 58.  TNF-α activates p38 MAPK and double knockout of 
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one subunit from each TNF-R1 and TNF-R2 (p55-/-;p75-/-) blocks p38 MAPK activation and 
results in muscle regeneration defects 59.  p38 MAPK activation is required for muscle 
regeneration and can be rescued by forced activation of p38 MAPK signaling 60.  We have shown 
that activation of p38α/β MAPK in satellite cells is required for satellite cell activation and entry 
into the cell cycle (discussed further below) 61.  e main source of TNF-α aer acute muscle 
injury is from neutrophils and macrophages 11, which play a supportive role in the process of 
muscle regeneration 62.  However, increased systemic TNF-α due to dysregulation of TNF-α 
mRNA stability results in muscle cachexia 63.  Although TNF-α acts to initiate muscle repair 
through satellite cell activation, eventual inhibition of the in(ammatory response is required for 
normal muscle repair 64.  HGF, FGF and TNF-α signaling all activate satellite cells; however, it is 
likely that the initial stimuli that results in satellite activation is context speci!c.  
HGF, FGF, and TNF-α likely activate MAPK signaling in quiescent satellite cells.  We have 
shown that activation of p38α/β acts as a critical molecular switch to activate quiescent satellite 
cells.  e active dual-phosphorylated form of p38α/β is detected in 40% of satellite cells within 20 
minutes following muscle injury 61.  Currently, phosphorylated p38α/β is the earliest molecular 
event identi!ed during satellite cell activation 61.  Based on Cre-mediated genetic deletion of 
p38β, p38ɣ and p38δ, these isoforms are dispensible for normal adult muscle regeneration 65.  
Cre-mediated genetic deletion of p38α results in increased Pax7 positive cells in neonates, but 
studies of adult muscle regeneration have not been published 66.   e downstream eﬀectors of 
p38α MAPK signaling during satellite cell activation are not characterized.  However, we have 
shown that inhibition of p38α signaling, blocks satellite cells from expressing MyoD and 
committing to the myogenic lineage 61. 
Satellite cells express MyoD and commit to the myogenic lineage prior to entry into the 
cell-cycle.  Following injury, MyoD mRNA is the !rst to be detected in rat and concurrent with 
Myf5 mRNA in mouse satellite cells by RT-PCR 38,39.  Within muscle cross-sections, ~28% of 
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satellite cells are positive for MyoD protein within 3 hours of muscle injury 67.  Further, MyoD 
protein is detected in ~40% of satellite cells associated with myo!bers aer 3h culture 61.  Prior to 
characterization of p38α/β phosphorylation, MyoD was the !rst known molecular event upon 
activation and still is oen used as a marker of activated satellite cells 39.  Satellite cells from MyoD 
null mice are defective in proliferation and diﬀerentiation, re(ecting an inability to progress 
through the normal regenerative process 50,68-70.  MyoD null mice with an mdx background, a 
mouse model for DMD, cannot repair muscle resulting in early death 68.  ese data underscore 
the importance of MyoD during skeletal muscle repair.  Once activated satellite cells express 
MyoD protein, they are committed to the myogenic lineage and are termed myoblasts that 
subsequently enter the cell-cycle.
Proliferating Myoblasts  
Our understanding of the mechanisms regulating transition from G1 to S-phase has 
largely been from studies in vitro.  Many studies have used the MM14 satellite cell line, which 
exhibits gene expression pro!les similar to primary satellite cells71.  FGF-2 strongly inhibits 
diﬀerentiation in MM14 cells and is required for entry into S-phase 72,73.  IGF-1 also induces 
proliferation of cultured myoblasts but it is also involved in induction of diﬀerentiation 74. 
e decision of myoblasts to proliferate or diﬀerentiate is mutually exclusive; however, it 
appears that overlapping pathways regulate this decision.  In MM14s, a decision point exists at the 
G1/S phase transition, where if the cells receive FGF, they enter into S-phase, if not they 
diﬀerentiate 55.  Activated-p38α/β signaling is required for MM14s to either enter S-phase or exit 
from the cell cycle for diﬀerentiation 61.  In primary satellite cells, p38α/β MAPK inhibition 
blocks MyoD expression and entry into the cell cycle 61.  Recent data shows that MyoD regulates 
entry into S-phase by transcriptional up-regulation of Cdc6 which is involved in licensing origins 
of DNA replication 75,76.  us, MyoD expression is required for entry into S-phase in satellite 
cells.  
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DNA replication in primary satellite cells begins approximately 12h aer isolation, as 
incorporation of the ymidine analog, BrdU is detected aer 12h in culture but not aer 6h 77.  
Regulation of the proliferating myoblast pool has been shown to be regulated by Notch signaling 
78.  Recently, we have shown that Syndecan-3 and Notch1 interact in a complex that regulates cell 
cycle progression and cell fate decisions in satellite cells 77.  As regeneration progresses, Notch 
signaling is inhibited by Numb and canonical Wnt signaling regulates myogenic diﬀerentiation 
78,79.
Diﬀerentiating Myoblasts
e late stages of muscle diﬀerentiation are similar between embryogenesis and adult 
myogenesis.  Myogenin and MRF4 mRNA are detected aer 48h hours in culture as satellite cells 
begin to diﬀerentiate 38,39,80.  As myoblasts up-regulate Myogenin, p21, the cyclin dependent 
kinase inhibitor drives the myoblasts to exit the cell cycle 81.  Concomitantly, growth-factor 
receptors are down-regulated 72.  Myoblasts either fuse together to form muscle !bers de novo or 
fuse to damaged muscle !bers for reparation 82,83.  e decision to exit the cell cycle and 
diﬀerentiate requires activated p38α/β MAPK signaling 61,84. 
e requirement of p38 MAPK signaling for skeletal muscle diﬀerentiation is well 
established 84,85.  Myogenesis is regulated by p38 MAPK phosphorylation of transcription factors 
and chromatin remodeling complexes which modulate the transcription of muscle speci!c gene 
targets 86.  Additionally, p38 MAPKs regulate the stability of myogenic mRNAs through 
phosphorylation of RNA-binding proteins 87.
Myogenic diﬀerentiation is largely regulated by the p38α MAPK isoform.  Cre-mediated 
deletion of p38α inhibits myogenic fusion in vitro 66.  p38α phosphorylation of E-proteins 88, 
bHLH proteins required for MRF transcriptional activity 89, results in increased MRF/E-protein 
association and transcription 88.  Further, p38α directs Swi/Snf chromatin remodeling complexes 
to muscle diﬀerentiation genes 90 and phosphorylates MEF2, which in conjunction with MyoD 
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up-regulates muscle diﬀerentiation genes 86.  In contrast, p38ɣ blocks premature diﬀerentiation by 
phosphorylation of MyoD which promotes its association with a histone methyl-transferase that 
negatively regulates gene transcription 91.  Muscle diﬀerentiation is regulated by p38 MAPKs at 
the level of gene transcription but p38 MAPKs also post-transcriptionally regulate myogenic 
mRNA stability.
Regulation of Myogenic mRNA stability by p38 MAPKs
p38 MAPK signaling modulates mRNA stability though phosphorylation of several 
known RNA-binding proteins 87,92-94.  RNA-binding proteins regulate transcripts by binding to 
AU-rich elements within the target 3‘ untranslated region (UTR)95.  RNA-binding proteins can 
either have a positive eﬀect on mRNA stability or decrease the half-life of the target mRNA 95,96.  
Changes as little as two-fold in mRNA half-life can signi!cantly aﬀect translated protein levels.  
For example, in mice, knockout of the protein, Tristetraprolin that regulates TNF-α mRNA 
stability, results in a 2-fold increase in TNF-α mRNA stability.  is causes increased systemic 
levels of TNF-α which results in a severe in(ammatory disorder 97,98 illustrating the importance of 
RNA-binding protein regulation. 
Activated p38 MAPK mediated phosphorylation of Human Antigen R (HuR) and KH-
type splicing regulatory protein (KSRP) plays a major role in muscle diﬀerentiation 87,99,100.  HuR, 
encoded by the Elavl1 gene, is an RNA-binding protein that positively regulates the stability of 
target transcripts 96.  HuR binds to mRNAs in the nucleus and the cytoplasm but the ability of 
HuR to stabilize mRNA occurs in the cytoplasm 101,102.  p38 MAPK phosphorylation of HuR 
results in increased cytoplasmic localization and target stability 103.  KSRP binds 3‘UTR regions of 
myogenic transcripts and mediates their decay 87.  Activated-p38 phosphorylation of KSRP results 
in the dissociation of KSRP from the mRNA resulting in increased transcript stability 87.  
Activated-p38 phosphorylation of both HuR and KSRP results in increased target stability.  Both 
HuR and KSRP have been shown to directly bind Myogenin and p21 mRNA 87,100.  However, it 
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remains untested whether HuR and KSRP bind simultaneously to Myogenin and p21 mRNAs or 
compete for common binding sites.  HuR also binds MyoD mRNA and increases its stability 
during myoblast diﬀerentiation 100.  Since HuR binds and regulates MyoD, Myogenin and p21 
mRNAs, it may regulate myogenic diﬀerentiation on a global level. In agreement with this idea, 
siRNA-mediated knock-down of HuR in C2C12 myoblasts results in inhibition of myogenic 
diﬀerentiation 100; whereas, over-expression of HuR results in accelerated diﬀerentiation of C2C12 
myoblasts 99.  
In addition to regulating myogenic diﬀerentiation, HuR positively in(uences C2C12 
myoblast proliferation.  Along with Pitx2, HuR binds and stabilizes CyclinD1 mRNA; but upon 
switch to diﬀerentiation conditions, this complex dissociates from the mRNA resulting in 
CyclinD1 mRNA decay and cell cycle exit (Gherzi, 2010).  us, HuR stabilizes target mRNAs 
during proliferation and diﬀerentiation in C2C12s, two mutually exclusive states, indicating that 
regulation of HuR targets is either in trans or through competition of cis-binding sites.
Here, I present my thesis work characterizing the mechanism by which p38α/β MAPK 
signaling acts as a molecular switch to activate satellite cells.  I present an in silico analysis of 
satellite cell activation, where it appears that post-transcriptional regulation of RNA switches 
quiescent satellite cells to committed myoblasts.  I have found that TTP directly binds and 
regulates the half-life of the 3‘UTR of MyoD mRNA.  In satellite cells, MyoD protein induction is 
dependent upon activated-p38α/β inhibition of TTP function.  I propose a model that MyoD 
mRNA in quiescent satellite cells is actively suppressed from being translated into protein.  I also 
explore the possibility that TTP directs diﬀerential polyadenylation of HuR mRNA.  TTP directed 
diﬀerential polyadenylation of HuR transcripts may result in inclusion of an AU-rich element in 
HuR mRNA.  An AU-rich element within HuR mRNA may allow for TTP-mediated instability of 
HuR transcripts.
12
Chapter 2:  In Silico Analysis of Satellite Cell Activation
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Introduction
Skeletal muscle maintenance and regeneration rely on a resident adult stem cell 
population called the satellite cell.  Satellite cells are a minor population in muscle, comprising 
only 4-6% of all basal lamina incapsulated nuclei within muscle 29.  Yet, this small population can 
rapidly regenerate muscle even aer repeated severe injuries 104.  Satellite cells lie between the 
plasma membrane of the myo!ber and the basal lamina surrounding the myo!ber 30.  ey 
remain in a mitotically quiescent state unless they receive signals from the muscle to activate in 
order to contribute to muscle maintenance and repair.  e molecular mechanisms regulating 
satellite cells are still elusive despite !y years of research.  
Satellite cell morphology has been described by electron and light microscopy.  As 
described by electron microscopy, the morphological characteristics of quiescent satellite cells 
implied that these cells were metabolically quiet 30.  Comparative analysis of activated satellite 
cells supported the idea of a cellular change to a more metabolically active state 32,105.  However, 
further understanding was not possible considering that at that time satellite cells were only 
distinguishable from myonuclei by electron microscopy.  Identi!cation of satellite cell speci!c 
expression of M(muscle)-Cadherin by immunocytochemistry (Bornemann, 1994) elicited a new 
era for the characterization of satellite cells by light microscopy.  Soon other “markers” of satellite 
cells permitted identi!cation of these cells with the light microscope and facilitated their isolation 
by FACS, aiding in understanding satellite cell gene expression changes occurring during the 
transition from quiescence to a proliferative state during muscle regeneration. 
Several proteins have been identi!ed that speci!cally mark quiescent, activated and 
proliferating satellite cells.  Pax7, a paired-box transcription factor, is a marker of quiescent and 
proliferating satellite cells.  Inducible lineage tracing of Pax7 expressing cells shows that cells 
marked during embryogenesis contribute to functional adult satellite cells that repair muscle 106.  
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However, it is currently uncharacterized whether all quiescent cells within the satellite cell 
position express Pax7.  e receptor for HGF, c-met is another marker of satellite cells 50.  C-met 
is expressed by quiescent, activated, proliferating, and diﬀerentiating satellite cells 39.  e 
activation of satellite cells is thought to occur by HGF activation of c-met and/or FGF activation 
of FGFRs 107,108.  ese receptor tyrosine kinases require Heparan Sulfate Proteoglycans (HSPGs) 
located on the cell surface for signaling 52.  Two HSPGs, Syndecan-3 and Syndecan-4 are 
expressed by satellite cells 53 and both Syndecan-3 and Syndecan-4 mark satellite cells in 
quiescence, proliferation, and diﬀerentiation 53.  
Genetic deletion of Sdc3 or Sdc4 reveals their unique roles in muscle regeneration 54,77.  
Whereas Syndecan-3 and Notch1 interact in a complex that regulates cell cycle progression and 
cell fate decisions in satellite cells 77,  Syndecan-4 is required for muscle regeneration regeneration 
54.  Sdc4-/- satellite cell defects include delayed satellite cell activation, MyoD expression, cell cycle 
entry and a failure to repair skeletal muscle upon an induced injury 54. 
Gene Expression Pro!les of Satellite Cells
Initial attempts to identify gene expression changes occurring during satellite cell 
activation utilized a candidate gene approach.  An unbiased approach to identify genes regulated 
during satellite cell activation employed C2C12 myoblasts as a model for quiescent satellite 
cells109.  When cultured in suspension, C2C12 myoblasts undergo a G0 cell-cycle arrest.  G0-
arrested C2C12s are not diﬀerentiated and re-enter the cell-cycle with similar kinetics as satellite 
cells upon activation.  Importantly, G0-arrested C2C12s do not express detectable levels of MyoD 
or Myf5 109,110.  Using diﬀerential display PCR, four transcripts were identi!ed as preferentially 
expressed by synchronized C2C12s verses asynchronous or diﬀerentiated C2C12s 109.  Matrilin-2, 
Znf216, LPS-inducible CXC chemokine (LIX) and Tristetraprolin (TTP).  ese transcripts were 
expressed at low levels aer synchronization in suspension but rapidly and transiently induced 
upon exit from G0.  Both LIX and TTP transcripts rapidly decreased and contain AU-rich 
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elements within their 3‘UTR regions which generally confer mRNA instability.  Using focal freeze 
injury, where the boundaries of injury are distinguishable from uninjured muscle, both LIX and 
TTP transcripts are induced within the injured tissue 109.  Speci!cally, TTP mRNA is detected in 
cells underneath the basal lamina aer injury by in situ hybridization.  
We utilized microarray analysis to perform an unbiased global analysis of gene expression 
changes occurring during satellite cell activation and applied a similar subtraction strategy to 
reduce the numbers of genes for analysis.  Here, I present my analysis of gene expression changes 
occurring in satellite cells during the initial 12 hours following an induced skeletal muscle injury.
Selection of Time Points Relevant to Satellite Cell Activation
e objective of our microarray analysis was to identify gene expression changes that 
occur when satellite cells transition from quiescence to an activated state.  Isolation of quiescent 
satellite cells is currently not possible, as disruption of the muscle tissue invariably results in their 
activation 61.  us, puri!ed satellite cells from uninjured muscle likely represent a mixed 
population of satellite cells at diﬀering stages of early activation prior to the expression of MyoD 
39.  To assist in identifying genes that were speci!c to satellite cell activation, we compared wild 
type satellite cells with activation defective satellite cells from uninjured muscle and 12h post-
injury.  Mutant Syndecan-4 null satellite cells delay expression of MyoD protein by 48h, are 
proliferation defective compared to wild type satellite cells and thus, activation-defective54.  us, 
we hypothesized that changes occurring in mutant Syndecan-4 null satellite cells would not be 
relevant to satellite cell activation. 
16
Results
Global Analysis of Gene Expression Changes Occurring Upon Satellite Cell Activation
Satellite cells are typically quiescent and can remain quiescent for years in humans 5.  To 
better understand the switch from a quiescent cell to an activated and proliferating myoblast, we 
examined global gene expression changes on Aﬀymetrix gene chips.  Wild type and Sdc4-/- 
satellite cells were puri!ed using Fluorescence-Activated Cell Sorting (FACS) from uninjured 
Tibialis Anterior (TA) muscles and satellite cells from TA muscles 12h post injury.  Sdc4-/- satellite 
cells are delayed in MyoD expression and cell cycle entry compared to wild type satellite cells.  We 
identi!ed gene expression changes occurring between wild type satellite cells from uninjured 
muscle and satellite cells 12h post injury.  From this list of genes, we subtracted genes that also 
changed in Sdc4-/- satellite cells following 12h of muscle injury.  e resulting genes will be 
referred to as the WT-S4 gene list (Appendix Table 1).  I re!ned the WT-S4 gene list to genes of 
interest by identi!cation of the following: 1) signi!cantly over-represented groups of transcripts, 
de!ned by gene ontology annotation; 2) known targets of p38α/β MAPKs; and 3) genes known to 
participate in muscle development or regeneration.
Ontological Analysis
To visualize all gene expression changes within the activation dataset, I !rst generated a 
heat map based on a hierarchy de!ned by 1) the level of expression in uninjured satellite cells 
(UI-SCs) and 2) the directionality of change in transcript abundance between uninjured satellite 
cells and satellite cells 12h post injury.  We observed about half of transcripts expressed in 
uninjured satellite cell decrease relative abundance 12h post-injury (Fig. 1; Total genes: 2850; 
Decreased: 1249 (44%) and, we postulated that transcripts decreasing in abundance may be 
required for maintenance of quiescence or to suppress satellite cell activation.
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Gene ontology (GO) analysis identi!ed several groups of genes to be enriched in the WT-
S4 gene list compared to all annotated mouse transcripts.  e gene ontology “Molecular 
Function” analysis, shows that the largest and most signi!cantly over-represented category within 
the WT-S4 gene list was the GO term: Binding (Fig 2; data set: 49.6%; annotated mouse genes: 
46.3%; p-value=9.81e-041).  While the term “binding” is not informative, the signi!cance of the 
p-value indicates that sub-categories within “binding” are highly over-represented.  
Figure 1: Heat map of WT-S4 gene list depicting gene expression changes occurring upon 
satellite cell activation.  
De!ned as WT-S4 gene list by 1) selecting genes signi!cantly (p<0.01) changing more than 2-
fold between UI and 12h post-injury in wild type satellite cells and 2) !ltering out genes that 
also signi!cantly change in Sdc4-/- satellite cells.  Out of 2850 genes represented in the activation 
data set, 1249 genes decrease (44%). Hierarchical cluster arranged by 1) level of expression in 
wild type UI-SCs and 2) directionality of change aer 12h post muscle injury.  Green denotes 
lower level of relative expression while red denotes higher level of expression.
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Within the GO term: “binding” one of the over-represented groups is “nucleic acid 
binding.”  is group includes transcription factors, translation initiation factors, ribosomal 
protein subunits among others that are regulated during transition from quiescence to activation.  
Within “nucleic acid binding” the sub-category, “RNA binding” is signi!cantly over-represented 
in the activation dataset.  To visually represent these data, I produced a heat map de!ned by 1) the 
level of expression in uninjured satellite cells and 2) the directionality of change in transcript 
abundance between uninjured satellite cells and satellite cells 12h post-injury.  Over half of “RNA 
binding” transcripts signi!cantly decrease.  Several decreasing transcripts encode proteins that 
target mRNA for decay.  us, exclusion of stable mRNAs from polysomes or suppression of 
expressed mRNAs may be a mechanism where quiescent satellite cells are able to rapidly respond 
Figure 2:  Molecular Function Gene Ontology Analysis Comparing All Mouse Annotated 
Transcripts Versus the WT-S4 gene list
Over-represented GO terms: Binding (p-value=9.81e-041), Catalytic Activity (p-
value=5.71e-07), Enzyme Regulator Activity (p-value=1.52e-07), Transcription Regulator 
Activity (p-value=5.59e-04), Transporter Activity (p-value=8.33e-04).  Categories in “other” 
are not signi!cantly over-represented within the WT-S4 gene list.
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to activating stimuli (Fig. 3; Total “RNA Binding” genes: 122; Decreased: 67 (55%) p-
value=8.73e-05). 
Microarray Evidence that mRNA Turnover, Translation and Splicing Regulates Satellite 
Cell Activation 
Gene expression is regulated by many diﬀerent mechanisms; one such mechanism is 
through post-transcriptional regulation of mRNA.  It is estimated that 5-8% of human mRNAs 
contain AU-rich elements (ARE) found within the 3‘UTR of the transcript 111.  RNA binding 
proteins are known to interact with AREs and either stabilize or destabilize the transcript 112,113.  
Figure 3:  Heat map depicting transcripts !ltered from the WT-S4 gene list with the 
Molecular Function GO term: RNA binding
Over half of transcripts with GO term: RNA binding decrease upon satellite cell activation 
but do not change in Sdc4-/- satellite cells. Total “RNA Binding” genes: 122; Decreased: 67 
(55%) p-value=8.73e-05.  Green denotes lower level of relative expression while red denotes 
higher relative level of expression.
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Splicing has also been shown to be important in switching from embryonic isoforms to adult 
splice variants of genes 114.  erefore, I wanted to ask whether genes that are known post-
transcriptional regulators of RNA, were diﬀerentially regulated as satellite cells activate. 
To test whether splicing and/or ARE-BPs regulate satellite cell activation, I identi!ed 
“RNA binding” transcripts that were ascribed “Biological Process” GO terms relating to 
translation, mRNA processing/cleavage/stabilization, and splicing.  Based on the set of “Biological 
Process” GO terms, I assigned a category to each gene.  e following categories were based on 
the protein’s in(uence on mRNA turnover, translation, or splicing:  negative regulator, positive 
regulator, splicing, or ambiguous/unknown.  From the WT-S4 gene list: subset RNA binding, I 
identi!ed 16 genes increasing and 43 decreasing in abundance that are known to regulate gene 
expression post-transcriptionally.  I converted the signal intensity for each transcript from Log2 to 
base 10 and calculated the diﬀerence between the expression in satellite cells 12h post-injury and 
in uninjured satellite cells.  Positive values correspond to transcripts increasing in abundance 











































Table 1:  Transcripts increasing in abundance between UI-SCs and 12h-SCs that were 
annotated as molecular function: RNA binding; Biological Process: RNA turnover, 
translation or splicing.  
Blue: positive regulators; Red: negative regulators; Green: proteins involved in splicing; Black: 
ambiguous/unknown.  False discovery rate (FDR) <0.05 and a p-value<0.01 was used to 














Eif4a2 -209.89 Snrpe -968.20
Eif3g -328.57 Zranb2 -98.03
Eif4h -151.26 Hnrpll -289.98
Pabpn1 -246.38 Snrpb -420.55
Eif4e2 -247.48 Rbm39 -214.46
Eif1a -126.37 Zcrb1 -180.64
Nxf1 -220.83 Sfrs3 -799.56
Eif2a -86.80 Mbnl1 -1,154.03
Paip2 -613.81 Tra2b -1,518.88
Calr -453.17 Cwc15 -97.20
Zfp36l2 -218.64 Rbm39 -314.06
Cugbp1 -497.66 Syncrip -62.83
Zfp36 -544.71 Hnrnpa2b1 -178.71
Nono -347.61 Cherp -131.05
Hnrnpk -5,402.07 Sfrs2 -44.78
Cugbp2 -82.29 Sfrs7 -48.72
Rbm3 -428.55 Srrm1 -33.19
Ddx5 -622.74 Sf3b4 -23.15
Zfp36l1 -1,766.51 Hnrnpc -1,110.43
Magoh -52.92 Khdrbs1 -134.52
Ddx19a -24.63
Table 2:  Transcripts decreasing in abundance between UI-SCs and 12h-SCs that were 
annotated as molecular function: RNA binding; Biological Process: RNA turnover, 
translation or splicing.  
Blue: positive regulators; Red: negative regulators; Green: proteins involved in splicing; Black: 
ambiguous/unknown.  False discovery rate (FDR) <0.05 and a p-value<0.01 was used to 
determine signi!cance of change between uninjured satellite cells and 12 post-injury.
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To visualize the overall trends of each category, I graphed the diﬀerence of each transcript, 
color coded to indicate the assigned category (Fig. 4).  ere are two major diﬀerences between 
increasing and decreasing post-translational regulators, 1) while I identi!ed 42 diﬀerent known 
post-transcriptional regulators decreasing in abundance, I only identi!ed 16 that increased, and 
2) the median of increasing transcripts is a relative expression value of 12.01 versus -219.7 for 
transcripts decreasing.  e diﬀerence in magnitude of change between expression in uninjured 
satellite cells and satellite cells 12h post-injury underscores the importance of this switch in post-




























































































































































Figure 4:  Post-transcriptional regulators decreasing in abundance.
Graph of post-transcriptional regulators decreasing in abundance upon satellite cell activation.  
Cugbp1, Cugbp2, Zfp36, Zfp36l1, Zfp36l2, and Mbnl1 (columns with grey outlines) are 



















































































Figure 4 (continued):  Post-transcriptional regulators increasing in abundance.
Elavl1 is discussed further in the text.
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My analysis shows that several known post-transcriptional regulators of myogenic 
transcripts are diﬀerentially regulated upon activation.  For example, the AU-Rich element 
binding proteins, Cugbp1(-497.7), Cugbp2 (-82.3), and Elavl1 (protein known as HuR) (+12.6).  
Recently, knockdown of Cugbp1 in C2C12 myoblasts resulted in stabilization of MyoD mRNA 
and it appears that Cugbp1 binds to MyoD mRNA via a GU-Rich element (GRE) (Lee, 2010).  
HuR binds and stabilizes MyoD mRNA 99,100, thus it appears that these two proteins may 
antagonize each other during MyoD mRNA regulation.  Several transcripts are regulated by HuR 
in conjunction with one or more proteins that in(uence mRNA turnover and/or negatively 
regulate translation (Pautz, 2010; Sureban, 2007; Mazan-Mamczarz K, 2007; Linker, 2005; Briata, 
2003).  Whether HuR and other RNA-BPs bind together or compete for binding to any given 
3‘UTR is less understood and likely sequence speci!c.
ree Tristetraprolin family members (TTP (Zfp36), Brf1 (Zfp36l1), and Brf2 (Zfp356l2)) 
signi!cantly decrease between wild type uninjured satellite cells and satellite cells 12h post-injury 
but do not change in expression between uninjured Sdc4-/- satellite cells and Sdc4-/- satellite cells 
12h post-injury (Fig. 5).  Tristetraprolin (TTP) is currently the most well studied ARE-BP and has 
been shown to regulate the stability of several transcripts involved in innate immunity 115.  TTP 
binds to AU-rich elements within the 3‘UTR of target transcripts and recruits mRNA decay 
enzymes to the transcript 116.  Activated-p38α/β signaling results in phosphorylation of TTP 117.  
is results in TTP association with 14:3:3 proteins blocking its ability to recruit deadenylases 
which results in stabilization of the target transcripts 118,119.
ese data support a model of post-transcriptional regulation of gene expression, 
including mRNA turnover and translation, as a mechanism of satellite cell maintenance of 
quiescence and/or suppression of activation.
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 Identi!cation of p38α/β Target Transcripts
Activated p38α/β MAPKs are detected within minutes of muscle injury 61.  Furthermore, 
p38α/β signaling is required for satellite cell activation, commitment to the myogenic lineage, and 
entry into the cell cycle, making p38α/β activation a critical molecular switch from quiescence to 
activation 61.  To identify p38α/β targets within the WT-S4 gene list: subset RNA binding, I 
entered these transcripts into Ingenuity Pathway Analysis (IPA) soware, a bioinformatics 
program used to make connections between complex biological pathways.  I queried the dataset 
for all known direct p38α/β targets.  TTP was identi!ed along with Brf1, which function is also 
inhibited by p38α/β MAPK signaling 94.  In addition, peroxisome proliferator-activated receptor 
gamma, coactivator 1 α (PPARGC1A or PCG-1α), ribosomal protein L22 (RPL22), and splicing 
factor, arginine/serine-rich 5 (SFRS5) were identi!ed within the WT-S4 gene list: subset RNA 
binding.  I decided to investigate whether the TTP family regulates satellite cell activation because 
1) in human cells, TTP regulates HuR mRNA stability, a known regulator of myogenic 
transcripts, 2) HuR (Elavl1) and the TTP family (Zfp36, Zfp36l1 and Zfp36l2) of transcripts are 
diﬀerentially regulated in the WT-S4 gene list, and 4) p38α/β MAPK signaling inhibits TTP and 






Figure 5:  Transcripts encoding the TTP family (Zfp36) signi!cantly decrease in wild type 
satellite cells 12h post injury while no change was observed in Sdc4-/- satellite cells aer 
12h of muscle injury.
Heat maps depicting gene expression change between uninjured satellite cells and satellite 
cells 12h post-injury in both wild type and Syndecan-4 null cells.
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targeted by the TTP protein family for AU-rich mediated decay.  Upon muscle injury, p38α/β 
MAPK signaling would inhibit TTP function and with a concurrent increase in HuR, “activation” 
transcripts may be rapidly stabilized. 
Con!rmation of Select Transcripts
I wanted to con!rm the changes in transcript abundance between uninjured satellite cells 
and satellite cells 12h post injury.  Consistent with the microarray data, expression of Zfp36, 
Zfp36l1, and Zfp36l2 all decreased, and Elavl1 increased in abundance between uninjured 
satellite cells and satellite cells 12 post-injury (Fig.6). 
Microarray Data Mining with the ARE-Database
Knockout of TTP in mice results in early on-set arthritis, cachexia, and chronic 
in(ammation 115; thus, identifying targets of ARE-BPs may provide insights into these and other 
debilitating human diseases.  TTP and other RNA-Binding proteins bind to AU-rich elements 
within the 3‘UTR of target mRNA, and these sequences are thought to confer regulation of the 
stability of the transcript 120.  It is thought that between 5-8% of human mRNAs contain AU-rich 
sequences with the 3‘UTR.  e Human ARE-database (ARED) was developed as a 
bioinformatics search engine to identify novel genes which contain AU-rich elements (AREs) 111.  





























Figure 6:  Expression of the Zfp36 family and Elavl1 are diﬀerentially regulated. 
Satellite cells were puri!ed by FACS and expression of Zfp36, Zfp36l1, and Zfp36l2 were 
detected by QT-PCR using primers directed to the Exon1/2 junction of each corresponding 
transcript.  e transcript abundance was estimated using the delta-delta Ct method.
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e ARED groups AU-rich sequences into !ve clusters.  Clusters 1-4 contain (AUUUA)5, 
(AUUUA)4, (AUUUA)3, and (AUUUA)2 consecutive pentameric sequences, respectively.  Cluster 
5 contains one AUUUA within an AU-rich context 111.  To identify transcripts that could be post-
transcriptionally regulated by RNA-binding proteins during satellite cell activation, we entered 
the WT-S4 gene list into the ARE Database.  e ARE Database identi!ed, TTP (Zfp36) and the 
TTP family members (Zfp36l1 and Zfp36l2) as containing AU-rich elements with their 3‘UTRs.  
(Table 3). is is consistent with the fact that TTP has been shown to bind and regulate its own 
mRNA via an AU-rich element within its 3‘UTR 93,121.    
Select ARE containing genes










zinc !nger protein 36 -544.71 Cluster 5
zinc !nger protein 36, C3H type-like 1 -1,766.51 Cluster 4
zinc !nger protein 36, C3H type-like 2 -218.64 Cluster 5
Table 3:  ARE-BP Genes Identi!ed as containing AREs by the ARE database
Myogenic/Satellite Cell Transcripts with AU-rich Elements
Since p38α/β signaling antagonizes TTP-mediated mRNA decay 121 and we observe TTP 
mRNA decreasing by 12h post-injury, I expected putative TTP target transcripts to increase in 
abundance in satellite cells 12h post injury versus uninjured satellite cells.  Several ARE-
containing transcripts were identi!ed for the WT-S4 gene list.  Interestingly, many identi!ed 
ARE-containing transcripts had previously been shown to be involved in muscle or myogenesis 
(Table 4).  
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embryonic lethal abnormal vision-like 1 12.63 Cluster 2
myocyte enhancer factor 2A 14.77 Cluster 5
T-cell lymphoma invasion and metastasis 1 5.59 Cluster 5
inhibitor of DNA binding 2 -638.65 Cluster 5
*Elavl1 - found using ARED 3.0, current ARED Organism does not identify Elavl1 as containing an AU-rich element.
Table 4: Myogenic genes or genes implicated in satellite cell biogenesis that contain AU-rich 
elements as determined by ARE Database.
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Discussion
I sought to characterize the global transcriptional changes by microarray analysis that 
occur when satellite cells transition from quiescence to an activated, committed myoblast.  Based 
on these data, it appears that regulation of mRNA turnover and translation suppresses activation 
in quiescent satellite cells.  is conclusion is based on the following observations: 1) transcripts 
with GO term: RNA binding are over-represented within genes changing in wild type satellite 
cells and over half of these transcripts decrease in abundance; 2) the magnitude of change and 
number of negative regulators of mRNA turnover and translation that decrease compared to 
those that increase in abundance; 3) positive post-transcriptional regulators of myogenic 
transcripts increase while negative post-transcriptional regulators of myogenic transcripts 
decrease; 4) all known members of the TTP family of ARE-BPs are decreasing in abundance 
which are antagonized by p38α/β MAPK signaling, eﬀectively “shutting oﬀ” mRNA decay 
mediated by these proteins.  Post-transcriptional regulation of mRNA during satellite cell 
activation, may be a mechanism where satellite cells could rapidly switch from a quiescent state to 
an activated state.  
Quiescence is generally regarded as a hypometabolic state 122 and quiescent satellite cells 
display morphological characteristics that are consistent with this idea 32.  However, we found that 
nearly half of all transcripts expressed by satellite cells from uninjured muscle signi!cantly 
decrease 12h post-injury.  is implies that uninjured satellite cells express several transcripts 
during quiescence that are no longer needed during muscle regeneration.  I found positive 
regulators of myogenesis increasing whereas several negative post-transcriptional regulators of 
myogenic mRNAs signi!cantly decrease aer 12h of injury.  us, it appears that myogenesis is 
actively suppressed in quiescent satellite cells.
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Several molecular events occur upon satellite cell activation that are necessary for normal 
muscle regeneration.  One of the earliest events is activation of p38α/β MAPK 61; which is 
required for MyoD induction and entry into the cell cycle 61.  Considering the transcripts that are 
diﬀerentially regulated, it appears that there is a switch between suppressors of MyoD, (Cugbp1 
123, Id2, and Id3 124 ) to positive post-transcriptional regulators of MyoD mRNA (HuR 99,100).  
Decreasing negative regulators of myogenesis represent a derepression of MyoD mRNA stability 
and MyoD transcriptional activity.  Cugbp1 is a known splicing regulator 125 but has just been 
found to bind to the 3‘UTR of MyoD mRNA and regulate its decay 123.  Inhibitor of DNA binding 
2 (Id2) binds and negatively regulates MyoD transcriptional activity by forming a dominant 
negative heterodimer with MyoD 124.  Id2 decreases in abundance in satellite cells 12h post-injury, 
implying that quiescent satellite cells may produce Id2 protein in order to inhibit any MyoD 
protein if it were to be made.  Another Id protein which negatively regulates MyoD 
transcriptional activity is Id3 124.  Transcripts encoding Id3 decreased in as wild type satellite cells 
activated but did not change in Sdc4-/- satellite cells 12h post injury.  us, MyoD appears to be 
suppressed in quiescent satellite cells by destabilzing MyoD mRNA and inhibiting MyoD 
transcriptional activity. 
Increased positive post-transcriptional regulators, such as HuR, may stabilize target 
transcripts required for satellite cell activation and commitment to myogenesis.  Regulation of 
myogenesis in vitro by HuR has been well established.  HuR binds and stabilizes several myogenic 
transcripts, including MyoD, Myogenin, and p21 during C2C12 diﬀerentiation 99,100.  Knockdown 
of HuR inhibits C2C12 diﬀerentiation; whereas, over-expression of HuR accelerates C2C12 
diﬀerentiation 99,100.  HuR positively in(uences C2C12 myoblast proliferation with Pitx2, by 
binding and stabilizing CyclinD1 mRNA.  Upon switching to diﬀerentiation conditions, HuR and 
Pitx2 dissociate from the mRNA resulting in CyclinD1 mRNA decay and cell cycle exit (Gherzi, 
2010).  us, HuR stabilizes target mRNA during proliferation and diﬀerentiation in C2C12s, two 
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mutually exclusive states, indicating that regulation of HuR targets is either in trans or through 
competition of cis-binding sites.  Currently, the regulation of HuR and its targets in satellite cells 
is poorly understood.
Transcripts that contain AU-rich elements and are represented in the WT-S4 gene list 
could represent additional targets of RNA-binding proteins which in(uence satellite cell 
activation and myogenic commitment.  I have identi!ed AU-rich containing transcripts using the 
ARE database and found several important genes known to regulate myogenesis (Table 4).  
Although not suﬃcient to drive myogenesis alone, myocyte enhancer factor 2A (Mef2a) 
transcriptionally regulates muscle-speci!c genes during development 126, adulthood 127 and 
potentially during regeneration 128.  p38 MAPKs regulate Mef2a by direct phosphorylation which 
increases its transcriptional activity 86.  Whether Mef2a mRNA turnover is post-transcriptionally 
regulated to ensure proper transcriptional induction of myogenic genes, remains uncharacterized. 
Another AU-rich containing transcript identi!ed though the ARE Database was Tiam1 (Table 4).  
(T-cell lymphoma invasion and metastasis 1 (Tiam1) in conjunction with the Par3 polarity 
complex regulates epithelial cell polarity 59 and growth factor directed migration 129.  Recently, we 
have shown that Tiam1 forms a complex with ParD3, thus Tiam1 may regulate satellite cell 
migration and asymmetric cell division (Olwin Lab, unpublished data).  Currently, post-
transcriptional regulation of Tiam1 mRNA turnover remains uncharacterized.
Together these data support a previously unappreciated role for post-transcriptional 




Satellite cells were isolated from Tibialis Anterior muscles that were either uninjured or 
12h post injury with 50ul of 1.2% BaCl to induce myonecrosis.  Satellite cells were puri!ed by 
FACS based on Syndecan-3 expression from at least three age matched wild type or Syndecan-4 
null mice as previously described 130.  Total RNA isolated using a PicoPure RNA Isolation Kit 
(Arcturus) was subjected to two rounds of linear T7-based ampli!cation (RiboAmp HA Kit, 
Arcturus).  Based on the number of cells collected, this resulted in an RNA equivalent of 5000 
Syndecan-3 positive cells.  Biotin-labeled cDNA was generated using an Aﬀymetrix IVT Labeling 
Kit.  Labeled cRNA was quanti!ed and analyzed for quality using BioAnalyzer (Agilent).  Labeled 
cRNA (5 µg) was fragmented and hybridized to Aﬀymetrix 430 v.2 mouse microarrays at the 
University of Colorado Core facilities.  Chips were scanned on a GeneChip Scanner 3000 
(Aﬀymetrix) and intensity data recovered in GCOS (Aﬀymetrix).  CEL !les from three replicate 
genechips were imported directly into Spot!re (TIBCO) and normalized by GCRMA.  Using a 
99% con!dence threshold (p-value ≤ 0.01), probe sets that changed in relative expression between 
Syndecan-4 uninjured satellite cells and Syndecan-4 satellite cells 12h post injury were subtracted 
from probe sets changing between wild type uninjured satellite cells and wild type satellite cells 
12h post injury.  is analysis resulted in the WT-S4 gene list.  Heat map arranged by 1) level of 
expression in wild type satellite cells from uninjured muscle and 2) directionality of change aer 
12h post muscle injury.  Gene ontology analysis was performed using Spot!re Ingenuity Pathway 
analysis. 
Spot!re analysis
Analysis of the microarray data was performed using Spot!re Soware.  A Robust Multi-
array Analysis (RMA) normalization across all of the microarray chips was performed.  Spot!re 
performed a “scale” normalization between all of the arrays in order to equalize the median.
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Statistical Analysis
Diﬀerences in gene expression over time and genotype were statistically analyzed by 2-
way analysis of variance (Anova).  e gene was considered expressed if the normalized log2 
expression value was greater or equal to 2.0 and genes were considered for further analysis if a 
greater than 2 fold-change in relative expression between time points was calculated.  Both of 
these assumptions were applied to wild type and Sdc4-/- data sets.  Transcripts signi!cantly 
changing were de!ned using a 99% con!dence threshold (p-value ≤ 0.01) when comparing the 
diﬀerence between wild type uninjured satellite cells versus wild type satellite cell 12h post-injury.  
From this list, genes that signi!cantly changed between Sdc4-/- uninjured satellite cells versus 
Sdc4-/- satellite cells 12h post-injury (p-value ≤ 0.01) were subtracted from the wild type gene list.  
e !nal list of genes is referred to as the WT-S4 gene list (Appendix Table 1).
Quantitative RT-PCR
Quantitative-PCR primers were designed against the !rst exon/exon junction for the 
following transcripts, Zfp36 (TTP), Zfp36l1 (Brf1), Zfp36l2 (Brf2), and Elavl1 (HuR). e fold 
diﬀerence was calculated as:  2*(-(deltaCt(12h)-deltaCt(UI)) normalized to GAPDH.  Primer 
sequences:  Elavl1 Exon1/2; (FOR: 5’ GCTTATTCGGGATAAAGTAGCAGGA; REV: 5' 
TTCACAAAACCGTAGCCCAAG).  Zfp36 Exon1/2; (FOR: 5’ GCCATCTACGAGAGCCTCCA; 
REV: 5’ CGTGGTCGGATGACAGGTC). Zfp36l1 Exon1/2; (FOR: 
5‘CGAAGTTTTATGCAAGGGTAA; REV: 5’ GCGCTGGGAGTGCTGTAGTT).  Zfp36l2 
Exon1/2; (FOR 5‘CGACCACACTTCTGTCACCCT; REV 5‘GGATTTCTCCGTCTTGCACAA).  
36




Skeletal muscle is dynamic and able to respond rapidly to a multitude of diﬀerent physical 
and chemical stresses 104.  Resident muscle stem cells called satellite cells are responsible for adult 
muscle growth and repair 7.  Satellite cells are typically quiescent and are able to remain 
mitotically quiescent for years 5,32.  Quiescent satellite cells have minimal cytoplasm, condensed 
chromatin, and few ribosomes 32,131.  When muscle requires repair, extracellular stimuli, such as 
HGF, FGF and/or TNF-α activate satellite cells to exit from G0 56-58,132.  Activated satellite cells 
begin to express the muscle speci!c transcription factor, MyoD and form a proliferating myoblast 
population61,75.  Upon diﬀerentiation, myoblasts begin to express Myogenin, a muscle speci!c 
transcription factor required for myogenic diﬀerentiation 133.  Fully regenerated muscle contains 
similar numbers of quiescent satellite cells as uninjured muscle and appears phenotypically 
normal.  e mechanisms governing activation of satellite cells are poorly understood.
e earliest known molecular markers of activated satellite cells are activated p38α/β 
MAPKs which occurs within minutes of muscle injury 61.  Rapid activation of p38α/β MAPKs act 
as molecular switches to activate quiescent satellite cells 61.  If p38α/β MAPK signaling is blocked 
satellite cells fail to express MyoD and fail to enter the cell-cycle 61.  MyoD expression is critical 
for normal muscle regeneration 68.  MyoD expression commits satellite cells to myogenesis and 
facilitates S-phase entry by regulating the licensing of origins of replication 75.  Although MyoD 
expression is required upon satellite cell activation, aberrant MyoD activity in quiescent satellite 
cells may cause precocious diﬀerentiation and stem cell loss since forced MyoD expression is 
suﬃcient to induce the complete myogenic transcriptional program 134.  e mechanistic 
relationship between p38α/β MAPK signaling and MyoD induction during satellite cell activation 
has not been explored.  
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Syndecan-4 is a heparan sulfate proteoglycan expressed on the surface of satellite cells 
which facilitates p38α/β MAPK activation and MyoD induction in satellite cells 53,54.  Following 
muscle injury, Sdc4-/- satellite cells delay p38α/β MAPK activation and fail to commit to 
myogenesis or divide in the !rst 48h following isolation 54.  We compared gene expression pro!les 
of wild type satellite cells to Sdc4-/- satellite cells FACS isolated from uninjured muscle and 
muscle 12h post injury .  We subtracted gene expression changes occurring in Sdc4-/- satellite 
cells from gene expression changes occurring in wild type satellite cells over the initial 12h post 
muscle injury.  Approximately half of transcripts expressed in satellite cells from uninjured 
muscle decreased 12h post injury.  Many decreasing transcripts encode proteins that target 
mRNA for decay, suggesting a role for post-transcriptional gene regulation in satellite cell 
activation.  We show that one of these RNA-binding proteins, Tristetraprolin (TTP) encoded by 
the Zfp36 gene, can suppress myogenesis.  
In macrophages, TTP binds and destabilizes pro-in(ammatory cytokine mRNAs via AU-
rich elements within the 3‘UTR of target transcripts targets 135.  TTP is rapidly inhibited upon 
activation of the p38α/β MAPK pathway resulting in the induction of cytokine expression.  In 
macrophages, this mechanism quickly translates extracellular stimuli into robust changes in gene 
expression.  In satellite cells, p38α/β MAPK inhibition of TTP may play a similar role in relaying 
muscle injury signals, rapidly changing gene expression through the regulation of mRNA stability. 
Here, we show that p38α/β MAPK regulation of MyoD mRNA stability plays a previously 
unappreciated key role in the activation of satellite cells.  We show that the MyoD 3‘UTR is 
directly destabilized by TTP.  Further, a mutant of TTP that constitutively decays target mRNAs is 
dominant over a known stabilizer of MyoD mRNA, the RNA-binding protein, HuR99,100.  Upon 
activation of p38α/β MAPKs, TTP-mediated destabilization of MyoD mRNA is blocked in a 
manner dependent upon phosphorylation of TTP.  Our data suggests that activated-p38α/β 
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MAPK inhibition of TTP increases MyoD mRNA stability rapidly switching quiescent satellite 
cells to activated myoblasts.
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Results
Transcripts Encoding “RNA-Binding” Proteins Decrease Upon Satellite Cell Activation 
Satellite cells are typically quiescent and can remain quiescent for years in humans 5.  
Upon injury, satellite cells rapidly activate, commit to myogenesis, and repair the muscle tissue.  
We performed an Aﬀymetrix gene chip experiment to better understand the global gene 
expression changes occurring as quiescent satellite cells switch to activated proliferating 
myoblasts.  e gene expression pro!les of satellite cells enriched by FACS from uninjured muscle 
were compared to satellite cells isolated from muscle 12h post-injury.  Genes changing in wild 
type and mutant Syndecan-4 (Sdc4-/-) null satellite cells over the !rst 12h post muscle injury were 
compared.  Sdc4-/- satellite cells are severely delayed in activation, MyoD expression, cell cycle 
entry, and are unable to repair muscle 54.  To identify genes regulating the switch to an activated 
satellite cell, we subtracted genes changing in wild type satellite cells that also changed in Sdc4-/- 
satellite cells 12h post injury (Fig. 1A). e list of unique wild type genes will be referred to as the 
“WT-S4 gene list” (Appendix Table 1). 
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Figure 1: Transcripts Encoding RNA Binding Proteins are Diﬀerentially Regulated During 
Satellite Cell Activation. 
A.  Illustrative depiction of the WT-S4 gene list where transcripts changing from uninjured to 12h 
post injury in activation-de!cient Syndecan-4 null were subtracted from genes changing in wild 
type satellite cells from uninjured to 12h post injury.  B. Out of 4093 genes represented in the 
WT-S4 gene list, 1915 genes decrease (47%).  Green denotes lower level of relative expression 
while red denotes higher level of expression.  C. Heat map depicting transcripts !ltered from the 
WT-S4 gene list with the Molecular Function GO term: RNA binding.  Over half of transcripts 
with GO term: RNA binding decrease upon satellite cell activation but do not change in Sdc4 null 
satellite cells. Total “RNA Binding” genes: 152; Decreased: 107 (70%), p-value=8.73e-05.  D. 
Elavl1 probe sets encoding HuR signi!cantly increase in wild type satellite cells but do not change 
in abundance in Sdc4 null satellite cells 12h post injury.  E. HuR mRNA increases as satellite cells 
activate in culture.  F.  Zfp36 probe sets encoding TTP signi!cantly decrease in wild type satellite 
cells while no change was observed in Sdc4 null satellite cells 12h post injury.  G. TTP mRNA 
expression decreases as wild type satellite activate in vitro.  Graphs represent average +/- standard 













































































Satellite cells exit quiescence and undergo cell growth and organelle biogenesis 41-46; thus, 
we expected mostly an increase in transcript abundance 12h following muscle injury.  
Unexpectedly, we observed that 47% of probe sets in the WT-S4 gene list decreased as satellite 
cells activated (Fig. 1B).  To determine the types of genes represented within our gene list, we 
further examined the WT-S4 gene list for gene ontology (GO) terms with signi!cant enrichment.  
Probe sets annotated as “nucleic acid binding: RNA binding,” were signi!cantly over-represented 
in the WT-S4 gene list (Fig. 1C).  One of the transcripts encoding an “RNA binding”protein 
increasing in abundance 12h post-injury was Elavl1, which encodes HuR (Fig. 1D).  HuR has 
been shown to positively regulate the stability of myogenic transcripts, including MyoD mRNA 
99,100.  Since upon injury, MyoD is rapidly induced in satellite cells, HuR may stabilize MyoD 
mRNA during satellite cell activation.  To verify the microarray data, quantitative PCR analysis of 
HuR mRNA in satellite cells indicated that HuR mRNA begins to increase aer 4h in culture (Fig. 
1E).  Aer 12h in culture, we detect a 3-fold increase in HuR mRNA.  ese data are consistent 
with a role for HuR in the stabilization of MyoD transcripts upon satellite cell activation.
e gene ontology term “RNA binding” includes the genes encoding translational 
machinery.  Since quiescent satellite cells drastically increase protein synthesis upon activation 
42-45, we expected most transcripts encoding “RNA binding” proteins to increase upon satellite cell 
activation; however, we observed that 70% of genes encoding “RNA binding” proteins 
represented in the WT-S4 gene list signi!cantly decreased 12h post-injury.  We observed that 
some decreasing transcripts encoded proteins known to destabilize mRNA, thus we hypothesized 
that this may represent a derepression of genes required for satellite cell activation.  One such 
decreasing “RNA binding” gene was Zfp36, which encodes Tristetraprolin (TTP) (Fig 1F.).  
Additionally, the two TTP family members, Zfp36L1 and Zfp36L2, which encode Brf1 and Brf2, 
respectively, also decreased upon satellite cell activation (Fig. 1H and I).  Previously, TTP was 
identi!ed in a screen for genes that may regulate satellite cell activation 109.  TTP recruits decay 
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enzymes to mRNAs that contain AU-rich sequences in their 3‘UTRs 116,119 and may repress 
mRNAs that are required for satellite cell activation.  Quantitative PCR analysis of satellite cell 
mRNA showed that 2h aer culture, TTP mRNA decreased 10-fold in abundance when 
compared to freshly isolated satellite cells (Fig. 1G).  Quantitative PCR showed that Brf1 and Brf2 
mRNAs also decreased as satellite cells activated (Fig 1J and K). 
In conjunction with decreased TTP mRNA abundance, TTP function may also be rapidly 
inhibited upon muscle injury.  Previously, we have shown that p38α/β MAPK signaling is 
required for satellite cells to commitment to myogenesis and occurs within minutes of muscle 
injury 61 and TTP-mediated mRNA decay is inhibited by p38α/β MAPK signaling 136.  We 
postulated that TTP-mediated mRNA decay suppresses myogenesis in quiescent satellite cells and 
Figure 1 (cont.): Transcripts Encoding the RNA Binding Proteins Brf1 and Brf2 Decrease 
During Satellite Cell Activation.
H. and I.  Zfp36L1 and Zfp36L2 probe sets encoding Brf1 and Brf2, respectively, signi!cantly 
decrease in wild type satellite cells while no change was observed in Sdc4 null satellite cells 12h 
post injury.  J. and K. Brf1 and Brf2 mRNA expression decreases as wild type satellite activate in 




























































that upon muscle injury p38α/β MAPK signaling rapidly inhibits TTP resulting in increased 
myogenic transcript stability.
siRNA Knockdown of TTP Induces Myogenesis
Following muscle injury, commitment of activated satellite cells to myogenesis may 
require p38α/β MAPK inhibition of TTP-mediated mRNA decay.  To test whether TTP 
suppresses myogenesis, we knocked-down the Zfp36 family members, TTP, Brf1 and Brf2 
(denoted TTPmix) with siRNAs in C2C12 myoblasts.  We targeted these three Zfp36 members 
with siRNAs since they all possess the CCCH Zinc Finger RNA binding motif and may target 
common transcripts 115.  To test the eﬃcacy of TTP knock-down, C2C12 myoblasts were co-
transfected with myc-tagged TTP and either control siRNA or TTPmix siRNAs and were 
analyzed by western blotting for anti-myc.  We observed approximately 50% knockdown of myc-
tagged TTP when co-transfected with TTPmix siRNAs (Fig. 2A).  e Brf1 and Brf2 siRNAs have 
been functionally tested using pulse-chase decay assays 137.
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C2C12 myoblasts were co-transfected with TTPmix siRNA or negative control siRNA 
along with eGFP to serve as a transfection marker.  Following FACS enrichment for live eGFP+ 
siRNA transfected C2C12s (Fig. 2B-E), the cells were analyzed by western blotting.  TTPmix 
siRNA transfection resulted in an approximate 2.7-fold increase in MyoD protein when compared 
to control siRNA transfected cells (Fig. 3A).  Typically MyoD induction in C2C12 myoblasts 
results in increased Myogenin expression which drives the cells to diﬀerentiate 138.  us, we 
tested whether the increase in MyoD observed in TTPmix siRNA transfected cells was suﬃcient 
to induce Myogenin in C2C12 myoblasts.  Nearly 10-fold more C2C12 myoblasts expressed 
Myogenin while in proliferation conditions when transfected with TTPmix siRNA compared to 
control siRNA transfected cells (Fig. 3B and C).  is result was recapitulated in the MM14 






































































Figure 2:  TTPmix siRNA knockdown
A.  Proliferating C2C12 myoblasts were transfected with either empty vector or myc-tagged TTP 
(Lanes 2-5) and control siRNA (lanes 1,2) or TTPmix siRNA (lane 3) B.-D.  FACS isolation of 
eGFP transfected cells either co-transfected with control siRNAs or 2.5ug TTPmix siRNAs.  B.  
Cells were harvested by trypsin digestion and stained with Vybrant DyeCycle™  Vital Dye to 
detect viable cells.  C.  Untransfected control cells showing background (uorescence.  D.  Cells 
transfected with negative control siRNA and eGFP; 12.63% sorted as identi!ed eGFP positive.  E.  
Cells transfected with TTPmix siRNA and eGFP; 22.13% sorted as identi!ed eGFP positive.
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of Myogenin expressing MM14 cells under proliferation conditions (Fig. 3C).  ese data are 




















































Figure 2:  TTP Suppresses Myogenic Diﬀerentiation
A.  Transfection of TTPmix siRNAs Increases MyoD Expression by ~3-Fold.  Proliferating C2C12 
myoblasts were transfected with either 2.5µg control siRNAs (Qiagen All-Star Negative control) 
or 2.5µg TTPmix which consisted of an equal mix of siRNAs against TTP, Brf1, and Brf2.  
Transfected cells were cultured for an additional 36h in proliferation conditions (15% horse 
serum).  Transfected eGFP(+), DAPI(-) cells were enriched by FACS.  MyoD signal intensities 
were normalized to α-Tubulin and eGFP as loading and transfection controls, respectively.  
Control siRNA normalized MyoD intensity was set to 100% and TTPmix siRNA normalized 
MyoD intensity fold-increase was calculated with respect to control siRNA.  B-C. Transfection of 
TTPmix siRNA induces diﬀerentiation in proliferation conditions.  B and C. Proliferating C2C12 
and C. MM14 myoblasts were transfected with either 2.5µg control siRNA or 2.5µg TTPmix 
siRNA and cultured for an additional 36h in proliferation media.  Cells were stained for 
myogenin (red) to detect diﬀerentiating cells, anti-GFP (green) to detect transfected cells and 
DAPI (blue).  Average +/- Std Dev plotted for 3 independent experiments.  *Student’s 2-tailed t-
test; p-value<0.01.  D.  TTP is very low or undetectable in Syndecan-4 positive satellite cells in 
perfused resting muscle.  4% paraformaldehyde was perfused throughout the mouse in order to 
preserve quiescent satellite cells and stained for TTP (red), Syndecan-4 (green) and Laminin 
(white) to identify sub-laminar satellite cells and DAPI to mark nuclei (blue).  Carets denote sub-
laminar Syndecan-4 positive satellite cells.  E.  e majority of TTP protein appears cytoplasmic 
in Syndecan-4 (S4) positive satellite cells in freshly isolated uninjured muscle.  Fixed muscle 
tissue was stained as in D.  Carets denote sub-laminar Syndecan-4 positive satellite cells.  White 
scale bars = 25 µm.
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TTP is Detected in Satellite Cells
Active TTP (unphosphorylated) is unstable making active TTP protein diﬃcult to detect 
97,139.  Conversely, p38α/β-mediated phosphorylation of TTP increases its protein stability 
resulting in a rapid increase in TTP 139.  To study quiescent satellite cells in resting muscle, we 
perfused a mouse with 4% PFA to !x the tissue in situ.  Under these conditions, TTP was either 
undetectable or very low in satellite cells (Fig. 3D) and thus, quiescent satellite cells may have 
active TTP (unphosphorylated).  Dissection of the muscle activates p38α/β MAPKs in satellite 
cells prior to !xation 61 and this may result in TTP phosphorylation and stabilization.  We 
detected a greater intensity of TTP staining in most satellite cells from freshly isolated muscle 
when compared to perfused muscle (Fig. 3E).  ese data are consistent with the idea that TTP is 
stabilized by p38α/β MAPK signaling upon satellite cell activation.
p38α/β MAPKs phosphorylates TTP and regulates HuR expression in Satellite Cells
Muscle injury rapidly activates p38α/β MAPKs 61 but targets of p38α/β MAPKs in 
activated satellite cells have not been characterized.  Both HuR and TTP are known targets of 
p38α/β MAPK signaling in other systems 103,117.  To test whether p38α/β MAPK signaling 
regulates TTP and HuR in satellite cells, we inhibited p38α/β MAPK signaling in freshly isolated 
satellite cells.  Since muscle dissection activates p38α/β MAPKs 61; we developed a method to 
inhibit p38α/β MAPK signaling prior to muscle dissection (Fig. 4A).  By injecting mice 
intraperitoneal (i.p.) with a p38α/β MAPK inhibitor one hour prior to dissection, we signi!cantly 
reduced p38α/β MAPK-mediated phosphorylation of TTP and HuR protein induction while the 
staining intensity of the satellite cell marker, Syndecan-4, did not diﬀer in from the control 
condition (Fig 4 B-D).  Additionally. we signi!cantly reduced phosphorylated-MK2 staining, a 
direct downstream target of p38α/β MAPKS, in satellite cells (Fig. 4E).  As a positive control, 
Lipopolysaccharide stimulation of RAW264.7 macrophages resulted in increased phospho-TTP 







































Figure 4:  Inhibition of p38α/β MAPK reduces phosphorylation of TTP and HuR expression.
A.  Inhibition of p38α/β MAPK signaling in satellite cells prior and during isolation.  Satellite 
cells were isolated 1h following either an intraperitoneal injection of 15mg/kg SB203580 or 
DMSO control.  Dissected muscle tissue was placed immediately in media containing 25µM 
SB203580 or DMSO, and remained in inhibitor or control for the remainder of the procedure.  
Upon isolation of a single cell suspension, cells were dried down onto coverslips and immediately 
!xed with 4% paraformaldehyde.  B. and C. Cells were stained with phospho-TTP (Red), HuR 
(white), Syndecan-4 (Green) and DAPI (Blue).  D. Mean (uorescence intensity was measured 
using Slidebook soware.  Student’s two-tailed t-test: phos-TTP and HuR; p-value<0.001.  
Average +/- SEM; N=4 independent experiments.  White scale bars = 25 µm.
49
Mutant TTP Blocks Satellite Cell Myogenic Commitment
p38α/β MAPK-mediated phosphorylation and inhibition of TTP may result in HuR 
induction which would stabilize MyoD mRNA committing the satellite cell to myogenesis. 
Activated-p38α/β acts through the downstream kinase, MAP kinase-activated protein kinase 2 
(MK2) which directly phosphorylates TTP to inhibit its function 139-141.  We blocked p38α/β-
mediated TTP inhibition during satellite cell activation by transfecting satellite cells with a 
constitutively active TTP mutant.  Substitution of S52 and S178 residues with alanine results in a 
constitutively active TTP mutant 140.  TTPS52AS178A (TTP-AA-myc) binds TTP target transcripts 
and recruits mRNA decay factors resulting in target instability 119,140.  TTP-AA-myc is not 
inhibited by p38α/β-activated MK2 signaling 140.  Satellite cells on associated myo!bers were 
transfected with either control (pcDNA3.1) or pcDNA3-TTP-AA-myc and cultured for an 
additional 24h.  e majority of control transfected satellite cells express MyoD protein aer 30h 
in culture (Fig. 5A); however, over-expression of TTP-AA-myc blocks MyoD expression in a 
signi!cant subset of transfected satellite cells (Fig. 5B and C).  e dotted line denotes the 
expected percentage of MyoD positive satellite cells at the time of transfection (20% MyoD(+) 
Figure 4 (cont.):  Inhibition of p38α/β MAPK decreases phospho-MK2 positive satellite cells 
but LPS stimulation increases phospho-TTP intensity in macrophages.
E.  Percentage of phosphorylated MK2 satellite cells.  TA muscle was harvested 30min following 
BaCl2 injury from either control of SB203580 injected mice.  F. RAW 264.7 macrophages 
stimulated with LPS for 2h or unstimulated were stained with phosphorylated-TTP and DAPI.  
e average (uorescence intensity was calculated by drawing cell masks in Slidebook soware as 





























aer 6h culture) (Fig. 5C).  e required time to isolate myo!bers prior to transfection is a 
disadvantage of transfecting satellite cells associated with myo!bers; however, ex vivo !ber culture 
retains satellite cell-!ber association resulting and increased retention of satellite cell stem cell 
characteristics 57,142,143.  e ability of TTP-AA-myc to block MyoD expression is consistent with 
the idea that TTP suppresses myogenesis in satellite cells.  
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Figure 5:  Mutant TTP is suﬃcient to block MyoD induction in satellite cells
Satellite cells associated with myo!bers were transfected aer harvest (6h post muscle dissection) 
with eGFP as a transfection marker and either A. control plasmid (pcDNA3) or B. a plasmid 
expressing TTP-AA-myc.  Myo!bers were cultured for an additional 24h for a total of 30h in 
culture.  A. and B. Myo!bers were stained with Syndecan-4 (Red) to mark satellite cells, MyoD 
(white) to detect activated satellite cells, and DAPI (blue) to mark nuclei.  Transfected cells were 
identi!ed by expression of eGFP.  C. Average +/- SEM plotted for 3 independent experiments 
with all transfected satellite cells scored from at least 25 myo!bers per condition.  * Student’s 2-
tailed t-test; p-value<0.01.  D. and E.  TTP-AA-myc is insuﬃcient to block HuR protein 
induction.  Satellite cells associated with myo!bers were transfected aer harvest (6h post muscle 
dissection) with either D. pcDNA3 and CMV-LacZ or E. a plasmid expressing TTP-AA-myc.  
Myo!bers were cultured for an additional 24h for a total of 30h in culture.  D. and E. Myo!bers 
were stained with Syndecan-4 (Red) to mark satellite cells, HuR (white), DAPI (Blue) and either 
β-Gal (Green) or Myc-tag (Green) to mark transfected cells.  In two independent experiments, 
100% of control and 98.4% of TTP-AA-myc transfected satellite cells stain positive for HuR aer 
30h in culture.  White scale bars = 25 µm.  
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Mutant TTP is Not Suﬃcient to Block HuR Protein Induction
We observed that both phosphorylation of TTP and HuR protein induction were 
regulated by p38α/β MAPK signaling in primary satellite cells.  e ability of the p38α/β MAPK 
phosphorylation mutant, TTP-AA-myc, to inhibit MyoD expression may be through constitutive 
decay of HuR mRNA since TTP has been shown to destabilize HuR mRNA 144.  us, we tested 
whether TTP-AA-myc over-expression was suﬃcient to block HuR protein induction.  Satellite 
cells associated with myo!bers were transfected with either pcDNA3-LacZ (Fig. 5D) or TTP-AA-
myc (Fig. 5E) and stained for HuR aer an additional 24h in culture.  TTP-AA-myc transfection 
was not suﬃcient to block HuR protein expression (Fig. 5E).  us, it appears that the ability of 
TTP-AA-myc to block MyoD expression in satellite cells is dominant over the presumed ability of 
HuR to stabilize MyoD mRNA during satellite cell activation. 
TTP Binds and Regulates the MyoD 3‘UTR
Activated satellite cells rapidly commit to myogenesis by inducing MyoD expression.  e 
constitutively active TTP mutant, TTP-AA-myc is suﬃcient to block MyoD induction in primary 
satellite cells.  To address whether TTP could directly bind and regulate MyoD mRNA, the MyoD 
3‘UTR was searched for TTP binding sites.  e MyoD 3‘UTR contains a TTP binding sequence, 
UAUUUAU, that is highly conserved among mammals and is downstream of HuR binding sites 
(U-rich regions) (Fig. 6A).  e full length MyoD 3‘UTR was cloned into a Tet-Oﬀ β-Globin 
reporter construct (referred to as β-MyoD) and utilized in co-immunoprecipitation and pulse-
chase RNA decay assays to test whether TTP regulates MyoD mRNA.  Wild type Flag-tagged-
TTP eﬃciently co-immunoprecipitated β-MyoD when compared to a negative control β-globin 
reporter not bound by TTP (β-GAP) (Fig. 6B).  As an internal positive control, a portion of the 
3‘UTR sequence of Granulocyte Macrophage Colony Stimulating factor (GM-CSF), which is 
directly regulated by TTP was eﬃciently pulled-down by wild type Flag-tagged-TTP (Fig. 6B).  
Conversely, the RNA binding defective TTP mutant (TTPF126N ) was ineﬀective at pelleting β-
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MyoD mRNA or β-GM-CSF RNA (Fig. 6B).  An unrelated non-RNA binding protein, the MS2 
viral coat protein did not pull down β-GAP, β-MyoD nor β-GM-CSF (Fig. 6B).  Based on these 
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Figure 6:  TTP binds and regulates the 3‘UTR of MyoD
A.  Illustration of the 684bp MyoD 3‘UTR showing the putative TTP binding sequence.  
Upstream of the TTP binding sequence are U-rich HuR binding sites.  B.  TTP binds the MyoD 
3‘UTR.  Northern blots showing co-immunoprecipitation assays of reporter transcripts from 
HEK293T extracts.  Assays were performed using cells co-expressing FLAG-tagged wild type 
TTP (WT, lanes 1 and 4), an RNA binding mutant of TTP (F126N, lanes 2 and 5), or an 
unrelated non-RNA binding protein, (MS2, lanes 3 and 6) together with reporter β-globin 
mRNA containing the MyoD 3’UTR (β-MyoD) or the GM-CSF 3’ UTR (β-GM-CSF).  A β-
globin reporter with no putative TTP binding sites served as an internal negative control (β-
GAP).  Pellet (lanes 4-6) and 10% input (lanes 1-3) fractions were loaded as indicated above the 
panels.  C. and D. TTP regulates the MyoD 3‘UTR.  Tet-oﬀ Hela cells were transfected with 
pcTET2-β-MyoD and CMV-β-Globin, a tetracycline unresponsive loading and transfection 
control.  C. Northern blots showing pulse-chase mRNA decay assays.  Assays were performed 
with cells transfected with empty vector, TTP, or TTP and constitutively active MK2 (TTP+MK2-
EE).  D. Calculated half-life of β-MyoD.  Average + SEM plotted of 7 independent experiments.  
Student’s two-tailed t-test; * β-MyoD + TTP p-value<0.05; **β-MyoD + TTP + MK2EE p-
value<0.01.  
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TTP binds to target transcripts and mediates their decay.  Activated-p38α/β directly 
phosphorylates MAPKAP2 (MK2) which in turn phosphorylates TTP and inhibits its function 
140.  To test whether TTP regulates the stability of the MyoD3‘UTR, we performed pulse-chase 
RNA decay assays.  β-MyoD contains a Tetracycline responsive element (TRE) upstream of the 
promoter which in the absence of tetracycline is bound by a Tet-trans-activator (tTA) that drives 
transcription of the reporter construct.  Upon addition of tetracycline to the media, the tTA 
rapidly dissociates from the TRE causing the transcription to stop.  β-MyoD transcription was 
pulsed for 6h and shut-oﬀ by the addition of tetracycline to the media.  β-MyoD mRNA was 
chased for 6h, allowing for calculation of its half-life by northern blot probed for β-globin RNA 
(Fig. 6D).  TTP co-transfection results in a signi!cant decrease in β-MyoD mRNA stability (Fig. 
6E).  Whereas, inhibition of TTP function by co-transfection of a constitutively active mutant of 
MK2 (MK2-EE) results in a signi!cant increase in β-MyoD mRNA stability (Fig.6E).  ese data 




Activation of quiescent satellite cells and subsequent commitment to myogenesis are 
critical events for normal skeletal muscle regeneration 51,54,68,77.  Cellular quiescence is generally 
regarded as a low metabolic state 122 but surprisingly we observed a signi!cant portion of 
transcripts expressed by satellite cells from uninjured muscle decrease in activated satellite cells.  
Transcripts encoding RNA-binding proteins were signi!cantly over-represented and 70% of these 
transcripts decreased, consistent with a derepression of gene expression upon satellite cell 
activation.  Here, we present evidence that TTP destabilizes MyoD mRNA and that satellite cell 
activation is dependent upon p38α/β MAPK inhibition of TTP-mediated mRNA decay.  
Regulation of TTP mRNA
TTP mRNA increases in abundance and stability aer cell isolation, stimulation by 
growth factors, or cellular stresses 145,146.  ese data and our data are consistent with the idea that 
TTP function is high in quiescent satellite cells but the protein and mRNA levels are low.  
Activated-p38α/β MAPK Signaling Rapidly Phosphorylates TTP in Satellite Cells
Characterization of satellite cell activation has been diﬃcult considering that isolation of 
satellite cells inevitably results in their activation.  We have shown that p38α/β MAPK activation 
occurs rapidly within the !rst minutes following an injury and is currently the earliest marker of 
activated satellite cells 61.  Downstream p38α/β signaling is critical to satellite cell activation since 
inhibiting p38α/β MAPK signaling blocks MyoD expression and cell-cycle entry in primary 
satellite cells 61.  e downstream targets of p38α/β MAPK were previously unknown, now we 
have established TTP as a downstream target of activated-p38α/β MAPK signaling in satellite 
cells.  Since p38α/β is activated so rapidly in satellite cells, !xing the tissue in situ via whole mouse 
perfusion allows us to study quiescent satellite cells.  When muscle is !xed in situ, detection of 
TTP by immuno(uorescence in quiescent satellite cells is diﬃcult, which is consistent with TTP 
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levels in serum starved !broblasts and unstimulated macrophages, yet under these conditions it is 
well established that TTP is active and targeting transcripts for decay 93,147,148.  Due to the intrinsic 
complications of studying quiescent satellite cells, we developed a method to stall satellite cells 
early in the activation process by inhibiting p38α/β MAPK signaling prior to muscle dissection.  
Using this technique, we show that p38α/β MAPK signaling targets TTP for rapid 
phosphorylation in primary satellite cells.  We now consider both activated-p38α/β MAPKs and 
phospho-TTP to be markers of activated satellite cells. 
Distinct p38α/β MAPK Targets During Satellite Cell Activation vs. Myogenic 
Diﬀerentiation
Activated p38α/β MAPK signaling is required for both satellite cell activation and 
myogenic diﬀerentiation 61,84.  Here, we have established TTP as a downstream target of activated-
p38α/β MAPK signaling during satellite cell activation.  p38α/β has been shown to target another 
family member of RNA-binding proteins, KH-type Splicing Regulatory Protein (KSRP) during 
myogenic diﬀerentiation of C2C12 myoblasts 87.  Similarly to TTP, KSRP promotes decay of 
myogenic transcripts.  Upon p38α/β activation, KSRP becomes phosphorylated and dissociates 
from myogenic transcripts 87.  is is distinct from TTP, since TTP remains bound to target 
transcripts when phosphorylated although its mRNA decay function is inhibited 119.  We 
hypothesize that this diﬀerence may be signi!cant, as it is thought that phosphorylated-TTP 
which remains bound, protects target mRNAs from other RNA-binding proteins which mediate 
their decay 119.  In our array data using satellite cells, KSRP transcripts were not regulated in 
either wild type or Syndecan-4 null satellite cells 12h post injury.  us, p38α/β MAPKs may 
target TTP during satellite cell activation and KSRP during myogenic diﬀerentiation.
TTP Regulation of MyoD is Dominant over HuR-mediated MyoD mRNA Stability
It is thought that HuR expression is ubiquitous 149-151, but it appears that freshly isolated 
satellite cells express low levels of HuR and inhibition of p38α/β appears to inhibit HuR protein 
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expression.  Activated-p38α/β mediated induction of HuR may be due to a positive auto-
regulatory loop since p38 MAPK phosphorylates HuR which increases its cytoplasmic 
localization, resulting in increased target mRNA stability, which includes its own mRNA 103,144,152.  
Since HuR stabilizes MyoD and promotes cell-cycle entry in C2C12 myoblasts, in vivo it likely 
synergizes with phospho-TTP (inactive but stabilized) to promote MyoD mRNA stability.  is 
may complement transcriptional induction of MyoD to rapidly and infallibly commit satellite 
cells to myogenesis.  Nevertheless, TTP appears to be dominant over HuR-mediated MyoD 
mRNA stability, since constitutive TTP activity is able to block MyoD induction in the presence 
of HuR.  In satellite cells, activated-p38α/β mediated inhibition of TTP function appears required 
for MyoD expression.
TTP Directly Regulates the 3‘UTR of MyoD 
Constitutively active TTP blocks MyoD induction in a signi!cant portion of transfected 
satellite cells; however, this does not prove that TTP is directly involved in blocking MyoD 
protein induction.  However, we show that TTP directly binds and regulates the MyoD 3‘UTR; 
supporting a direct role for TTP in mediating MyoD protein induction.  Direct TTP-mediated 
decay of MyoD mRNA would connect extracellular signals that activate p38α/β MAPK and cell-
fate commitment in satellite cells.  Also, this would allow for tight regulation of MyoD expression 
downstream of the MyoD locus since MyoD directly activates its own promoter 153.  is level of 
regulation must be necessary as increased levels of MyoD drives myoblasts out of the cell-cycle 
resulting in terminal diﬀerentiation; whereas lower levels of MyoD allows myoblasts to proliferate 
154.  However, MyoD must be infallibly induced as quiescent satellite cells switch to proliferating 
myoblasts because MyoD expression is required for timely cell-cycle entry and induction of cdc6 
which is essential in licensing origins of DNA replication at the G1/S transition 75.  
Post-transcriptional regulation of MyoD mRNA stability in quiescent satellite cells may 
provide a mechanism for rapid commitment to the myogenic lineage upon activation.  e idea 
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that TTP regulates MyoD mRNA in quiescent satellite cells requires that MyoD mRNA be present 
in quiescent satellite cells.  We can envision two scenarios in which this may be achieved.  Firstly, 
quiescent satellite cells may express very low levels of MyoD mRNA which is rapidly subjected to 
AU-rich mediated decay by TTP and/or its homologs Brf1 and Brf2.  In the second scenario, 
MyoD mRNA is expressed by satellite cell progenitors, TTP binds the message but does not 
mediate decay and MyoD mRNA is stored and sequestered away from the translational 
machinery.  In human cells, TTP has been shown to stably store AU-rich containing mRNAs and 
sequester them away from the translational machinery when mRNA decay factors are limiting 137.  
Either of these scenarios are not mutually exclusive.  e second scenario requires that the MyoD 
locus be active in satellite cell progenitors.  By using Cre-mediated lineage tracing of the MyoD 
locus, satellite cell progenitors were shown to have activated the MyoD locus prior to entering 
quiescence 40.  If the MyoD locus was still active in quiescent satellite cells, Cre may be detected as 
it would not be subjected to AU-rich mediated decay.  Cre protein was not detected by 
immuno(uorescence in 90% of freshly isolated satellite cells.  However, we would expect that if 
the MyoD locus was active in quiescent satellite cells, it would be expressed at a very low level, 
possibly too low for Cre protein detection by immuno(uorescence.  Either mechanism would 
ensure that quiescent satellite cells rapidly activate and commit to the myogenic lineage upon 
receiving activation signals from the muscle.  Alternatively, if MyoD mRNA is not actively 
expressed or stored in quiescent satellite cells, once MyoD transcription was activated, 
phosphorylated-TTP may synergize with HuR resulting in stabilized MyoD mRNA.
Here, we provide the !rst in vivo evidence that post-transcriptional regulation of MyoD 
mRNA, a master regulatory transcription factor in muscle, is essential for satellite cell 
commitment to myogenesis.  is may be a general mechanism for stringent control of other 




Mice were bred and housed according to National Institutes of Health (NIH) guidelines 
for the ethical treatment of animals in a pathogen-free facility at the University of Colorado. 
Wild-type mice were C57Bl/6xDBA2 (B6D2F1; Jackson Labs); Syndecan-4 null mice are 
previously described 54.  Cells or myo!bers were harvested from female mice 3–6 months old.
Microarray Analysis
Satellite cells were isolated from Tibialis Anterior muscles that were either uninjured or 
12h post injury with 50ul of 1.2% BaCl to induce myonecrosis.  Satellite cells were puri!ed by 
FACS based on Syndecan-3 expression from at least three age matched wild type or Syndecan-4 
null mice as previously described 130.  Total RNA isolated using a PicoPure RNA Isolation Kit 
(Arcturus) was subjected to two rounds of linear T7-based ampli!cation (RiboAmp HA Kit, 
Arcturus).  Based on the number of cells collected, this resulted in an RNA equivalent of 5000 
Syndecan-3 positive cells.  Biotin-labeled cDNA was generated using an Aﬀymetrix IVT Labeling 
Kit.  Labeled cRNA was quanti!ed and analyzed for quality using BioAnalyzer (Agilent).  Labeled 
cRNA (5 mg) was fragmented and hybridized to Aﬀymetrix 430 v.2 mouse microarrays at the 
University of Colorado Core facilities.  Chips were scanned on a GeneChip Scanner 3000 
(Aﬀymetrix) and intensity data recovered in GCOS (Aﬀymetrix).  CEL !les from three replicate 
genechips were imported directly into Spot!re (TIBCO) and normalized by GCRMA.  Using a 
99% con!dence threshold (p-value ≤ 0.01), probe sets that changed in relative expression between 
Syndecan-4 uninjured satellite cells and Syndecan-4 satellite cells 12h post injury were subtracted 
from probe sets changing between wild type uninjured satellite cells and wild type satellite cells 
12h post injury.  is analysis resulted in the WT-S4 gene list (available upon request).  Heat map 
arranged by 1) level of expression in wild type satellite cells from uninjured muscle and 2) 
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directionality of change aer 12h post muscle injury.  Gene ontology analysis was performed 
using Spot!re Ingenuity Pathway analysis. 
QT-PCR Analysis
For in vitro activation, satellite cells were isolated from 5 wild type mice, pooled, and 
cultured for 0h (freshly isolated), 2h, 4h, 8h and 12h; 2 independent experiments.  Superscript III 
RT was used for reverse transcription of RNA into cDNA.  Fast SYBR Green™ master mix was 
used according to manufacture’s instructions to amplify target transcripts using primers spanning 
exon/exon junctions for Elavl1 and Zfp36.  18S rRNA was used as a reference gene and samples 
were analyzed in triplicate. Primer sequences:  Elavl1 Exon1/2; (FOR: 5’ 
GCTTATTCGGGATAAAGTAGCAGGA; REV: 5' TTCACAAAACCGTAGCCCAAG).  Zfp36 
Exon1/2; (FOR: 5’ GCCATCTACGAGAGCCTCCA; REV: 5’ CGTGGTCGGATGACAGGTC)
Cryosection Immuno&uorescence
Whole Tibialis Anterior muscles were either perfused or !xed upon dissection from the 
limb with 4% Paraformaldehyde for 2h on ice.  Muscles were sunk in 30% sucrose and mounted 
in OCT.  Cryosections were post-!xed onto slides, permeablized for 5 min with 0.5% TritonX-100 
in 1X PBS, blocked for 1h at room temperature with 10% normal goat serum.  Primary antibodies 
were used at the following dilutions: 1:300 Rat anti-Laminin (4HB-2 Sigma), 1 µg/ml Rabbit anti-
TTP (ab33058 Abcam),  1:1000 Chicken anti-Syndecan-4.  DNA was stained with DAPI and 
sections were mounted with Vectashield (Vector Labs).
Immuno&uorescence of cell lines and primary satellite cells
C2C12 myoblasts were grown on sterilized uncoated coverslips from Corning in DMEM 
with 10% Fetal Bovine Serum.  MM14 myoblasts were grown on gelatin-coated coverslips in F12-
C with 15% Horse serum and 2nM FGF-2.  Primary satellite cells were dried down on gelatin 
coated-coverslips as described in Figure 3.  All cells were !xed with 4% Paraformadehyde for 
10min at room temperature.  Syndecan-4 staining for the primary satellite cells was done as on 
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!bers.  Primary antibodies: 1:2000 chicken anti-GFP (Abcam ab13970); Neat F5D mouse anti-
myogenin supernatant; 1:500 mouse anti-HuR (Steitz Lab) and 1:200 Rabbit anti-phospho-TTP 
(Stoecklin Lab).  For (uorescence intensity: blinded to the condition, masks overlapping 
Syndecan-4 staining were made plus a mask corresponding to background staining and Slidebook 
calculated mean intensity for all (uorescence channels.
Transfection and Enrichment for siRNA transfected C2C12 myoblasts by FACS
C2C12 myoblasts were plated at 2.5x104 cells/well and MM14 cells were plated at 1.5x104 
cells/well 24h prior to transfection.  C2C12 cells were transfected with Dharmafect Duo and 
MM14 cells were transfected with Qiagen Transmessenger reagent according to manufacture’s 
instructions.  AllStars Negative siRNA Cat# 1027292 or an equal amount of Zfp36, Zfp36l1  and 
Zfp36l2 totaling 2.0ug of siRNA per well. siRNA sequences: Zfp36 5’ 
UUAUGUUCCAAAGUCCUCCGA; Zfp36l1 5’ UUAGAUGAAGUUUAAACCCAG; Zfp36l2 5’ 
UUCCGCAUCACAACCGCCCTG. 
Transfected C2C12s were washed with PBS and brie(y incubated 0.1% trypsin-EDTA.  
Cell suspensions were washed with DMEM with 10% FBS to remove the trypsin.  Viable cells 
were detected by staining the cell suspensions with DyeCycle Vital Dye Violet according to 
manufacture’s instructions.  Sorting gates were determined using non-transfected cells to detect 
auto(uorescence that had also been stained with Vital dye.  Only live cells were sorted and the 
sorting conditions were set for enrichment.  Sorted cells were washed twice with cold 1X PBS and 
lysed immediately in 2X protein sample buﬀer.  Proteins were separated by 10% SDS-PAGE and 
transferred onto PDVF membrane.  Antibodies: 1:500 mouse anti-MyoD (5.8A Novus Cat 
#NB100-56511), 1:5000 chicken anti-GFP (Abcam ab13970) and 1:1000 mouse α-Tubulin (Sigma 
Cat #T-6199) were detected by antibody staining and secondary HRP antibodies from Millipore 
and detected using ECL Plus western blotting detection kit (GE Healthcare Cat #RPN2132) HRP 
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substrate.  Blot was scanned using a Storm phosphoimager and the bands quanti!ed with 
ImageQuant soware. 
Preparation, Transfection and Immuno&uorescence of Myo!bers
Muscle was dissected from hind limbs and digested for 1.5 h at 37deg C in 400U/ml Type 
I Collagenase (Worthington).  Muscle slurry was placed into tissue culture dishes containing 15% 
horse serum in F12-C media.  Fibers were teased apart from the muscle using pulled glass pipets 
and placed into fresh media.  Fiy !bers were transferred to 6-well plates containing 2ml 15%HS 
F12-C + 2nM FGF-2.  Fibers were transfected with 2.75ug TTP-AA-myc + 0.25ug eGFP-N1 with 
Lipofectamine 2000 according to manufactures instructions for 4 hours.  Fibers were then washed 
with fresh media and incubated for an additional 20h for a total of 30h in culture.  Fibers were 
washed with PBS and  !xed with 4% paraformaldehyde for 10 minutes.  Aer incubation of the 
!bers with 10% goat serum for 1h at room temperature, !bers were incubated overnight with 
1:1000 chicken anti-Syndecan-4 antibody.  Secondary staining was performed with anti-chicken 
1:1000 AlexaFluor 555, then !bers were post-!xed and permeabilized to detect internal epitopes.  
Following a 1h block with 10% goat serum,  1:50 mouse anti-MyoD (Vector Labs) or 1:500 mouse 
anti-HuR (Steitz lab) were incubated overnight at 4 deg C.  1:500 Alexa Fluor 647 was incubated 
with the !bers for 1h at room temperature and mounted on slides with Vectashield with DAPI.
Intraperitoneal Injection and inhibition of p38α/β with SB203580
Dosage is 15mg/kg of body weight.  SB203580 was diluted with 1X saline to a !nal 
concentration of 1.5mg/ml.  Mice were weighed and injected with 10ul/gram with the diluted 
drug.  Control mice were diluted with a corresponding amount of DMSO drug carrier.  Injections 
were performed 1hr prior to harvest.  Upon harvest, muscle tissue was immediately placed in 
25μM SB 203580.  Muscle was digested with 400U/ml Type I Collagenase (Worthington) for 1h 
with brief vortexing every 10 minutes.  During isolation, satellite cells were maintained in either 
SB203580 or DMSO control and !xed immediately upon isolation of a single cell suspension.
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RNA Decay Assays with the β-Globin-MyoD 3‘UTR Reporter
e entire 3‘UTR of MyoD was ampli!ed by PCR from C2C12 myoblast cDNA using the 
following primers: (FOR: 5’ GCATCCATGCGGCCGCGGATGGTGTCCCTGGTTCTT; REV 5’ 
GCAATCATGCGGCCGCGCGTCTTTATTTCCAACACCT).  e PCR product was cloned into 
NotI sites of the Tetracycline responsive β-Globin reporter construct as previously described 155.  
Tet-oﬀ Hela cells were transfected with 2.25ug pcTET2-β-MyoD and 0.05ug CMV-β-Globin, a 
tetracycline unresponsive loading and transfection control with or without 0.05ug CMV-wtTTP 
and 0.5ug Flag-MK2EE.  Transcription was pulsed for 6h by removal of tetracycline from the 
media.  Tetracycline was added for 20min prior to cell harvest to fully shut oﬀ transcription.  
RNA was chased for at least 6h, puri!ed with Trizol according to the manufacture’s instructions 
and separated on a 1.2% Agarose Formaldehyde gel.  RNA was transferred to Nylon membrane, 
probed for β-globin, and the 1/2 life was calculated as previously described 156. 
Flag-tagged Immunoprecipitations of TTP bound to the MyoD 3‘UTR
HEK293T were plated onto 15cm plates 24 hours prior to transfection with  FLAG-tagged 
wild type TTP, an RNA binding mutant of TTP (F126N), or an unrelated non-RNA binding 
protein, (MS2) together with reporter β-globin mRNA containing the MyoD 3’UTR (β-MyoD) or 
the GM-CSF 3’ UTR (β-GM-CSF).  A β-globin reporter with no putative TTP binding sites 
served as an internal negative control (β-GAP).  Cells were transfected with Lipofectamine 2000 
according to manufacture’s directions.  Pellet and 10% input fractions were separated on a 1.2% 
agarose formaldehyde gel, transferred to nylon, and probed for β-Globin as previously described 
156.
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Chapter 4:  Evidence of Diﬀerential Polyadenylation of HuR 
mRNA in Quiescent Versus Activated Satellite Cells 
64
Introduction
One mechanism cells use to rapidly change gene expression pro!les is through post-
transcriptional regulation of mRNA stability.  Upon satellite cell activation, we observe a dynamic 
switch in proteins which are known negative post-transcriptional regulators of mRNA stability 
with proteins that positively regulate myogenic transcript stability.  Tristetraprolin (TTP), a 
known negative regulator of mRNA stability plays a signi!cant role in satellite cell activation.  
TTP binds to AU-rich elements within the 3‘UTR of target mRNAs and recruits mRNA decay 
enzymes to destabilize the transcript 113,116.  Activated-p38α/β signaling results in 
phosphorylation of TTP 117.  is results in TTP association with 14:3:3 adapter proteins which 
block its ability to recruit deadenylases resulting in stabilization of the target transcript 118,119.  I 
have shown that p38α/β mediated inhibition of TTP is required for satellite cells to express the 
muscle transcription factor MyoD.  MyoD expression is required for satellite cells to commit to 
myogenesis and for normal muscle regeneration 68.  TTP binds and directly regulates the MyoD 
3‘UTR.  My hypothesis is that upon muscle injury, TTP is inhibited by activated-p38α/β MAPK 
signaling resulting in rapid stabilization of MyoD mRNA.  However, MyoD mRNA has been 
shown to be regulated by other AU-rich RNA binding proteins such as HuR.  HuR binds and 
stabilizes MyoD mRNA in C2C12 myoblasts 99,100.  We observe an increase in HuR mRNA as 
satellite cells activate; however, the mechanism of HuR mRNA regulation in satellite cells during 
muscle repair is unknown.
In humans, the HuR mRNA 3‘UTR has been shown to be diﬀerentially polyadenylated, 
resulting in three transcripts of diﬀering lengths 144.  e longest form of the human HuR 
transcript contains an AU-rich element that is regulated by TTP 144.  e yeast homolog of TTP, 
Cth2 was recently shown to direct diﬀerential polyadenylation of several yeast genes resulting in 
extended transcripts containing AU-rich elements 157.  Cth2 directed diﬀerential polyadenylation 
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was speci!c for genes containing AU-rich elements that were downstream of the standard polyA 
site, thus genes without 3’ AU-rich elements were not extended 157.  Cth2 and TTP share the 
highly conserved tandem zinc !nger domains required for RNA binding, but it is unknown 
whether TTP is able to direct diﬀerential polyadenylation resulting in transcripts containing AU-
rich elements.  If TTP were to direct diﬀerential polyadenylation, it would need to be localized to 
the nucleus.  In fact, TTP is located in the nucleus in unstimulated macrophages and it is actively 
directing mRNA decay 158.  Upon p38α/β MAPK activation, TTP accumulates in the cytoplasm, 
concurrent with inhibition of AU-rich mediated decay 158.  If TTP does regulate HuR transcript 
length and stability, this may be a mechanism where HuR mRNA is rapidly stabilized as satellite 
cells activate, similar to TTP regulation of MyoD mRNA.  I have found that proliferating C2C12 
myoblasts express a long form of HuR mRNA which possibly contains an AU-rich element.  
While TTP did not regulate the stability of a short form of the HuR 3‘UTR expressed from a 
reporter plasmid, a long form of the HuR 3‘UTR reporter appeared more unstable in the presence 
of TTP.  Finally, I present evidence supporting a possible ARE-containing polyadenylation variant 
of HuR mRNA expressed in uninjured satellite cells, which appeared to decrease 12h following 
muscle injury.  
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Results
Human cells contain three diﬀerentially polyadenylated species of HuR mRNA, the 
longest transcript contains an AU-rich element regulated by TTP 144.  To look for evidence of 
diﬀerential polyadenylation of the HuR 3‘UTR, I investigated the gene that encodes HuR, Elavl1, 
using the University of California, Santa Cruz (UCSC) genome browser.  Based on 1) mouse 
mRNAs from GenBank, 2) mouse ESTs including unspliced, 3) locations of the conical 
polyadenylation sequence, AATAAA, and 4) regions of high mammalian conservation, there was 
evidence for two or three alternative HuR transcripts (Fig. 1). 
To determine whether C2C12 myoblasts produced a long form of HuR, I performed QT-
PCR analysis of proliferating C2C12 myoblasts.  Primers were designed against a proximal region 
and a distal region of putative HuR transcripts (Fig. 2A).  Proliferating C2C12 cDNA was 
Figure 1: Schematic of the 3’ end of Elavl1.
Within the 3‘UTR of Elavl1 (light blue box) three putative polyadenylation sites are shown as pA.  
ese predictions are based on 1) the presence of a conical polyA sequence (AATAAA), 2) mouse 
mRNAs from GenBank (shown in orange) 3) mouse ESTs including unspliced (not shown), and 
4) regions of high mammalian conservancy (shown in dark blue boxes, height of the boxes 
indicates amount conserved).  Depicted by the red and yellow box is the TTP preferred class II 
AU-rich element.  e purple lines represent the probe sets identi!ed as regulated in wild type 
satellite cells but not in activation-de!cient Syndecan-4 null satellite cells 12h post-injury.  
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ampli!ed by QT-PCR using primers against the junction of exon 1 and 2, proximal, and distal 
regions of HuR mRNA.  Preliminary data suggested that approximately 50% of HuR mRNA 
expressed by proliferating C2C12 myoblasts contained the distal region of the 3‘UTR (Fig 2B).
If HuR mRNA contains a class II AU-rich element, it is likely to be regulated by TTP.  To 
test whether TTP regulates HuR mRNA stability, I cloned the full length HuR 3‘UTR into a Tet-
Oﬀ β-Globin reporter construct (β-HuR).  In Hela cells and C2C12 myoblasts, the major β-HuR 
band by Northern blot was 1.85 kb (Fig 3 Major band).  By performing pulse-chase assays, I 

















































QT-PCR Analysis of HuR Expression
Figure 2: Approximately 50% of HuR mRNA expressed by C2C12 myoblasts is the distal form. 
RNA puri!ed from C2C12 myoblasts was subjected to reverse transcription reactions with or 
without Superscript III RT.  QT-PCR ampli!cation was run in triplicate.
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is band was considerably shorter than the expected full length 3‘UTR of HuR, which would 
have produced an approximately 4.4kb band.  Upon close inspection of Northern Blots of β-HuR 
transfected C2C12s, I observed a 4.4 kb band that could represent a long form of β-HuR (Fig. 3, 
Minor band).  Upon transfection with TTP, this band was no longer detectable (Fig 3; star); 
however, I have no direct evidence that its stability was being regulated by TTP.
If TTP regulates HuR mRNA stability in satellite cells, I would expect satellite cells to 
express an AU-rich containing form of HuR mRNA.  To determine whether satellite cells express 
a long form of HuR that contains an ARE, QT-PCR primers were designed to (ank the ARE in 
the 3‘UTR of HuR.  Expression of three regions of HuR mRNA were compared between satellite 




Figure 3:  Northern Blot Analysis of Bands produced by β-HuR reporter.
Transfection of β-HuR reporter into C2C12 myoblasts resulted in one major and one minor band 
produced.  Lane 1: β-HuR; Lane 2: β-HuR + 0.1ug wild type TTP.  Star denotes band that 
decreases in the presence of TTP.  nsb=non-speci!c band.





suggest that satellite cells from uninjured muscle (UI) express 5-fold more ARE-containing HuR 
mRNA than satellite cells 12h post-injury (UI-SC (Distal ARE Avg Ct=33.2, Avg GAPDH 
Ct=18.7); 12h-SC (Distal ARE Avg Ct=37.3, GAPDH Avg Ct=20.1) (Fig. 4).  Based on the Raw Ct 
value of the Distal ARE 3‘UTR amplicon, satellite cells 12h post muscle injury express very little if 
any HuR mRNA that contains an ARE. 






























QT-PCR Analysis of HuR Expression in Satellite Cells
Figure 4:  Satellite cells from uninjured muscle (UI-SCs) express ~5-fold more ARE 
containing HuR mRNA than satellite cells aer 12h of muscle injury (12h-SCs).





In chapter 3, I presented data showing that 1) HuR is diﬀerentially regulated with respect 
to TTP, 2) inhibition of p38α/β MAPK signaling blocks early HuR protein induction and 3) a 
constitutively active mutant TTP when over-expressed is insuﬃcient to block HuR protein 
induction in satellite cells.  Here, I have shown that an ARE containing HuR transcript is 
expressed in uninjured satellite cells but is no longer present 12h following muscle injury.  is 
implies that upon satellite cell activation, a switch occurs between a form of HuR mRNA that may 
be regulated by TTP to a form that is not regulated by TTP.  ese data are consistent with data 
showing that early HuR protein induction was regulated by p38α/β MAPK signaling and may be 
dependent upon inhibition of TTP by activated-p38α/β MAPK signaling.  Data showing that the 
constitutively active TTP mutant (TTP-AA) was unable to block HuR protein induction in 
satellite cells, 24h aer transfection is consistent with the idea that the HuR transcript switches to 
a form which TTP no longer regulates.  is is in contrast to the ability of the TTP-AA mutant to 
block MyoD protein induction in satellite cells 24h aer transfection.   Clearly, MyoD protein 
induction is dependent upon activated-p38α/β MAPK inhibition of TTP-mediated MyoD mRNA 
decay.    Alternatively, p38α/β MAPK signaling may regulate HuR protein induction completely 
independent of its regulation of TTP and this is why I observed an inhibition of HuR protein 
induction early in satellite cell activation.  e data presented here supports the idea that a long 
form of HuR mRNA containing an ARE is being made in uninjured satellite cells.  However, I 
have no data as to whether TTP directly in(uences the production of this form of HuR mRNA. 
To test whether TTP would be able to mediate diﬀerential polyadenylation, I would 
attempt to force C2C12 myoblasts to make the HuR mRNA containing an ARE by transfecting 
them with wild type TTP.  Since the yeast homolog of TTP regulates diﬀerential polyadenylation 
not through its RNA binding domain but through a region within the N-terminus, I would also 
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transfect mutant TTP proteins which either had a truncated N-terminus or C-terminus.  I would 
then perform QT-PCR to address whether I could detect any increase in an ARE containing HuR 
mRNA under any of these conditions.  is experiment may provide insight into whether TTP 
was able to direct read through of the normal polyadenylation site resulting in the production of 
an HuR mRNA containing an AU-rich element within its 3‘UTR.  If TTP could direct extension 
of transcripts and diﬀerential polyadenylation in mammalian cells, it may provide a mechanism 
to force AU-rich mediated decay on several transcripts not normally containing AU-rich 
elements.  is may result in post-transcriptional regulation of many transcripts that would now 
be subjected to AU-rich mediated decay.  In quiescent satellite cells, if TTP is directing the 
production of an HuR mRNA containing an AU-rich element and mediating its decay, this would 
be consistent with TTP suppression of myogenesis since HuR is known to stabilize myogenic 
transcripts 99,100.  
Materials and Methods
QT-PCR Analysis
Proliferating C2C12 RNA was puri!ed using a GE Illustra RNAspin Mini kit, including 
on-column DNase treatment.  cDNA was made using Superscript III RT and ampli!cation of 
cDNA and no RT controls was performed using Fast SYBR Green PCR master mix from Applied 
Biosystems according to manufactures instructions.  Primary satellite cells were puri!ed by FACS 
analysis as previously described (Tanaka, 2009).  Tissue used for sorted satellite cells was the 
Tibialis anterior muscle, either uninjured or injured with 50ul BaCl₂ for 12h to produce 
myonecrosis.  RNA was puri!ed using Arcturus PicoPure RNA isolation kit, quanti!ed using a 
nanospec and equal amounts of RNA were ampli!ed using Nugen’s WT-Ovation FFPE System 
v1.0.  Input RNA for GAPDH, Exon1/Exon2 and Proximal  was 2ng while for distal 3‘ARE HuR 
was 31.25ng.  Primers sequences:  Exon1/Exon2 junction (FOR 
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5’GCTTATTCGGGATAAAGTAGCAGGA; REV 5'TTCACAAAACCGTAGCCCAAG).  
Proximal 3‘UTR (FOR 5’GGACCAAAGAGTTTCAGGGC; REV 
5’CAGACGCTCAGGATGTCAGAGG).  Distal 3‘UTR (FOR 5’ 
AGGCTGGGCAGAAATACAGA; REV 5‘GGGTTGTGACTTTTCCTCCA).  Distal ARE 3‘UTR 
(FOR 5’CCTTTTGCTGATGTGGTTCA; REV GCAAATACTTGGCAGCTGGT).  GAPDH 
(FOR 5’CACCACCATGGAGAAGGCC;  REV 5’GATGACCCTTTTGGCTCCAC.  18S rRNA 
(FOR 5‘GCCGCTAGAGGTGAAATTCTTG; REV 5‘CTTTCGCTCTGGTCCGTCTT).
Northern Blot Analysis
e β-HuR reporter construct:  the full length HuR 3‘UTR was cloned into the NotI site of 
pcTET2-β-globin, a tet-oﬀ construct previously described (Lykke-Andersen, 2000).  Primers for 
3‘UTR HuR (FOR 5’  C2C12 myoblasts were transfected with 1ug Tet-trans repressor, 2ug β-HuR 
reporter construct and either with or without 0.1ug of pcDNA3-wtTTP.  Twenty-four hours 
following transfection, tetracycline was added to the media for 20min to turn oﬀ transcription 
from the β-HuR plasmid.  Total RNA was puri!ed using Trizol according to the manufactures 
instructions.  Samples were boiled in Formamide/Formaldehyde loading buﬀer and were run on a 
1.2% agarose formaldehyde gel at 80V overnight at room temperature.  RNA was blotted onto 
nylon membrane using upward capillary transfer overnight.  Blots were cross-linked using the 
auto settings on a Stratalinker 2000 and subsequently blocked and probed with anti-sense β-
globin P32 labelled riboprobes overnight at 60deg C.  Blots were washed and exposed to a 
phophor screen overnight and scanned using a Storm Phosphoimager.  
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Chapter 5:  Discussion
Maintenance of Long-term Stem Cell Quiescence
Human satellite cells maintain a quiescent state for years without losing the capacity to 
regenerate muscle 5,11.  Furthermore, the quiescent satellite cell population is renewed even aer 
many rounds of skeletal muscle injury 104.  us, skeletal muscle regeneration mediated by 
satellite cells is a relevant model for studying adult stem cell quiescence.  Other adult stem cell 
populations are also able to maintain quiescence for extended periods of time, for example a 
dormant population within the hematopoietic stem cell (HSC) population divides only !ve times 
over the lifetime of the mouse 4.  
Little is known about the molecular mechanisms regulating long-term quiescence of 
vertebrate stem cell populations.  Nevertheless there appears to be a correlation between the 
timing of entry into long-term quiescence between HSCs and satellite cells.  Four weeks aer 
birth, mouse HSCs undergo a dramatic switch from a highly proliferative and self-renewing state 
to a quiescent state with less self-renewing capabilities 159.  Approximately three weeks aer birth, 
satellite cells undergo a similar switch characterized by reduced fusion with existing muscle !bers 
and entry into quiescence 37.  e relatively similar timing of these two stem cell populations 
entering into quiescence, corresponds to onset of puberty in mice 160.  Since puberty is 
characterized by hormonal regulation of gamete maturation, there may exist a systemic 
mechanism to switch from post-natal growth characterized by ongoing stem cell proliferation to a 
state of stem cell quiescence and tissue maintenance.  e timing of entry into quiescence of these 
two stem cell populations has just been characterized, thus it is unknown whether the 
mechanisms regulating this switch into quiescence are similar.  
e switch to quiescence observed in HSCs and satellite cells is the inverse of what is 
observed in both of these two populations in response to either bone marrow injury or muscle 
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injury, respectively.  Both HSCs and satellite cells exit G0, enter the cell cycle within 24h, and 
continue to proliferate in response to injury 4,77.  Whether satellite cells can reversibly switch from 
proliferation back to quiescence is unknown.  However, long-term dormant HSCs were shown to 
be able to re-enter into quiescence following a proliferative state in response to bone marrow 
injury 4.  ere are several important diﬀerences between the dormant HSC population and 
quiescent satellite cells.  First, satellite cells remain quiescent for much longer periods of time in 
normal resting muscle.  Second, activated satellite cells rapidly commit to the myogenic lineage; 
whereas dormant HSCs give rise to multi-potent blood lineage stem cells 4,61,75.  e ability of the 
dormant HSC population to activate upon injury, proliferate, and re-enter quiescence is a 
mechanism of self-renewal that has not yet been characterized in satellite cells. 
Post-transcriptional Suppression of Satellite Cell Activation  
Quiescence is generally regarded as low metabolic state 122 and satellite cells display 
characteristics of a metabolically quiet cells 32.  ese characteristics include: condensed 
chromatin, no identi!able polysome structures, no rough endoplasmic reticulum (ER), or Golgi 
cisternae, and very few ribosomes 32.  Once a satellite cell is activated, it grows in size concurrent 
with the appearance of polysomes, rough ER, Golgi cisternae and less condensed chromatin 41-46.  
By physical diﬀerences alone, it is obvious that a quiescent satellite cell undergoes a fundamental 
cellular change upon activation in response to muscle injury.  us, it seems reasonable to assume 
that a quiescent satellite cell is metabolically inactive.  Further, I would expect that activation of a 
quiescent satellite cell would require an induction in gene expression.  
Microarray gene chip experiments allow for a global view of gene expression in cells.  To 
better understand the gene expression changes that occur upon satellite cell activation, we 
performed Aﬀymetrix microarray analysis on FACS isolated satellite cells from uninjured muscle 
and satellite cells isolated aer 12h post muscle injury.  In order to isolate genes that were more 
likely to be involved in satellite cell activation, we identi!ed gene expression changes occurring in 
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wild type satellite cells that did not occur in mutant Sdc4-/- satellite cells.  Upon muscle injury, 
Sdc4-/- satellite cells fail to activate and commit to the myogenic lineage 54.  Further, they do not 
divide within the !rst 48h following isolation 54.  We subtracted gene expression changes 
occurring in Sdc4-/- satellite cells from gene expression changes occurring in wild type satellite 
cells during the initial 12h post muscle injury.  Approximately half of transcripts expressed in 
satellite cells from uninjured muscle decrease 12h post injury.  Moreover, RNA binding proteins 
were over-represented within the WT-S4 gene list compared to the proportion of known RNA 
binding proteins in the mouse transcriptome.  RNA binding proteins that regulate mRNA 
stability and splicing were diﬀerentially expressed implying that post-transcriptional mechanisms 
could be playing a role in satellite cell activation.  Within this subset of RNA-Binding proteins, 
known negative regulators of myogenesis decreased whereas known positive regulators of 
myogenesis increased in abundance 12h post-injury.  us, I hypothesized that myogenesis is 
actively suppressed in quiescent satellite cells.  In support of this hypothesis, I have shown that 
p38α/β MAPK-dependent inhibition of TTP is required for MyoD induction in satellite cells.  
TTP binds to the MyoD 3‘UTR and mediates the decay of the MyoD transcript.  us, it appears 
that TTP and/or its homologs Brf1 and Brf2 suppress myogenesis in quiescent satellite cells by 
directly regulating MyoD mRNA (Fig. 1)
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Figure 1:  Activated-p38α/β Inhibition of TTP Stabilizes MyoD to Commit Satellite Cells to 
the Myogenic Lineage.
Quiescent satellite cells must activate and commit to myogenesis to repair muscle.  We propose 
that in quiescent satellite cells very low levels of MyoD mRNA are present; however, it is either 
actively destabilized by TTP or sequestered away from translational machinery by TTP.  Upon 
muscle injury, p38α/β MAPKs are rapidly activated resulting in phosphorylation of TTP.  
Phosphorylated-TTP no longer suppresses MyoD mRNA resulting in rapid induction of MyoD 
likely accompanied by transcriptional up-regulation of the MyoD gene locus and increased MyoD 
mRNA stability mediated by HuR. 





























Post-transcriptional regulation of MyoD mRNA in quiescent satellite cells may provide a 
mechanism for rapid commitment of satellite cells to the myogenic lineage upon activation.  e 
idea that TTP regulates MyoD mRNA in quiescent satellite cells requires that MyoD mRNA is 
present.  Quiescent satellite cells may express very low levels of MyoD mRNA which is rapidly 
subjected to AU-rich mediated decay by TTP and/or its homologs Brf1 and Brf2.  Alternatively, 
MyoD mRNA is expressed by satellite cell progenitors and TTP binds the message and sequesters 
MyoD mRNA away from the translational machinery.  In human cells, TTP has been shown to 
stably store AU-rich containing mRNAs and sequester them away from the translational 
machinery when mRNA decay factors are limiting 137.  However, this hypothesis requires that the 
MyoD locus be active in satellite cell progenitors.  By using Cre-mediated lineage tracing of the 
MyoD locus, satellite cell progenitors were shown to have activated the MyoD locus prior to 
entering quiescence 40.  e MyoD locus may be active at a very low levels in quiescent satellite 
cells; however, this has not been directly tested.  
Storage and sequestration of MyoD message or active MyoD mRNA decay in quiescent 
satellite cells would provide a pool of available MyoD mRNA for translation.  Upon receiving 
activation signals, a quiescent satellite cell could mobilize this available pool of MyoD mRNA to 
be rapidly translated into MyoD protein (Fig 1).  Alternatively, if MyoD mRNA is not actively 
expressed or stored in quiescent satellite cells, upon satellite cell activation MyoD transcription 
would be up-regulated.  Phosphorylated-TTP and HuR may bind nascent MyoD mRNA and 
synergistically stabilize MyoD transcripts. 
TTP regulation of MyoD mRNA may be involved in driving satellite cells to re-enter 
quiescence.  MyoD is required for satellite cells to enter the cell cycle 75, and during ex-vivo 
myo!ber culture, all satellite cells enter into the !rst round of cell division following isolation 
(Olwin Lab, unpublished).  us, satellite cells are MyoD positive prior to entering the !rst cell 
division.  A sub-population of satellite cells exit the cell cycle aer the !rst cell division following 
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isolation (Olwin Lab, unpublished).  MyoD protein is undetectable in the majority of this non-
dividing sub-population of satellite cells (Olwin Lab, unpublished).  us, MyoD expression may 
have been down-regulated in this non-dividing satellite cell population.  Down-regulation of 
MyoD expression may be achieved by transcriptional, post-transcriptional and post-translational 
mechanisms.  TTP may mediate decay of MyoD mRNA at the post-transcriptional level to assist 
in down-regulation of MyoD in this sub-population of non-dividing satellite cells.  is sub-
population of non-dividing satellite cells express Pax 7, a paired box transcription factor 
expressed in quiescent satellite cells 35 (Olwin lab, unpublished).  Pax7 appears to play a central 
role in down-regulation of MyoD at the post-translational level in proliferating satellite cells.  
Pax7 mediates instability of MyoD protein 161 and directly up-regulates Id3, an inhibitor of MyoD 
transcriptional activity 162.  e combination of TTP directed MyoD mRNA decay and Pax7 post-
translational regulation of MyoD may be able to eﬀectively switch satellite cells to a MyoD 
negative status upon exit from the cell cycle.  
Concluding Remarks
Collectively, my data support the hypothesis that post-transcriptional regulation of mRNA  
plays an important role in the switch from a quiescent satellite cell to an activated proliferating 
myoblast.  In particular, activated-p38α/β MAPK inhibition of the Tristetraprolin family of RNA 
binding proteins is essential for satellite cells to induce MyoD and commit to the myogenic 
lineage upon satellite cell activation.
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!"2$&&3'() EF)<" # $/!*+1*%
!""&0%0'='() EF)% # 0/!&+1*3
!"#%%$3'() C!#**2"R!&,-. # #/!$+1*$
!"$00*#'() D(B:(29" # "/%!+1*#
!"$%*!*'='() O6?$ # "/2"+1*0
!"2#&0&'('() E<B2$(2& # $/#!+1*#
!"##!%3'='() $3#*"$%S2#,-. # !/00+1*3
!"$%&00'() E(59!! # #/!&+1*"
!"$!322'('() EB8:2 # 2/**+1*"
!"2#!0!'() RA833 # 2/3&+1*"
!"$0#&%'() @TD!***"$*!# # !/*"+1*"
!"$0%*"'='() DFA!!(! # 2/#3+1*3
!"2**"#'?'() 4GNB! # 3/%*+1*"
!"$2*&3'() DGU!3 # !/!2+1*"
!"#!$%$'() "&#*$!!S2",-. # 2/2#+1*#
!"#&**0'() P<H% # #/&"+1*%
!"##3$$'() PM() # 3/#"+1*0
!"$2"3!'() J<BM2 # 2/0*+1*"
!"2%00*'() J6=$ # $/3"+1*#
!"2202#'() E)8(% # !/%&+1*"
!"2%!$!'('() E)=# # 0/#*+1*$
99
!"##$%#&'( ")#$""%*+$,-. # "/$$01$2
!"#+23$&'( !4$$!+45$3,-. # #/3)01$2
!"#23+%&6&'( 7893+)+"+ # "/)"01$"
!"+)344&'( !4$$$230++,-. # "/3!01$3
!"")"%4&'( 9:;:4$ # !/4)01$"
!"+)!%!&'( !4$$$$)<!4,-. # 2/#+01$#
!"2%3+!&'( =;>4% # #/!!01$"
!"#+2#)&'&'( ?@A2" # !/+201$#
!"!%#$3&'( 9>BCC! # +/"!01$#
!""2+33&'( 0>::! # )/%%01$3
!"#$")%&'( )!#$$$)D$!,-. # +/##01$"
!"!)%++&'( 0-E#F # +/"#01$#
!"++3)2&'( G(BH! # !/)$01$#
!"+##4)&'( ?E'(:" # +/3)01$#
!"++"$)&'( IFJ# # +/)%01$2
!""#2+2&'( 5C6+ # 4/+#01$%
!"""3)+&'( KD#!3%"" # "/"301$3
!"+!3%+&'&'( G:(F# # 4/2!01$4
!"!)+"$&'( GF6!" # "/3"01$#
!"2%4"2&'( 5!%0>(;+$!F # +/"$01$#
!"#++%#&'( ")#$"!4L!$,-. # "/#$01!!
!""$4)%&6&'( 7>>:3 # #/%)01$"
!"#"!$$&6&'( <A'>M:!' # #/3"01$"
!""2!+$&'( KN$+!)44 # 4/3$01$4
!"#4%)$&'( !2$$$$2D$+,-. # #/##01$"
!"#$%4+&'( ")#$"!+8!#,-. # 4/!$01$"
!"#)#4$&6&'( OE#C2 # !/$+01$2
!"!)"$%&'( O-63 # #/#401!+
!"+)))+&'( OAFF>"C # 2/4)01$3
!"2#3$"&'&'( ICJ!P # #/+301$2
!"+3%$)&'( 9"#$$$"0!2,-. # 3/%+01$"
!""+$"$&'( GQFQ!+2 # "/!"01$3
!"+)342&'( !4$$$+#K!3,-. # !/$!01$#
!"+#2$3&'&'( ?R'( # !/3)01$#
!"##+22&'( %"#$"#4S$4,-. # #/2)01$#
!"#"%$#&'&'( OB:R # "/#401$"
!"#)4)#&'( LT'# # !/!!01$2
!"+4%2!&6&'( DMH1UV22% # 2/2401$2
!""!23#&'( +"!$$!4<$4,-. # #/2+01$#
!"""+2!&6&'( 5"0>(;!!!F # !/#!01$2
!"#$#4"&'( OP:+2'#4 # 4/!!01$)
!"2$#3%&'&'( <AA#>! # !/+"01$2
!"##%44&'( "4#+"4#S!3,-. # 3/+"01$4
!"#%#+4&'( WEA2## # +/4"01$#
!"242"!&'( K.'A!" # #/"+01$"
!"2"!+"&'( !4$$$34*$!,-. # 4/$#01$"
!"22%$+&6&'( KM>+ # +/+!01$%
!"+)#$3&'( 7X-: # !/!+01$#
!""#!$%&'( )*+,! - -.$/01%-
!"--#/-&'( 0!-%-%23!"45, - #.6701%"
!""-7%#&'( 89(:$; - ".7!01%"
!"722-7&'( <<7!/7#$ - $.-"01%7
!"76-!%&'( <$-%%7#=%#45, - !./"01%7
!"!#626&'&'( >?@- - /.$#01%7
!"7/#%#&A&'( <)%!7$$6 - 6.-!01%"
!"7!"7"&'( B9:*$% - $.6"01%#
!""/7/%&C&'( <"-%!%#<!$45, - !.#-01%-
!"$6#/2&C&'( %#!%%!%8!"45, - !.$-01%"
!""%2!!&'( DEF$-'! - ".2201%7
!""/7-#&'( GHC+:$ - $.$"01%"
!"-2!!$&'( $6!%""$>$!45, - !.#701%-
!"-6!62&C&'( 0IJ".2 - -.6201%#
!""76/!&'( <>-!7-/# - $.%601%"
!"7-$//&'( -%$!"%!K$-45, - $.!201%"
!"$/$!/&'( L@I"77 - ".%-01%/
!"-//%$&'( MN+# - !.-%01%2
!"-%/!"&'( "2-%"7!D!745, - /.!-01%7
!""/6$!&'( !/%%%7!8$$45, - -.$$01%"
!"-#6!7&A&'( !6!%%!%3%!45, - 7.!%01%"
!"7#--$&'( M+O+!/ - ".6-01%/
!"-2-/#&A&'( 3+P! - !.%701%"
!"7#"$6&'( DA9F!7 - #.$"01%-
!"$#6!!&'( BII$?7J - !.2$01%-
!"-7"27&'( <:E?'! - !.!701%"
!"$6$##&'( QHF- - 7.6601%7
!"$226!&'&'( "2--"$#8$!45,; - $.%%01%"
!"-%%/-&'( $2%%%!#R%!45, - /.7$01%7
!"-/6#%&'( B?,9O - $.%601%/
!""-#7#&'( ST(6 - /."-01%-
!"-/#2-&'( 3!B'C! - !.!701%-
!"-/$-$&'( RI5F$ - !."/01%"
!""!2%2&C&'( 27-%%##8$-45, - 7.6601%/
!"7-2$!&'( "2-%"$2S!!45, - !.-601%7
!"7!76%&'&'( M(? - $.%701%-
!"-/#""&'( R-N'F($ - $./$01%/
!"7$#-!&'( 4T@H$ - 2.!%01%/
!"72/2%&A&'( <FA- - !.!701%"
!"#%$-6&'( QCFU - ".7701%"
!"--"#2&'( G??U$ - 6./$01%7
!"76"-2&'&'( 3V5I- - ".//01%"
!"-/-#/&'( R'(!' - -./"01%-
!"7%/6$&'( WU(" - $.-!01%"
!""!#!6&'( <?*N'I$2 - #.#$01%7
!"$72#-&'( D'JI/ - 7.-/01%-
!"-!%6-&'&'( !6!%%!"R%!45, - ".2!01%"
!""%%/"&'( 0X"-$266 - !.-701%-
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!""#$%$&'( )*+"! , -./!01#"
!"2$%!2&'( )*+3 , ,.-#01#%
!"-2,/%&'( 4'55, , 2.3"01#%
!"2"!$$&'( 67*7,/' , $.--01#,
!",,#23&'( 89:;3 , 2.$/01#,
!"2#2%3&'( 2%!#2#!<!,=>? , ,.#"01#,
!"-2%##&'( 6'@%5 , $.2"01#"
!"2"/$/&'( AB9C"D , !.2,01#,
!"--/%-&'( E:F7! , !.3%01#$
!"2!-",&'( GHIJ" , /.!/01#-
!""/$%%&'( K;H! , 2.2"01#,
!"-,#$,&'( -/,#"#,G22=>? , 2.2/01#"
!""#$,-&'( LJ5B,? , 2.%!01#"
!"-"#"-&'&'( LMF! , ,.#/01#"
!"!$2!-&'( ='H2$H , 2.,$01#,
!""/$%/&'( NJM , ,.2#01#-
!"!3$"%&'( "3,,"2/K2#=>? , !.-"01#,
!",2-!2&'( "3,!",,<#!=>? , !./-01#$
!"2,#"-&'( O9HP2 , !.//01#,
!",#-"-&'( )H@" , !."#01#%
!",2/-!&'( LC'9(B! , !.!"01#,
!"-"$%/&'( 89:@! , !.$,01#"
!""#32!&'( O5BP!2 , !.2301#,
!"2!"!/&'&'( LFM!3 , "."%01#$
!""$2$2&F&'( <(P!#' , ,.,/01#%
!""2,-,&'( E(P' , ,.,301#,
!"22##/&'&'( <QP, , ".,301#3
!"223/%&'( 0FBBH , 2.$201#,
!""%3#!&'( <R#22#$$ , 2.-,01#%
!"22-#"&'( K5BH , !.#201#$
!"222$,&'( N7P!H , 2.!"01#"
!"2%%33&'( <R#"#,2# , 2./%01#,
!",323%&'( LB>9?5*, , %.!301#"
!""$232&'( <9(B!H , ".3"01#"
!",$!"#&'( "3,#"!2G!-=>? , !./301#"
!""$%#,&I&'( !$###2$S#-=>? , ,.%/01#"
!"!3/,!&'( <<"!%"-, , 3.2$01#,
!"-3/#3&I&'( !$###%,)#-=>? , 2.,301#"
!"%#"!-&'&'( TU"# , 3.#-01#"
!""$2$,&I&'( <(P!#' , ,.2!01#,
!"-!/33&'&'( KV2>BU! , !.-%01#,
!""3"//&'( L>(I! , 2.-!01#"
!"2"$!3&'&'( N'P( , $."201#-
!",!!/!&'&'( AW9$5 , 2.!201#,
!",2-%"&'( !$###%%T#-=>? , 3.3%01#-
!"-!--,&'( <B(- , !.2301#"
!"2-/$#&'&'( 89:>P2 , !.$,01#%
!"232/#&'( TJ522'! , !./201#"
!"!#$%"&'( )*+, - "./"012-
!"#2-#"&'&'( 3(455/ - %.26012-
!"//-$-&'( 7!89% - !."!012$
!""%%$#&'( 0:%%#2-- - -."-012"
!"///%2&;&'( <=8# - -.%2012"
!""-$->&'( !6222!2?//@AB - -.$/0126
!"!6%#$&'( C98+" - /.2%012-
!"!%2##&'( D,E/ - /.%>012"
!"%2"-6&'( 35=4" - !."$012-
!"#"%#-&'( <*FG> - /.#>012"
!"#2"6%&'( <F8/ - "./$012"
!"-2%#$&'&'( :54,'/ - /.#-0126
!"%2!/6&'( ?FH"+ - 6.%$012>
!"##6"$&'( C,G,!$! - %.2/012"
!"---6-&'( IJ*(6K - !.%/0126
!"-"/!"&'( 2>!222!L2>@AB - #.-!012"
!"/$#6#&'( M=NO! - 6.>6012"
!"/-$#%&'( 3O*4=- - 6.>-012"
!"/#$2-&'&'( P94/ - %.$!012-
!"-/"#>&'&'( Q9(9-/ - !.-%012"
!"##!>$&'&'( 3**/8-' - $."/012%
!"/-"-$&'( R*(F - /.2#012-
!"">2--&'( CFH85H!!9 - >.$-012#
!""#//>&'( S+'(! - /.>"012-
!""-6!-&'( <NK! - -.6%012$
!"-/->$&'( !6222$"T!/@AB - ".!2012$
!"#!>"2&;&'( C84F - #.2!012$
!"-//!$&'&'( UOK> - !./-012-
!"-$"%"&'( D8A4"' - ".-2012"
!"#!>>!&'( 0*N'6 - !.!6012-
!""66"6&;&'( D4'K - -.#!012-
!"--/6/&'( D"-2!!2D/!@AB - >.-#012-
!"/6$%"&'( ?A5(!N-9V - %.%-012#
!"/>$6-&'( !622!/#?/2@AB - -.$/012$
!"/26--&'( <'9->K - >.6/012-
!"/#"/6&'( DM2%62%!V - /.>$012"
!"-!>#-&'( D(*$'/ - >.-/012#
!"/!-"$&'&'( <GF4! - ".62012#
!"-6%/-&;&'( W8==- - $.!60126
!"#2%-!&;&'( SGH=8/" - !.#%012#
!""#/6!&'( >/-2!2#0!2@AB - %.2#012%
!"-2#%>&'( C(=>= - /.%"012-
!"->>$"&'( 3(455/ - "."!012-
!"#-//6&'( @NO9(9- - >."6012"
!"-66>"&'( <'9AF! - >.!#012"
!"-$--6&;&'( >>-22-/X//@AB - -.2-012$
!"#!!2-&'( S!"08(4#22G - #.>$012-
!"-26%"&'( !6222/-M2%@AB - !.!$012#
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!""!#!$%&' ()*+, $ !-."/012
!",,,3,%&%&' 456,36 $ 3-.!/013
!"31#!,%&' 78"&! $ ,-../013
!""".91%&' (&:&$ $ #-23/01"
!"$1"9,%&' ,$!111,(1#;<= $ 9-.1/01$
!""#3$#%&' 78"&95 $ !-$!/012
!",,",,%&' >?@6A" $ !-.#/012
!",92!"%&' BC6"9&! $ $-"2/01$
!"3!19,%&%&' D?E3C $ 9-"$/01$
!""!3#1%&' F6GH3 $ ,-.$/01"
!"329"3%&' 4!$112#I!$;<= $ 9-1#/012
!"$,"##%&%&' JK?"K $ !-"1/01"
!"$3##9%&' 4&A5!! $ "-!#/01$
!",#239%&' "#$!",.L1";<= $ $-#!/013
!"3"1$3%&' $!!111#/,,;<= $ ,-99/01"
!",3123%&' I&'&5,K $ 3-#1/01"
!"$111,%&' MN6@! $ !-2./013
!",9931%&' 7OP. $ ,-#9/012
!"$#,9$%&' (Q4!",!1 $ ,-$$/01"
!""392"%&' R'S#K $ "-29/01#
!"$9.$!%&' MN)K $ .-1,/012
!"3211,%&' T@+"1. $ ,-$1/01"
!"",#91%&' 7)6,1 $ ,-,"/01$
!"$!29.%&%&' DA:'$ $ !-1./012
!",,$#,%&' U!A69 $ ,-.2/01"
!"3"$,$%&' 3.$1"$$>,$;<= $ !-#3/01$
!"$33""%&' /EV869 $ 2-1#/01$
!"$#""9%&' W41".312 $ "-#9/01$
!"$..,#%&' ;G@!93 $ "-!,/01$
!"$2!1"%&' RA@S?@! $ $-91/019
!"3$..#%&' "#$1"9!4!3;<= $ $-,#/01"
!"3$$.,%&' LKEV", $ #-.#/01$
!"$"#13%&' X5)@&"C, $ 9-1./01$
!",,#.2%&' X'G! $ 9-3#/01$
!"$9$!"%&' B6OC, $ 3-"./01"
!",##2.%&' 3.$1"92/12;<= $ ,-93/01.
!"3$$.#%&%&' BP,K, $ #-33/01$
!"91$.$%&' IG&V! $ #-22/01"
!"3.!11%&' 4.2"., $ 2-$1/01"
!"$9#1$%&' JKNCG$ $ .-##/01$
!",9$.#%&' 4&:=!5 $ !-!,/01"
!"",9!,%&' 42$11$9/!#;<= $ .-23/01#
!"913"#%&%&' 456,$ $ ,-1!/01"
!"$,!,!%&%&' (AA6"" $ !-,1/013
!",$31"%&' Y&:$ $ 3-,./01"
!"!##99%&' Z)KK,&0+8, $ !-"9/012
!"$3$$9%&' 4?C8A, $ #-"!/01"
!"3,1!2%&' BVE!3 $ !-!3/01"
!"#$##"%&%'( )*(*#' + !,-$./-$
!""!-01%'( #0!--!!2!3456 + +,!"./-+
!"7+1!-%'( 8*9*!!$ + +,-3./-+
!""+##3%'( :(';# + !,"$./-"
!""+!7"%'( $-+-"+0<-! + 3,#+./-"
!"!13+3%'( 4';7!'=! + 7,!+./-0
!""-!$$%&%'( >(?!; + $,3"./-"
!"#7"7-%'( )@5+A" + !,17./-+
!"7$7$-%'( B*3+ + 1,30./-"
!"#3+01%'( B?'= + #,#"./-+
!"+++--%'( #3----7C-"456 + !,3"./-1
!"7-0+#%'( >D&E7 + !,#1./-+
!"773$0%&%'( 8*9;# + 1,-3./-+
!"73+"$%'( 8F9G# + $,!1./-"
!"+!+7#%F%'( HI(! + !,!7./-$
!"!303#%'( !!!--#!<-#456 + !,"1./-"
!"73#+!%'( H6G! + #,"-./-$
!"7$737%&%'( B@ + 1,"#./-$
!"77$3!%'( )J=#!'! + 0,17./-"
!"+0$!1%'( K9?=5G'1 + 7,-+./-"
!"7!#$3%'( H;L;!! + ",1+./-+
!"7+7++%'( "3++"-+M-0456 + !,$1./-$
!"!3--#%F%'( N''( + +,1+./-"
!"+!$17%'%'( BO#5P + 7,17./-$
!"7-+#1%'( H#?&A! + +,7-./-+
!"7-#"-%'%'( KJ(A! + #,"#./-+
!"77#+"%'( N+Q'A(! + !,7-./-1
!"#-+-!%'( ::"!"3-+ + !,!"./-+
!"#!37!%'( 2@&! + !,!3./-"
!"!0#"7%'%'( 4R*3 + 0,!3./-+
!""-"3!%'( KAE!'+ + !,""./-$
!""301#%'( >F=R+ + +,#!./-"
!""770#%'( 2M)!---"7+"- + !,30./-"
!""3!#-%'%'( HE*! + +,0!./-3
!"#!73!%'( )JAE! + ","0./-1
!"7+!!"%'( SDA3 + !,0!./-7
!"""-70%'( TL5=+ + +,7-./-+
!"#31"!%'( UEGI! + $,#0./-$
!"+0#1-%'( :C0"$!"0 + !,3$./-+
!"7!$++%'%'( BGQ(! + 7,-0./-7
!"++"#+%'( ##!---0S-!456 + !,#3./-+
!""71--%'( #+!--"1V!7456 + $,31./-$
!"7--"3%'%'( >5?' + !,$$./-7
!"+317+%&%'( K5&" + ",0#./-7
!"+!7$-%'( TE'6; + ",30./-+
!"#10#$%'%'( KAED!R# + 1,1#./-0
!""1$!1%'( );6# + 1,#0./-1
!"7"3-+%'( SQW? + !,$7./-+
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!"""!#$%&' ()*! + $,$-./0"
!""+12$%&' 1++02023#"456 + ",!$./0+
!"##-$#%&' 789:!* + -,+0./0+
!"2;;"0%&' (<=; + !,+-./02
!"+-+21%>%&' ";++"+#?0+456 + !,-"./01
!"+"0;;%&' @9&:A<!& + +,2-./0$
!"2-##;%&' 4B*B# + ",+2./01
!"!1001%&' CD6 + +,;#./02
!"+$12+%&' E:AF + $,-"./02




!"2-11#%&' J&&8! + ",;-./0"
!"+-!#2%&' K#+00-23!2456 + !,0#./0+
!"!;#;"%&' !$000!!L!"456 + !,!2./0+
!"+212$%&' (E"#2;;; + ",!0./0"
!"#!"+$%>%&' @<DM*!" + #,11./0-
!"!$$;$%&%&' !-!00!;N!1456 + !,##./0$
!"2+1#!%&' OPK!000""1;1 + +,-"./0$
!"!;2!#%&' @:9Q"0* + #,;-./0+
!""22+$%&' #+!00+;R!+456 + #,#1./0+
!"##$$+%&' CS'! + !,#2./02
!"!;#+$%&' H)9#; + 2,+1./0"
!""+-"0%>%&' !$000!0L##456 + !,12./0"
!"";#2+%&' G8<!* + ",!;./0"
!"2$;++%&' I8!;1" + #,2#./0"
!"2""1"%&' #$000$-R02456 + !,2;./0+
!"###-"%&' 36>#/; + 1,+"./0+
!"+--$"%&' 38T$ + #,#-./02
!"#20;0%)%&' ?<=<" + #,++./02
!"2+$!!%&' 4)9B" + !,##./0+
!"20$1+%>%&' U='+ + ;,!!./0$
!"#1-;$%&' 4<<# + ",#+./0"




!"!;$;#%&' C9MB)9M! + +,!;./0;
!"+$"1"%&' G9&'&$ + ",!;./0+
!"2+!2+%&' O5=)# + #,"!./0+
!"+;+2+%>%&' W8T821 + !,;"./01
!"+;12"%&' .I+!;##2 + +,2!./0+
!"+;;2+%&' @88# + !,0!./0+
!"";$"#%&' ((2##0#0 + $,0;./0$
!"";+$"%&' @59B> + 2,+!./0+
!"2;-";%>%&' X<959! + ;,1$./01
!"+-#-1%&' P'YD$& + +,$+./0"
!"#";0!%&' I<='+ + ",22./01
!"+#;$2%&' #+!00+-.!$456 + !,""./0+
!"#$!!%&'( )*!))!#+!",-. / !0#"12)"
!""/*")&'( 345*!% / %06!12)*
!""/"$%&'( 7#/))$$8!#,-. / /0$612)"
!""))!%&'( 9:;.<=/ / >0"%12)*
!"")%%$&'( !%)))$"?!6,-. / #0!%12)"
!""**//&'( 7(=% / >0!%12)"
!"/6#/*&'( +!$1@(A$)6; / !0!*12)/
!"/#!%/&'( B;@5-CD!# / >0$%12)$
!"/%$%>&'( E:F'# / 60#/12)%
!"#!"##&'( $)//"!!+!#,-. / $0$%12)"
!"/)%"6&'( #>!))")E)$,-. / "0$!12)>
!"/#!%6&G&'( #>!)"//?)!,-. / %0>#12)"
!"#%!##&'( EH5=#'I# / !0*#12)%
!"$)"*)&'( 7J5/ / $0/$12)"
!"/!*#)&'( "6/)""#8!6,-. / !0#/12)"
!"""$6/&'( 9<:55: / "0")12)/
!"/#*/)&'( KC.I / #0*!12)"
!"*))!$&'( BH<:<! / !06!12)"
!"#!/6$&'( 3-.! / *0)612)>
!"##)>/&'( K:@6 / !06612)/
!"/""*"&'( 7J5!# / >0!/12)/
!"$"!!>&'( LME!)))"//!6 / %0##12)"
!"/%6/!&'( K:@!# / 60"*12)/
!""%#!%&'( N<@4# / $06>12)/
!"""$/"&'( O>/))#!+!!,-. / $0"*12)/
!"#6/*6&'( KC5H/ / "0#%12)/
!"$>/$"&G&'( ?@(#> / !0>$12)/
!"$//")&'( !%)))$%+)/,-. / !0*>12)"
!"#)$*%&'( 9@.FC / %06"12)$
!"/)*!6&'&'( PQ. / #0>#12)"
!"#*%/!&'( +;I / /0>$12)"
!"##*!%&'( RS@ / %0"%12)$
!"/%$%$&'( PFS6 / 60%"12)%
!""%*>#&G&'( K@'4$ / #0#/12)*
!"!*6*)&'( T/='(/ / 60)612)/
!"#*%!!&'( KSFH/ / #0$$12)/
!"/%$*6&'( KS;S!/#; / !0!>12)$
!"#">%)&'( MID5:!) / "0!/12)/
!"/$>$/&'( EU5#A!# / !0!*12)"
!"/*/6#&I&'( KF4'5#F / !0>%12)"
!"/"%$6&'( L@@(S/ / *06/12)*
!"$!"/>&I&'( E:;F#< / %0#"12)$
!"/>//#&'( B:F##'* / %0#/12)"
!""%6/%&'&'( "6//")6?)%,-.V / !0""12)/
!"$%##%&'( 7W>"/%$$ / !0/!12)$
!"/$"!#&'( !%))))%1)*,-. / /0$!12)"
!"/>))%&'( 7W>$!%6) / #0%/12)$
!"/**#>&'( N:." / >0>#12)"
103
!"#$%"#&'( )*+,% - %./"012"
!""###$&'( 23!22"24!25*6 - #.2#012#
!"-$#3$&'( 472%-!$8 - 3.$-0123
!""-#2%&'( 4*+,$ - !.!-012-
!"#-2/3&'( 3--2"2/92%5*6 - #.#$012"
!""2!8!&:&'( ;<=>8 - 8.!8012"
!"#/8""&'( ;?7!222"-!-%@ - /./%012#
!""%8-/&'( )!%0+(A%"$< - %.%!012#
!""%/32&'( )>6B - %.#2012"
!""#2/8&'( )!30+(A$$/< - !.380123
!"-3$!/&'( CDEF! - !.2!012"
!"%$33-&'&'( 7G6" - !./-012-
!"-/$8!&'( !$222!3H2"5*6 - !.-"012-
!"-$2!/&'( H=I'% - 8.#%012-
!"#--2#&'( JK,A - "./%012"
!"-22$"&D&'( /"-2"%3L!85*6 - !.!!012-
!""8!%/&'( 7,A,"- - 8.-20123
!"#3/3%&'( M*D" - /.$!012/
!"#"!%!&D&'( 7,A,!/ - %.--012$
!"!/%$/&'( 9EN,- - -.2%012"
!""$#3$&'( )!-222$L!#5*6 - -.#"012"
!"#33"-&'( 8%-2!!"O!"5*6 - !.--012-
!"#3/38&'( PQE$/$ - "./$012"
!"%8#"2&'( 7=Q= - !."!012#
!"-!"%#&'&'( "8-2#-#42-5*6 - !.%-012$
!"%/3#-&D&'( 0G'RG! - 8./2012$
!"%$$3$&'&'( 7S+ - %.!$012#
!"!/###&D&'( ME*, - #.!/012-
!"-$"!#&'( "8--"%$)235*6 - 8.2/0123
!"-8-$8&D&'( H+I! - -.%3012#
!"-/-%"&'( 8--2!/%;235*6 - !.#-0123
!"%-2/"&'( 4->'G(% - -.23012$
!"""$82&'( !/!222#O!-5*6 - !.#-012#
!""88!-&'( PQE% - %.3%012#
!"%"8$$&'( "8-2"!/T!#5*6 - -.%%012#
!"#!!"$&D&'( 7:A,% - /./2012-
!"#-/3#&'&'( ?(UA# - %."3012"
!"!$$%8&'( VWF3 - -.$!0123
!""-/#!&'( /"-2"!#02"5*6 - !.-!012-
!"#%#$$&'( J>F - !.$-012-
!"--"!8&'( "8-2"2#92$5*6 - !."20123
!"-%!!-&'( 7,A,!/ - -./"012$
!"#3$!/&'( XI<I#3 - !."!0123
!"#3838&'( 9A'I(:# - ".%-012$
!""/-%3&'&'( 7+'BE! - !.!#012#
!"%$!$2&'( H:I'/ - ".""012-
!"#-2"3&'( ;?7!222"%222 - #.-$012-
!"-!!!#&'( X>*Q% - !.-$012-
!"!#$%"&'( )'*+! , $-$%./%"
!"",%%%&'( 0,.1(2,%%3 , 4-5$./%,
!"",%66&'( 74,%,$894":;+ , 8-%,./%6
!"!88#4&'( <=>,6'6 , !-6!./%,
!"444%,&'( <=>!5', , 8-46./%,
!""64",&'( 0!%.1(26,,3 , !-4,./%"
!""65"8&'( 7)%$!4!4? , $-!#./%$
!"6%5!4&'( 7>=4'!'? , !-8!./%6
!"64%48&'&'( @A1B , !-5%./%"
!"6#%%8&'( :CDE(E, , 4-",./%6




!",$#46&'( .!,%,%$0!8:;+ , 4-6#./%"
!"!5$%%&'( L=M! , !-4"./%6
!"6,#!6&'( <N4> , 4-64./%"
!"4##5,&'( .1EE" , 4-""./%"
!"4"8!#&'&'( O;P;! , ,-!,./%,
!"6#$,"&'( QG)!%%%"",!# , 5-%8./%5
!"46#!!&'&'( F+(!? , !-88./%$
!",5#%8&'( O;P;! , #-54./%"
!"4$45!&'( )'(RP31! , 4-"#./%"
!"",#"8&S&'( <=>!', , $-#4./%"
!""4%$%&'( @13P= , 6-#"./%$
!"48#$5&'( 0(T' , 4-,#./%"
!",#465&'( <P114' , ,-4%./%"
!",#%84&'( QG)!%%%"5,#$ , 6-,%./%,
!",56#"&'( KP1!64 , "-56./%6
!""85,"&'( I'B;S , ,-$!./%"
!""6#",&'( .,,%%4"U4%:;+ , !-%$./%#
!",,45,&R&'( G1=V , 4-5!./%,
!",%#5#&'( 4,!%%6%7%6:;+ , !-4!./%"
!"46"$$&'( <3TP4 , ,-$8./%,
!"4#%%8&'( Q'*'6 , 8-#5./%,
!",!"%#&'( 4,!%%4"W%8:;+ , 4-4!./%5
!"",85#&'( L=C=!5 , 8-!8./%,
!"6$#4,&'( 7!,%%66I4":;+ , "-%5./%6
!"6586$&'( @;(PT*, , !-68./%,
!",#85,&'( <'==! , "-"8./%"
!"""6#,&'( Q*(+, , ,-%%./%"
!""##8"&S&'( @='>5=! , 6-4%./%5
!""!4%"&'( F!,%%!8@!%:;+ , 4-#"./%,
!""84"%&'( KRER , "-6%./%"
!"!655,&'&'( .=', , !-!"./%,
!"6%$!"&S&'( XMT'6 , 6-$"./%,
!"6"64#&'( 5",%",#7%#:;+ , 8-5%./%#
!"6,"#$&'( !#%%%$%U%6:;+ , "-!$./%,
!",$$!4&'( 4"!%%%"X%!:;+ , 5-56./%6
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!"#$%!$&'( %!!))"*+!,-./ % %01#23)*
!",1!$#&'( 4'56',7, % $0"#23)#
!"#%",$&'( ,*)))"#8!!-./ % !0%,23)%
!"%))$1&'( 49:6'; % $0)%23)*
!",*"1,&'( 2,<% % %0,#23)"
!"!;1%,&'( =>5(' % ,0$%23)%
!",!*%$&'( ?'@:',A % ;0%$23)#
!"#1,"1&B&'( =C@C@ % ,0!%23)#
!"!$$11&'( 4DC,"'! % !0;#23)"
!"#"*#)&'&'( E4)#*##, % #0,#23)%
!""**%$&F&'( G6/:7!%7 % #0%;23)%
!"#;))1&'&'( HI4!)))")#,; % 10;"23)#
!"#$%*%&'( ?>6! % !0%%23)#
!",";!%&'( ,%!))""?!*-./ % 10)!23)1
!"!$;)%&'( GJC, % *0!"23)#
!"%*###&'( E':9K, % ,0%#23)#
!"##"%!&'( LK5#'! % #01123)%
!"#1%1$&'( 2?,!"%,! % !0*123)%
!"%;!#*&'( E(6K; % "0#,23)1
!"%!;"1&'&'( M>5'@% % "0""23)%
!"%$!;)&B&'( =C@C' % "01#23)*
!"#1)1$&'( M<'F5 % ,0"!23)%
!"")!**&'( ;1%)),*2!*-./ % !0!$23)1
!"%%!%*&'( #)%!"!#N!,-./ % "0##23)%
!",;;%"&'( ";%)#),2!$-./ % ;0;"23)"
!"!1*!!&'( =@:! % "0$)23)#
!"%!1;%&'&'( OK!*@ % "0*"23)%
!"#);$;&'( =7P<! % ,0;%23)"
!"%#,))&'( 1%%)"!;Q,"-./ % !0#)23)%
!""!%*;&'( GR)"#);" % #0*)23)"
!"%",";&F&'( =:.S; % ;0!#23)$
!"#*!,!&'( I@FK! % !0,,23)%
!"")$,!&B&'( I7<! % ;0,!23);
!"#!#$%&'&'( E4),#)*1 % "0)!23)%
!",*%1)&'( ";%)#)*T)#-./ % ,0;123)%
!"%**!;&B&'( G,%))"1U)%-./ % *0%,23)#
!",1;!;&'( O(P@! % !0,#23)1
!"#1;;#&'( ,*)))"#8!!-./ % ,0!,23)1
!""))),&'( -6S( % ;01;23)"
!"%*1#;&'( GKF,5:!! % *0$!23)*
!"",$);&'( L56;' % #0)"23)#
!"1)*,$&F&'( O6P" % #0%,23)"
!"%%;""&'( N>5(7, % #0%$23)#
!"%*$,"&'( ?:.7, % ,0,"23)$
!",;,)%&'( ,"!))*1O,!-./ % *0)"23)"
!",#,!,&'&'( =6<:F<!; % #0,,23)%
!"#1,,"&B&'( 4'P>! % !0#$23)1
!"!*##1&'( V'@C! % !0)!23)%
!""#!"$%&' ()$**+$" , !-*,./$,
!""0,$+%&' 1&22# , !-#"./$3
!""!000%&' .45! , *-+6./$"
!",+$+$%&' 789:!! , *-*,./$"
!"##!$$%&' (;8!<! , +-+!./$0
!",$+60%&' "6,!"*+1!+=>; , *-$6./$,
!",+!6,%&' ?85@, , ,-*0./$,
!"#+!!6%&' A:B*#&*0 , "-+*./$,
!"#,"#*%&' "6,$#!0C!3=>; , 3-$0./$,
!"#0,#*%5%&' ADE9: , 0-$,./$+
!"!003#%&%&' (4F! , 3-!0./$,
!"#0##$%&' 6#,$$#6G!"=>; , !-+*./$"
!"*66$!%&' ?;&>@* , *-+3./$3
!"#3#!!%5%&' .8&2 , 3-0"./$"
!"#"!,+%&%&' A';,! , !-,#./$0
!"#0"#3%&' 7&9,;!$ , ,-#,./$,
!""!,+0%&' HI$,$,", , !-3*./$,
!"#*6,+%&' (@;2!J , *-6#./$0
!"#3++*%&' AE5!* , 0-"*./$,
!"#"#0$%&' #+,$",*K!!=>; , !-+!./$#
!"*#6#6%5%&' L:8&!M , ,-,,./$3
!"*$0"+%&%&' (<&'! , ,-!*./$0
!"*0+3,%&' N>2'!O,JM , !-0$./$,
!"##"!#%&' (0,$$#3($3=>; , +-0,./$0
!"*0,6!%&%&' IE:!*&! , !-,*./$,
!",3"03%&' P&@<# , *-"0./$,
!"#3*33%&' =9:,$ , !-$"./$0
!",$!$3%&' !0$$!*31!$=>; , 0-$6./$0
!"#!+$$%&' QBB* , +-60./$0
!"*06,3%&' RO@2:! , "-6!./$"
!""$$00%&' 3,,$#"6P*,=>; , *-+$./$#
!"*63",%&%&' S<T!B , +-#6./$,
!"#330!%&' RJ8U, , 0-6!./$"
!"#"**#%2%&' P,.8'<0#!T , !-,3./$#
!"#",6*%&' 6*,$!!*C!0=>; , 3-$,./$#
!",$*!6%&' (;V9 , "-$3./$3
!",6+,"%&' *"$$$$6H$+=>; , !-+"./$,
!"#""0*%&' *6$$$6*?**=>; , "-0*./$"
!"*,##$%&' A:B!&" , +-,+./$,
!"#,,!6%&' IB&8! , "-,*./$+
!",$+$,%&' 1>@*+J , "-!$./$#
!"#,3"0%&' .!,$!!*?!$=>; , !-0+./$,
!"#0#"#%&' 6#,$$,3G!!=>; , ,-60./$"
!"",6*0%&' )J&3 , #-,#./$+
!""*!#+%&' 7&2'" , #-3!./$#
!""#*#0%&' ()$**#,! , !-!+./$3
!"*,+,*%&' S8;&U* , 0-!*./$0
!",60,+%&' #3,$"$!P*"=>; , ,-3#./$"
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!"#$$%#&'( )*+,-" . ./0$123"
!"#440"&'&'( 5678#' . ./"!123.
!"!94.%&'( :;(" . 0/$#123.
!""00#$&'( <9%$.9 . %/%91239
!""%."9&'( <-6"3 . 4/041230
!""#%4$&'( $..3!!!=3%>?@ . ./40123%
!"".!.%&'( <*A" . "/4#1230
!"%033!&'( B68.' . 4/9#123%
!"%.00$&'( "$.3%49<!$>?@ . !/30123"
!".!%94&'( <6-64 . 0/%#123"
!"%%%!$&'( C+A!D . 4/901239
!".#!%3&'( 5E8E%$ . 0/"%1239
!"%".39&'( !4333.3<!3>?@ . !/..1230
!"%9$00&'( <93#49 . !/901234
!""4#40&'( C!.1;(-.48 . !/3$123"
!"%9!%!&'( "9.."""F!$>?@ . 0/.%123.
!"..##$&'( $".33.!G39>?@ . %/9"123.
!"#0.3.&'( H"A'I(4 . !/4$1230
!""$9..&'( J,;;#7 . !/!91230
!"#%"94&'( JIK4 . ./3!123.
!"!43%3&'( <!L(M7" . ./!.123.
!"%49.9&'( <-6"%I . "/.3123"
!".%.0%&'( "4.#"!%)#.>?@ . #/.01234
!"%00.!&'( BN<!333"3400 . !/"41234
!"%%0$%&'( J(9+?'! . !/0#123"
!"".$9"&'( B?M$ . 4/"%123%
!"!99%%&'( B68!I . "/#%1239
!"%$$$3&'( C-;! . #/$3123.
!"%%#93&'( O;8E! . "/#9123"
!".#%.4&'( "$.3"0%P!#>?@ . $/!0123.
!".9!!.&'( QE'(" . !/#"1239
!"#"!33&+&'( <8M-! . !/%!123"
!"%40#4&R&'( >*,M!I . !/!4123"
!"%!$40&+&'( <E(E#' . 9/49123"
!"##..0&'( S*R'!. . 0/%"123.
!"#9.$$&'&'( P;E6$ . !/""123"
!"%!9.9&'&'( 56#M . 4/.$1234
!""4"$9&'( 1-'; . 0/$.1230
!"#4#"$&R&'( )K,. . ./091239
!"#0"4$&'&'( <M,T. . $/0%123.
!".$"#4&'( <I-M$ . ./$"123.
!"%3.!3&'( F;?-#?, . ./%%123.
!"!40#$&'( U;*-V . !/#0123.
!""%4!!&'( HH!0.393 . ./%#123"
!"%#3#"&'&'( B-D! . "/.$123.
!".!9.$&'&'( <6-69! . #/""123%
!".4!$%&R&'( )',@!3 . 4/#01230
!".$34%&'( U*I;.7 . !/#!123.
!"""#"$%&' ()&*+! , #-./01$,
!"""2#3%&' 04///.$/ , ,-5.01$2
!"#/5#3%&' #3$$$"/4$367+ , 5-2301$,
!""!3,3%8%&' #"!$$$,9!/67+ # !-2/01$2
!",.""3%&' :;<"#=>& # !-3$01$5
!"#2332%?%&' @'! # !-.501$,
!""",2.%&' A=8B!! # !-!!01$"
!",,"!5%&' .$,$"35C#!67+ # 2-!!01$2
!",3$$,%?%&' !5$$$$.A#!67+D # .-!.01$2
!",!5##%&%&' EFG7; # 2-3,01$,
!"".2!"%&' :H82= # 5-./01$,
!"2/#.#%&' /5#$"25I$#67+ # #-!/01$2
!"#32##%&' E*+J;"# # !-""01!$
!"""2!#%&' EJ)K&>#3 # /-3301$,
!""#5/,%?%&' L'BB!$ # 5-2/01$"
!",,5.5%&' MNBB! # !-#!01$,
!""55./%&' O?<;! # !-$301$"
!""$,.#%&' P:$2!/#. # /-5.01$2
!"23#!/%&' L;J;5 # 5-5501$,
!"/$"#5%&%&' E;&G#. # /-"$01$,
!"25..!%&' C?=>B/ # !-#.01$"
!",2!"5%8%&' :&;G# # !-$!01$"
!"#5!,5%&' :N?2 # !-$.01$"
!",$5"2%&' 23,$"$34$/67+ # !-..01$"
!"2!,.3%&' I>)" # ,-,/01$"
!"2!5.5%&' :Q>#=!$ # !-3501$,
!",$.#.%&' LJGR # 2-,"01$,
!"#$,"2%&' :B;*!" # .-/301$"
!",.,52%&' A=B*# # #-"501$2
!"#$#!2%8%&' !.!$$!#S!/67+ # 3-,"01$"
!"#$"/.%&' E?=!5 # 5-$,01$,
!",#$!.%&' E?<B# # "-5,01$"
!",/"."%&' :$,$$!39$267+ # /-.201$2
!"2$333%&%&' !5$$$#3T!"67+ # !-3/01$"
!"2"!..%&' "3#!2$.I!#67+ # /-//01$,
!"!.,!!%&' A*,+ # ,-#/01$/
!"25!!3%&' !!!$$$,A$#67+ # ,-,,01$2
!"2$".!%&' UQ=B! # 2-"301$"
!"2#.2,%&' :&J+B # 5-,!01$2
!""$2"3%&' P#,$,,"V$567+ # #-3501$"
!",!"!$%&' I!/0J';"5#N # /-//01$5
!"!3"!/%&%&' 6&JK # "-3"01$"
!"",""#%&' EW$##$." # /-!301$2
!"/$/3,%&%&' :HB3&, # /-3301$2
!",/".,%&' UQ'!B # !-2/01$"
!"2#"$5%&' (>&K" # !-,"01$,
!"22,/,%&' P&7!D # .-$501$,
!""2//5%&' L=<!;!$& # !-!#01$,
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!""!#"$%&' (&)$ * !+!$,-./
!"!0#!*%&' 12$3& * $+4$,-.$
!"/#$!0%&' 5!$..$46!#789 * !+":,-.$
!"*#:$!%)%&' ;<=$ * #+"#,-.:
!"/#!4*%&' ;&=*9# * $+*.,-./
!"/"*:/%&%&' 5>?>!.@ * 0+!#,-.$
!"/!#.!%)%&' A2BC$ * *+:/,-."
!"***#.%&%&' 12:3& * 0+#0,-.$
!""$**/%&' 5?D3!? * !+#.,-.#
!"*.#4"%&' E?C!!& * *+*0,-."
!"/40$"%&' F/,3'B/./G * :+./,-./




!"*""0"%H%&' L2MN?O* * $+$$,-."
!"/:!04%&' !4!...#F!#789 * *+0*,-.0
!"/#04"%&' A3O * !+!:,-.#
!"$""*0%&' EM'!: * *+*#,-!.
!"/40##%&' 5/$..*!6.#789 * :+"/,-.#
!""0*"/%&' K38C*? * !+#0,-.$
!"/*!$:%&' E2?/&0 * !+$*,-.$
!""!:.$%&' EH'3$ * #+/$,-./
!"/:.$/%&' I)P$ * !+**,-.#
!""/.*!%&' E=Q!! * !+/#,-."
!"*/.$!%&' L9'C * :+*!,-.$
!"$.*//%&' R2P/ * *+4!,-.$
!"//0.#%)%&' (OS)*> * $+$*,-.#
!"*.$$/%&' FT?! * !+#0,-.:
!""4.04%&' 55/!#/"/ * !+.$,-./
!"$*0#.%&' "0$$"*$R!!789 * /+0!,-."
!"!44:#%&' AM=*"&! * !+0:,-./
!"$#0$/%&' "0$."4:K!!789 * :+4.,-.4
!"*0:.*%&' AB!:"2* * !+#:,-."
!"$*0##%&' 0.$.:.#U.*789 * $+4$,-.:
!"!0"$"%&' E2?*&!. * !+/.,-.$
!""*$*/%&' V>?!B*" * 0+//,-./
!"$0"*/%)%&' WA.*"4!" * !+:#,-.#
!"**:!4%)%&' XT3 * !+.",-.#
!"$$#.$%H%&' W&OB! * *+"*,-.$
!"/4:#0%&%&' V&'BC! * #+/$,-.$
!"""*!:%&' ,T)! * !+0",-./
!"/:!*#%&' AC=M! * !+!#,-.$
!"*00*"%&' !#...!0Y!#789 * !+#:,-.$
!"***//%&' R?C&" * 0+*",-.$
!""##00%)%&' !#....!(.!789 * *+*.,-."




!""#$%"&'( )*++$ # $,#-).%/
!""0-"0&1&'( 2(3456 # 0,60).%6
!"#%$66&'&'( 789!8#' # /,$:).%0
!""#-%$&'( :"6%%6%;!0<=> # !,"0).%6
!"!:"%"&8&'( 2='?!'@ # !,"$).%$
!"/!$$"&1&'( A5*'!@ # :,06).%/
!"6"/-6&'( B4C4#$ # #,%#).%/
!"/$:6-&'( 24'*+D! # -,$-).%"
!""06#$&8&'( E4F46 # 6,0%).%6
!"66:00&'( G868(6D! # ",6%).%$
!"!:%/#&'( HI35! # /,-0).%6
!"#"#-#&'( JC(!!#5 # !,6#).%6
!"/!"!%&'&'( 7*=K6 # :,-#).%6
!"!:!66&'( )IK5 # -,$-).%/
!""#/$$&'( 70--0- # ",06).%"
!""$/%!&'( L-6%%/6H#!<=> # :,$0).%6
!"#$##:&8&'( A*'8 # !,0").%0
!"/0-%0&'( M9K9'(! # :,0").%"
!"!:6":&'&'( 7FK#N: # #,!%).%6
!"6"":%&'( 2+'*O! # 0,$-).%0
!"#$/!#&'( H5O46 # -,/$).%/
!"#""##&8&'( P5'N!@ # 6,0:).%6
!"6/#--&'( 73*3!' # #,:$).%/
!""%:"/&'( M5++=! # $,//).%/
!"#66""&'( )K3* # ","%).%6
!"/#"-$&'&'( 7*F'' # ",60).%"
!"666-0&'( #:%%%##Q%0<=> # 6,60).%"
!"/$/!#&'( JNR*9" # !,:-).%6
!"/%0%:&'( SCO+*/@ # !,%!).%6
!"#%$0$&'( T+C!'! # !,%$).%$
!"6-$:0&'( B4C4!6#+ # 0,/6).%/
!"60!-"&'( MUO! # 0,66).%$
!"/0!#%&'( V(> # !,:-).%$
!"6:!6:&'( S#)*(N$"%C # !,$#).%"
!"/-$/#&'( #"!%%!"L%-<=> # -,/-).%/
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!""*+"+%&' CADB$ $ !-,#(.#/
!"/#7/!%&' "7//"#/1#/234 $ !-,0(.#,
!"$7/$"%&' !+###!$;!*234 $ /-$"(.#,
!"$$!,$%&' EF=! $ 0-0+(.#/
!"/$+7*%&' /!!##*+5#$234 $ $-$#(.#/
!"$*#*"%&' 5GA/&"" $ !-/*(.#/
!","!+*%&' (@990 $ *-+,(.#"
!"//7"+%&' 2&H/+ $ $-!,(.#/
!"!0+/"%&' I(!/*+*7 $ /-##(.#,
!"$+!!0%&' ,"/#"$!J$!234 $ $-,,(.#/
!"$!"+*%&%&' 5&K'! $ $-+$(.#/
!"""!*/%&' JD4, $ *-""(.#,
!"/#/$7%&' 5LK $ !-+7(.#/
!"/$!*7%&' "7/#,$/1!/234 $ /-*/(.#*
!"!0#//%<%&' 84<9&K* $ "-7$(.#"
!"$"0$"%&' CM&3K! $ !-,!(.#,
!"!0$$#%&' NO=B$ $ ,-"*(.#*
!"$**/0%&' C3=/ $ *-,,(.#/
!"$"0"+%&' JDP $ !-$7(.#/
!"",+#,%=%&' QAA0 $ $-$,(.#,
!"$"$$,%&' ;<H0 $ $-7"(.#"
!"/"!"*%&' )@3&$ $ *-/!(.#+
!",",**%&' "7//"/75$#234R $ /-+#(.#/
!"/7"7"%&' CM9,&7 $ 7-0+(.#0
!",0/$7%=%&' 615!###/7$$+R $ *-"#(.#0
!",+/!"%&' 6!'S! $ "-"+(.#"
!",+"7,%&' $7###,$J#!234 $ 7-/"(.#/
!"/77"0%&' I5#"*"#! $ 0-#*(.#/
!"""0#"%&' Q!+(@'S7*D $ !-7!(.#"
!""/!"/%&' NM@'! $ !-#"(.#"
!""//$/%&' 59S9+* $ ,-0/(.#,
!",*#7,%&' TG@ $ +-"$(.#+
!"!7*$*%&' ;S&F$, $ 7-#+(.#+
!"/+*#,%&' JA:<$ $ 0-/!(.#,




!"$!0+"%&%&' U@A<$/ $ /-7#(.#/
!""+$07%&' ;;+*/,$! $ "-7!(.#,
!"#$%$#&'&'( )*+*, - $."$/012
!"$2-3-&'( ",$-""141"567 - 2.,-/01"





9:;<=>?@A@4( +", ;B: >C>DEF99
9:;BBG<@A@4( H4.6; >B; DC><EFG=
9:DD??B@4@4( &IJ2"$ >G; 9C:BEFG:
9:;:<?B@4@4( '/2>D4: 9<> >CB9EFG=
9:D>>>>@4( I(", 9B? ?CG>EFGB
9:;BD>=@A@4( K,",6"& 9=< ;C>:EFG=
9:;<=D<@4@4( E15; 9=: :C?;EFGD
9:;<DD:@A@4( ELM:3 9DB 9CD=EFG?
9:>B::>@4@4( N66 9D> 9CDBEFG?
9:9D?;;@4@4( O#AD4 9D9 BC>DEFG?
9:DD<BD@A@4( P.?QM> 9:= =CBDEFGD
9:9=GD<@Q@4( N(6D29 9:D ;C9:EFG<
9::?=<=@Q@4( '26> 9:; =C;DEFG:
9:>GDD<@4( '%/6 9:; 9C9<EFG;
9::;B=>@Q@4( '$M> 9:9 =C9DEFG:
9:;B>99@A@4( E/#7/D 9:G ?CBDEFG:
9:D=>:D@A@4( H4.6; 9;> BC9GEFG=
9:;B9:;@4@4( PA,129 9>D 9C9DEFGD
9:>=D?;@4@4( 0$A#>> 9>: 9C:BEFG:
9:;;:<<@A@4( +,Q 9>> 9C?;EFG?
9:DG>?B@4( )/= 999 >C=DEFG:
9:D9?<?@4@4( R46"%> 99G :C<>EFG;
9:;B9=D@4@4( !2#/2% 99G <C>BEFGB
9:9=?:9@Q@4( ELM:3 9G= ;CB9EFGB
9:;=D=<@4( S4.> 9GD 9C?:EFGD
9:;B:B<@Q@4( ET1> 9GG =CD<EFG?
9:;B;G?@4@4( U649 9GG 9CB?EFG;
9:>;99G@4( O#/94> ?= ;C<BEFGB
9:;;B>;@Q@4( '%"M> ?= 9CB;EFGD
9:;B??;@A@4( V16" ?D ;C:DEFG:
9:D=GD=@4@4( *=WQ899=% ?D :C;=EFG:
9::<9G>@4@4( W1"=9 ?: =C9DEFG:
9:DG<<:@4( O1;= ?; 9CB9EFG;
9::<?G?@4@4( R"6/;? ?; DC:DEFG=
9::<9B<@4@4( O2(; ?> BC9GEFGD
9:;<9=?@4@4( 0".1:$ ?9 <C?:EFG:
9:>::=;@4( >>9GG9GXGDULY ?9 ;C;:EFG;
9:D=D=B@A@4( +", <? :C;9EFG?
9:D=B;?@A@4( N".2A> << ;CB?EFG:
9:;<;9<@A@4( Z51, <B 9C9:EFG=
9:9?>D>@4( E6Q9D <= >CG:EFG:
9::D<?B@Q@4( )[;D <: =CD9EFG:
9:;<G?9@4@4( K>4M\& <; 9C?<EFG:
9:>==<>@4( X]O9GGG:=;:; <9 9C;GEFG;
9:><=G<@4( R-/2>$ <9 >C<9EFG=
9:D>BDB@Q@4( K$4F49& <G =C>>EFG:
!"!#$%!&'( )*(+ $, !-!,./,0
!"#1021&3&'( #%2,",,4%"567 08 2-"1./,"
!"20,02&3&'( 9:,%##," 01 2-8#./,"
!"28%10&3&'( ;<3#' 01 "-,8./!,
!"2#2$1&'( :=> 01 !-,$./,"
!"!1,%!&'&'( ?'@*#A 0# "-1,./,"
!"28011&3&'( :BC>D 0# 2-,!./,"
!"%",!0&'&'( E6+(! 0" 2-!8./,#
!"!02%0&'( ;'F% 0" %-2"./,"
!"1,%",&'&'( E+G+*D 0" 8-#"./,#
!"%0,",&'( HIJD 0% 0-8,./,#
!"#,$$!&K&'( 4*G!20@ 0% 1-,0./,2
!""$"82&'( L'6*% 0% "-%,./,$
!"#,0$2&'( MJ(! 0! !-"#./,2
!"!1"#"&K&'( 9D('% 0, "-$1./,"
!"%8,$#&'( :BN>! 18 !-0!./,"
!"22"0#&'&'( ;0$228 1$ %-,8./,2
!"%,8%$&'( O(1C'P! 1$ "-2#./,#
!"#1,!%&3&'( 5+'KB(%'A 10 2-08./,0
!"%,$%8&'&'( Q=R'S 11 2-1%./,"
!"2",#1&'&'( )ITU1 1# !-#,./,1
!"21!#%&'&'( E@36* 1" !-"!./,2
!"220$1&3&'( OBG>% 1" 1-1$./,0
!"#%18%&'&'( )IT>F% 1" !-2#./,2
!"28!$"&K&'( V3+ID!0 12 0-8%./,1
!"%2,#0&'( ;'*N'% 12 !-!$./,"
!"2"228&'( ?+@*!P 12 !-2$./,1
!"!1%8#&'&'( MP%GC 12 !-$#./,1
!"21%8%&'&'( W'N! 1% 0-$,./,8
!"2002#&'( L**!G!%' 1% %-,$./,2
!"20"#1&3&'( Q(RI>! 1% 0-!"./,"
!"%%"8,&'( X+6*% 1% 2-$%./,0
!"201$0&3&'( ?7@*8 1% %-2,./,2
!"20%%2&K&'( Y@*! 1! 8-##./,#
!"%%%"!&'&'( )IT>'! 1! #-,"./!!
!"##$!1&'&'( ZD(I2 1! !-8$./,2
!"218""&3&'( "822"28;%,567A 1! 1-"$./,#
!"",!02&3&'( OBP* 1, !-0$./,2
!"!10%0&'&'( ;[@# 1, !-"2./,"
!"%081#&'( AOK@*! 1, !-88./,"
!""$!%2&K&'( VCU6 #8 !-"0./,0
!"##08%&3&'( )I+ #8 8-!%./,2
!"%2,"2&K&'( \I323A #$ !-21./,2
!"!$"21&'( O(30 #0 0-2!./,1
!"#,$$2&'&'( ;I21 #0 $-,,./,1
!"28%0!&3&'( M7 #0 %-82./,$
!"##8,$&'&'( OD*B*! #0 1-2!./,1
!"21880&3&'( OR2@CGP #0 %-0!./,1
Decreasing
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!"#$"%&'(')* +,-. %% /0&1231"
!"#&4"!'(')* 5678/ %% "0&9231#
!"!9!&%')')* 58:% %% !0!#2319
!"//&/"';')* 27;& %% /0"!231%
!""&44%')* +(<," %" 90""2319
!"%%&!%')')* =>:)? %" $0!#231"
!"/1&#1'(')* =>:)@ %" &0#%231"
!"#9$1&'(')* A<6" %" $0"/231#
!"/"!#!')* +B,9)# %# $0!%231&
!"%!#!#')')* !!!119$C//DEF %# /01&2319
!"%44&9')')* .D7;!$ %/ !0/#231$
!"!$$"4')')* GH7! %/ &0#%231"
!"#"1!!')')* IJ*;% %/ !0/%231#
!"%1&%$')')* +B,!)/ %/ "0%1231"
!"#9$%4'(')* +JJ#. %! 4041231%
!"!9!$%')')* K8)<# %1 !011231"
!"!9&!%';')* L-?# %1 !0"%231%
!"%91%$'(')* G6M6!14 %1 /0!$231%
!"#$114')')* NO7#9" "4 %0"#231"
!"#"/1/')')* L+1%%!1$ "4 #0%/231#
!"!94$1')')* +B($)/ "4 /0&/231#
!"!$/4/')* IP"$ "& /01"231"
!""!&$1';')* QF8/ "& !0%&231#
!"!&/$#')')* .D7,#1 "$ "0$!231&
!"!91&/')* D)?! "$ 90!#231%
!"#$11&'(')* G6M6!14 "$ /0!!231"
!"%"9!%'(')* RS7!" "$ !04#231"
!"/%##9'(')* T/3U! "$ /09$231"
!"!4$#&')')* G76/ "$ /0#!231#
!"#%9%/')')* VJ)E/. "9 /09/2319
!"/9411')* W6H8!< "9 #09$231%
!"#94%4'(')* XM,O "9 &09!231"
!"#$9&&'(')* 5*79)7/ "9 #019231"
!"%!!$/')* G7SY, "9 #0%1231"
!"%4&#%';')* CJ)H)! "9 #091231%
!"#&!$!'(')* AMZ,4 "9 #0&&231%
!""&11%')* R);:! "9 904!2319
!"!9"!$')')* X8-[$ "% !0$%2319
!"%/$#"')* DJ);M*/). "% #01#231"
!"#4"9/'(')* .G6M8!1 "% !0!&231"
!"!&!"/')* U<JH& "% /0%92319
!"!$///')')* G6M6!/# "% !0/"231$
!"!$919')')* +),S "% "0%1231$
!""$4/#')* !&!11/9L1%DEF "% &0!/231%
!"/4!&"')* V\EJ!. "" !0/#231#
!"#//$1')')* +:67% "# !0#$2319
!"%"999')* ]^+!111"9&%% "# &04!2319
!"%/9&#')* CJ)H<& "/ /0/9231#
!"#$#%!&'&'( )*+", "# -.//01/,
!"!,!23&'&'( 456 "# %.$201/%
!",/,#!&6&'( 789': "# %.#301/%
!"$",--&6&'( ;<=>5!/ "# !.#%01/,
!"$"2"2&'&'( ?@95A% "# %.%-01/%
!"!2-2#&'( B9@! "# %."$01/%
!"$,2#-&6&'( CAD! "! %./-01/%
!"%%3-"&'&'( E59# "! -."301/"
!"$"3"#&'( FGH'I "! "./$01/"
!"%--,-&'( J!"0K(5,,-> "! $.,,01/"
!"%/#--&6&'( 4+L#! "! ,.##01/$
!"#!$2!&'&'( ;MN,A!; "! #.,-01/$
!"$,/-,&6&'( ;O:H+! "! $./#01/"
!"!,"!$&'&'( P#'*Q "/ "."-01/$
!"##/"$&'&'( O(+I!# "/ !.,%01/,
!"$,#23&'&'( RA'+%! "/ !./201/%
!"#-#-3&'( ;?@*3 "/ $./-01/"
!"%3%-3&L&'( EN'5= "/ %.$/01/$
!"$!!22&'( JI'SH" "/ !./301/"
!"%,!2%&'( J@A! "/ %.3%01/,
!"!$23,&'( J'Q'+# %3 ,."201/2
!"##"-2&'( ;T='5" %3 %.$,01/$
!""3#$,&'&'( 4'H!!' %3 #.!%01/"
!"#////&L&'( UVH+! %3 #.2#01/"
!"!,2"#&'( W*5+! %3 !.2/01/%
!""-,3"&'( XYI %3 %.!!01/,
!""/!,2&L&'( M++ %3 %.,!01/"
!"#%!,,&'( W5%, %- ".-"01/"
!"!2-!/&'&'( ?AIH!; %- %.!301/"
!""3%,%&'( CZ% %- #.%#01/,
!"#!-"3&'( T('V# %- !./201/%
!""33#3&'( JNI@(% %- #.3%01/"
!",/!32&'&'( T(>'+" %- -.-/01/$
!"!,$-3&'( ;T+'KA %- #.%$01/$
!"%,!-/&'( JI'SA$ %2 !./$01/%
!"#/,"#&'&'( #/!/!//[!#4G\ %2 #."!01/,
!"%2-%2&6&'( OD@5G+% %2 $.2%01/,
!"%-,$#&6&'( OGV: %2 3./"01/%
!"$3-,!&L&'( BH6@!/; %2 !.--01/%
!"#"-//&'( 0I'9 %2 #.!#01/%
!""3%,-&'( JAI %, !.%301/%
!"$$/%#&'( WAIN@! %, ".2%01/$
!""-22$&'( U]#/% %, $./#01/$
!""3,##&L&'( C(+,'+! %, !./"01/"
!"$$,,#&6&'( 4+L!2 %, ".3"01/,
!"$$3%3&6&'( TK+!" %, -."201/"
!""-,#%&'( <=>=!#% %, !.!!01/,
!"#,3/,&'( U]#/% %$ -.#$01/%
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!"#$!%&'() *+,-./0 ,1 "21134%1
!"115#&'6'() 789:;! ,1 ,2,"34%,
!"11$1"'('() *8+! ,1 "2<!34%"
!",&<$5'6'() =0>? ,1 12&"34%"
!"#$<!1'() @#/A1 ,1 ,2#,34%"
!"<%&!<'('() =-B ,1 12%%34%"
!"!<5",'() C-;#;! ,1 "2!534%&
!"11$#"'6'() *D,( ,1 52,#34%&
!"!&"%5'() E>F ,1 #2&%34%"
!",1!%,'6'() G(/8- ,1 !2#%34%,
!"#,<%&'() H>9 ,1 <2#134%&
!"#$#,<'() I:-J1 ,1 !2$,34%"
!"1<1$%'8'() I)K1J ," #2"<34%<
!",<55"'('() LM8)!+!: ," "2#134%1
!"#&5!$'('() N+OP ," ,2$&34%"
!"#<<"#'() GF! ," ,2!#34%$
!"#<&%$'() IF)6/# ," ,2##34%,
!""&<#"'8'() *)O6# ," #2%%34%<
!"!$<&"'() Q89/ ," !2!#34%,
!"1#1""'6'() HQ=!%%%"1$<" ," ,2$,34!!
!",,51!'() I/01( ," ,25!34%"
!"!$$$1'('() RJ+,- ," !21%34%,
!",1!!#'('() I)K1+ ,, #2<#34%"
!"!1$"%'() 30OS01 ,, !2#"34%,
!",&555'6'() @M.P ,, <2!&34%,
!",&<#<'() TUK,<0# ,, 52&534%1
!"#,&<,'6'() ?NK8#$ ,, 12%#34%"
!"!$%&#'() LM8)!+#-: ,, &2!<34%"
!"1<#%1'6'() V-:( ,, !2<#34%"
!""$&$$'() =J#%% ,, #2%,34%"
!""511<'() ?L#4V#,? ,, 12&,34%,
!",,$,,'() GFJ:,- ,, $2<<34%1
!"!$!%!'('() N)F, ,, !2$#34%1
!"1"&<%'() L)()8U! ,, !2$<34%,
!"#,<<#'() I)K<(K# ,, ,2"534%"
!"11<5<'('() @/KU"- ,# <2!"34%"
!"#<<"1'() L8K5%((! ,# !2<<34%,
!"#%,&<'('() L,U,- ,# ,21&34%1
!"1!!$$'() ?WJ/#< ,# !2,"34%,
!",5"<<'8'() X>J,!? ,# &2%,34%"
!"#&<1!'6'() HQ=!%%%"1$<" ,# #21<34!!
!"!<!",'() I)K1Y ,# !2#$34%1
!"#%#"5'8'() =:0< ,# "25,34%1
!"11!%1'() @)KF!# ,# #2##34%<
!",&!&#'6'() L(J+- ,# &2,,34%"
!"!155!'('() Z0+J:, ,# $25!34%"
!""$15!'() =)88 ,# !2",34%1
!"!$%5%'() @0S(K ,# !2<&34%,
!"!#$%#&'( )*+,-. .! ,/0"12%.
!"3%,%4&'( 5*6! .! 3/#!12%"
!","!.$&'( 7'8!' .! $/4312%"
!""4,.4&'( ,#%%%3%1%,79: .! ./0"12%.
!"030.%&;&'( 1-<=-! .! ,/,%12%"
!"!3$,3&'( >?80.968! .! ,/!%12%.
!".#"30&'&'( @"A* .! !/#"12%0
!"03,$.&B&'( CD6A .! $/4!12%.
!".4#,.&'&'( E78B!% .! ./".12%0
!"0%".%&'( F?D! .! ./0$12%.
!"!3"#,&'( GH'8! .! ./4#12%0
!",,44!&B&'( GH8- .! #/!$12%3
!",3"%#&'( CIJ*8! .! ,/%312%.
!"3%!#$&'( K6'L'! .% !/,,12%"
!"0!!$0&'&'( >;6MD! .% !/,#12%.
!",.$03&'( EGN'8! .% 4/!.12%3
!".",40&'( 5?NM"' .% ,/"312%.
!""4"%%&'&'( GN'?DM, .% !/3.12%.
!""$0%#&'&'( CM"# .% !/,%12%"
!"0"##4&;&'( OPC!%%%".0,#E .% 3/4312%"
!"!3$0!&'&'( Q(83=!M .% !/$412%.
!",$%,4&'( K<D:!! .% ,/3012%"
!"!03#,&'( R<-J'# .% ./!%12%"
!".4%$,&;&'( S,'TU .% ./"012%0
!"!4443&B&'( VMA.* .% ./,,12%"
!",#443&'( @<N!,! .% 3/$%12%0
!",.,!#&'&'( ,0!%%"$V!$79: .% 0/,#12%"
!",.,03&'&'( Q(83=!J!E ,$ !/,012%.
!".34"4&;&'( VN8'! ,$ 0/4,12%.
!"!3""%&'( CM!3" ,$ ,/3012%"
!",.!44&'&'( 3#,%"03W%#79: ,$ #/.412%"
!",4,43&'( ,$%%%$#C!#79: ,$ ./."12%0
!""%#.$&'( X+JTD ,$ ,/$#12%$
!"!03$!&'( K-J!E ,$ ,/,,12%.
!".0$%3&;&'( R*8, ,$ "/$,12%"
!"!#.,!&'( K"YBI!.,+ ,$ !/.$12%.
!"!3"$4&'( @89D ,$ ./!$12%"
!".0.!0&B&'( ,$%%%."1,,79: ,$ #/%412%.
!".#$%#&'&'( >*D' ,$ ,/,"12%"
!".,!#3&'&'( 16J ,$ ,/0!12%.
!",".%$&'&'( F<DB, ,$ ,/.#12%"
!",$!0!&'( YM?34 ,$ !/"$12%0
!"0,,.!&;&'( VZ,%. ,4 ./3412%.
!"0!%#"&'( 76T!. ,4 $/0,12%3
!"!30%4&'( F+M,4 ,4 ,/0$12%.
!"000"3&B&'( GT.', ,4 ,/%!12%.
!"0,#3#&'( 7?*8! ,4 "/,$12%"
!"!3!4#&B&'( @6?D, ,4 ,/3012%0
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!""#"$"%&' ()*+',)#- #) #."#*/0$
!"11!2"%&' 3,4&5 #) !.6$*/0"
!"$27)$%8%&' 9:;&< #) !.#1*/0$
!"!2!1$%&' =+51"&> #) #.!0*/0"
!"106)1%&%&' ?@5# #) #.")*/0$
!"$)6##%8%&' >=AB#1&1 #) 6.!1*/0)
!"#7$"7%C%&' ?D<<#& #) 2.7$*/0$
!"$7)$)%8%&' E+CF! #7 $.!!*/0$
!"$")0!%8%&' =AB#1&1 #7 !.71*/01
!"$1"#6%8%&' G5C#7A #7 #.!0*/01
!"$7)"6%8%&' H+IB8# #7 !.)#*/01
!"#$#2$%&' >J$F$&> #7 !.)1*/0"
!"1#!#$%C%&' K+I,"< #7 ".6$*/0$
!"$$)67%&' HL167"2) #7 !.!!*/0$
!"1!21#%&%&' ?I-I!)) #7 $.#)*/0"
!"1!12"%&' M&+5!" #7 6.)7*/0$
!"100#!%&' N<OAP# #7 !.0$*/0$
!"16)1"%C%&' (QPA'$ #7 ".0)*/0$
!"10!$)%&%&' =-+5RP<2& #7 7.22*/0"
!"#2)!6%&' ST3!000")"$6 #7 1.$"*/01
!"")10"%&%&' 3<8$> #7 1."0*/0"
!"!6!)2%&%&' =')CR&" #7 ".)"*/0"
!"$)0#"%&' 3B,B60& #7 ).67*/0"
!"$$7"2%&' U,+$ #7 #.!"*/0"
!"!77$$%&' GPF!"2 #7 1.0#*/0$
!"!1)##%&' =B,# #7 6.!0*/01
!"1!#6"%C%&' =P+5- #7 ".60*/01
!"!6!70%&' ?I-I!17 #2 6.#6*/0"
!"!2"66%&%&' (B'P2 #2 #.!0*/0$
!"!17#"%&%&' 3,B"# #2 #.!1*/01
!"$"6$1%&' H&V!> #2 #.#6*/0$
!"#$6$6%&%&' 9RF!& #2 $.61*/0$
!"!2266%&' !!!000)K!$GRV #2 1.0"*/0"
!"!20)$%&' >WF&P,1 #2 !.00*/0"
!"##"$7%&' 3XA1&# #2 6.6)*/0$
!"#)2#"%&' #)!0")#L07GRV #2 !.02*/0"
!"1")!$%&' 3B,B7# #2 !.2)*/0$
!"$$71!%&' =AB$6&!0 #2 ".#1*/0$
!"!)!)6%C%&' Y&A&'! #2 !.)2*/0"
!"$70!2%8%&' >G&5#B #2 2.1$*/0"
!"$1"!2%8%&' MR4O #2 1.71*/0$
!"#6#1!%&' M+,I# #2 $.7"*/0$
!"$$772%&' S;F5 #2 !.7!*/02
!"1#!72%&' ZD5!1$ #2 #.17*/0$
!""0)$!%&' [&B;! #2 !.16*/0"
!"$$1$7%&' H'+8 #2 !.27*/0"
!"!162#%&' *RF$; #1 1.2#*/0$
!"!2$#2%&' 3+R5! #1 1.12*/0"
!"!##"$%&%'( )'*+ +$ !,-./0-1
!"11".2%'( 3.411# +$ !,.2/0-1
!"+.#+1%'( 567&(8+" +$ ",-#/0-1
!"1#-.4%'( 9:;:" +$ !,"-/0-2
!"+-44-%'%'( <=;'* +$ $,$"/0-$
!"!4$-$%'( >?@A(" +$ $,-+/0-2
!"+12#+%'( ?A@B'4 +$ +,#2/0-"
!"$$--#%'( 37A> +$ #,-./0-$
!"!.2"2%'%'( CDE$ +$ !,12/0-"
!"!2+11%'( /FB1F +$ 1,+1/0-1
!"1"+1+%'%'( +2!--1-G-2)FH +$ $,+4/0-1
!"14$-1%E%'( /AB!> +$ 1,$$/0-.
!"+"$"$%'( I3--1#2$ +$ #,4./0-"
!"+$."+%'%'( J&K++A! +$ #,21/0-"
!"$!-42%&%'( )'K! +$ +,#!/0-$
!"2-.-.%'( L(7"'+ +$ !,1"/0-"
!"1#"""%E%'( >J68A!- +$ $,$$/0-$
!"!.12.%'( L77+K' +$ 1,2#/0-1
!""4244%'( LMAE: +$ !,#$/0-"
!"!2!-!%'%'( GF&(!;!K +$ +,4"/0-1
!"+-4!$%'( NAF+ +$ .,4#/0-2
!"+$$24%'%'( J68611 +$ $,#!/0-2
!"$+.1.%'( +4!---4O+")FH +$ !,+#/0-1
!"!2."#%'( G(P'! +$ 1,"!/0-"
!"$+42.%'( 3M:"'1*7 +$ !,!1/0-1
!""4#-1%'( C877! +$ !,-+/0-1
!"!.2".%'( CDE$ +$ .,!./0-"
!"+41!"%'( LKD7 +" !,"$/0-1
!"!$.41%'( Q7&1$ +" !,"#/0-2
!"!2.$2%'( RD'S*! +" +,../0-"
!"+"1!4%'( !!!--2.R++)FH +" !,"1/0-"
!"+4+44%'( +1!--$!/!.)FH +" $,12/0-1
!"!.#2+%&%'( N;P +" .,#!/0-"
!""4!--%'( "411"1#T!#)FH +" !,+2/0-1
!"+-#$+%'( CMD +" ","1/0-$
!"+4!.4%&%'( JP'77K2* +" ",2$/0-1
!""41++%'%'( 3ME"F! +" 2,!4/0-$
!"1"1$2%'%'( L&6'$ +" 2,#-/0-2
!""4.#!%'( >CDE$ +" !,""/0-1
!"!$244%'( U*8+V! +" !,1#/0-"
!"$!--$%'( C@6M! +" !,.#/0-1
!"$2-2!%'( NF6'74 +" ",-2/0-1
!"+2".2%'( )'&'! +" 1,2!/0-1
!"1412-%E%'( >C:K+$'$ +" .,44/0-4
!"12#$!%E%'( JEDAK# +" $,!!/0-"
!"$#422%E%'( 3WX7!> +" #,"./0-1
!"11.-"%&%'( J:MK! +" 2,22/0-"
!"!41#+%'%'( N*71 +" !,4+/0-"
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!"#$"%$&'&() *+,-!! #" "./$01%2
!"!$/34&() *,5676'' #" 8."201%"
!"!/8"#&() 9:-7!% #" "./$01%"
!""$!%%&'&() /$2%/%3;%8:,< #" ".%%01%2
!"/4%2#&=&() 9>#(?@ #" !.4201%$
!"##38#&'&() >#10( #2 /.3%01%8




!"22/4#&'&() H)-/?! #2 !.#%01%2
!"2342!&=&() *)I!2 #2 4.%301%2
!"#2$8#&(&() J5)54 #2 2./"01%"
!"!42#8&() JKL-! #2 !./"01%4
!""$/!3&() *-=# #2 !.$801%2
!"##"3%&() DM=2 #2 3.2$01%/
!"224$4&() NM<! #2 $.4"01%/
!"/43$2&() J7,I/ #2 8.%%01%/




!"!3/!!&() O-) #2 !.3301%"
!"/%%!!&() >'B!$P!# #2 #.%"01%2
!"2$!""&=&() A'5(4 #2 #.$301%/
!"/%$!"&() H@,M! #2 !.3"01%"
!"#%"34&() CQ7$ #2 ".2401%"
!"#2!%4&() FP6#P #2 2.%#01%"
!"#!3"%&() HPI(! #2 #.%201%4
!"##4$!&'&() C((7(B# #2 2./301%$
!""3$$%&(&() H)-,?! #2 /.%201%"
!"232!#&'&() R)P-2 #2 2.3201%2
!"28""!&=&() R()'# #2 !./%01%"
!"22/"4&() GM' ## !.8!01%"
!"22$/"&() EPM7# ## !.%$01%2
!"!/3#8&() RP+ ## 2.8!01%/
!"/!$/4&() S7)! ## 2.4301%2
!"#8%""&() J(5'(-!7! ## 2.#!01%"
!"248%#&=&() 9*5'P!% ## #.!301%"
!"##4%3&() 9H+--!89 ## !.""01%/
!"#42"#&() DT2P ## !.8#01%2




!"!3"32&(&() GV)(! ## 2.#"01%2
!"234/4&=&() *,55!$P ## 4.#801%2
!"/!""4&() HM)=+! ## /.8"01%$
!"4%483&(&() D6I!!I ## 3.#201%/
!"2$$!"&=&() F'-!" ## 2.8"01%$
!""32!2&() *--! ## !.$"01%"
!"#$%$"&'&() *+,- .. /0"%123"
!".%##"&() 4')5! .. #03.123#
!""%.67&() 8')9! .. !03#123#
!"6"%$"&() :)-;$ .. !0."123#
!""$%7%&'&() <=>'/ .. /0"61236
!"..%76&() ?(5@" .. 6036123#
!"#6/!/&() AB@.3(! .! 60#3123#
!".3%%/&(&() C-@! .! !07"123#
!"6.!7.&() :A36#""3 .! "0"$123#
!"6/$./&,&() D(>' .! 60/61236
!"!//33&(&() EF(G! .! #0"3123#
!""%!"%&() H>G .! !0!#123#
!"!/""/&() I5+5#3( .! #0/"123"
!"6..%6&(&() 1J=#= .! 60."1236
!"6!"76&() KL(F .! !0#"1236
!".$"$6&(&() M;9J56 .! .0"%123"
!"!/7!!&(&() /##3"3$H!!EJN .! %0"%123$
!".!7.#&() <O#-@6 .! !06!123#
!".%66"&(&() !%!33#6P!$EJN .! /07/123#
!"#%636&'&() EG('+G .! 60!6123#
!"#"%%%&(&() Q()># .! !06"123#
!"6.$33&'&() R-)-;$ .! /07#1236
!"6"/6.&() S>(G-. .! "0""1236
!".$.##&() I'OT! .! /0%3123"
!"#%7$!&,&() U-+.O .! !0/"123#
!".63.3&() KU-,;" .! .033123#
!".7./6&(&() KEG=!#3 .! #0$/123"
!"#$73%&(&() 1>VJF! .! .036123"
!"#$"3.&,&() I5+5"!- .! 70%"1236
!".7!$$&,&() <W,!$ .! /0##123"
!"#""#"&'&() IF+>V! .3 .07$123"
!"!$!%"&'&() *--2-!K .3 %0.!123#
!"#"%#6&() L(@(9 .3 .0"/123#
!"6"/63&() I>J5#6 .3 #0%.123"
!"./%6"&(&() K<+) .3 #0.$123/
!".!73$&() Q+;! .3 !0!/123#
!"66.#/&,&() <+>=. .3 !0.!1236
!".#/"!&'&() AGW)$ .3 /0"61236
!".!$63&(&() ?-@! .3 !0.6123#
!"##$"7&() HG(!# .3 %0/3123%
!"#%.7.&,&() X;N .3 .03"123#
!"!/!7"&() AB@"-! .3 /0$#123/
!"6#!!%&'&() KE@9.. .3 60#6123"
!""%.%"&(&() Y;Z=F! .3 !0"$123#
!".".%#&() [)- .3 /0%$123#
!""%6.$&() M;F;!3 .3 !0"#123#
!"..3#.&(&() S=(G;/ .3 60#3123#
!"!7#/3&(&() <'!% .3 #0/6123#
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!""#!$%&'( )*+,- $. !/!%01.2
!"!32-!&'&'( 456*+'! $. "/-#01."
!"---3.&7&'( 86624 $. $/3.01.2
!"-$$$-&'( $.!.!.9:.!;<= $. "/-%01."
!"!9!""&'&'( >?7!- $. 9/#$01.9
!""#"29&'&'( @*A! $. !/%#01.-
!"2-92.&B&'( ),'($ $. !/9#01.2
!"2!..#&'( 4C$1D9 $. "/.%01.-
!""#$29&'( ;E7 $. $/$.01.2
!"--.-9&'( FGH3 $. $/!301."
!"!%%$-&B&'( I76E,!. $. "/%.01.2
!"-99..&'&'( ;6A3 $. 9/""01.2
!"!9.$"&7&'( 8,(2 !% 2/9201.2
!"22#2-&'( J++2,K !% $/9-01."
!"!3%29&'( 8,L% !% -/-$01."
!"-$%-$&'( %.2."!#M.!;<= !% !/..01.2
!"2"$!%&'( 5NG$ !% !/.901.2
!"22#2"&'( O'*,?9 !% !/"901.2
!""#2"2&'&'( PK*! !% %/$!01."
!""%2%9&'( )H,2 !% "/2201.-
!"2-!.9&'( F<G,?! !% 3/!"01."
!""#$!.&'( ;'K! !% !/!901."
!"!3!!!&'( O'6!' !% !/-!01."
!"-.!#9&B&'( :6'B !% !/.901."
!"!-#"!&'( >Q6,!<$ !% !/"201.9
!"!9%.#&B&'( IB6 !% 2/."01.2
!"!932!&'( IH+$K !% !/.901.-
!"-$#"2&'( @L9B( !% !/2$01."
!"!-9#3&'&'( JB'+ !% 2/9%01.9
!"$92#$&'( J+G!K !% 3/".01."
!"-.3.9&'&'( )*L2 !% !/#901.2
!"--!%3&'( ;6E! !% 9/%-01.9
!"-"9$9&'( 8L(, !% $/9201.3
!"$9%9"&'( 2!!...2)!3;<= !% -/-#01."
!"!393"&B&'( :HLR'" !% 3/!"01.9
!""3939&7&'( 5!..'!9 !% $/-$01."
!"2%!-2&'( ;6A!""K !% 9/#901.3
!"29#.%&'&'( 5+<6! !% 9/"!01.2
!""%.3#&'( 5(2R'L9 !% -/$.01.-
!"-2!3"&'( $2!..39:!2;<= !% -/9.01."
!"2"2!.&'( SG+*$ !# "/9$01.2
!"-.3#"&'( ;T,= !# 2/2-01.%
!"!93%%&'( I*+G3 !# $/.#01.2
!"232$3&7&'( 06H+?! !# -/.%01.2
!"$#$!%&'( 4;QK+ !# #/%.01.9
!"-$!9%&'&'( >R=U !# $/#"01."
!"!3299&B&'( 8'LG! !# "/#-01."
!"-2"93&B&'( ;+B!-' !# 3/%201.9
!"#$!#%&'&'( )*+,- !. !/01234"
!"$"1.!&'( 56678 !. 8/8"2348
!"#$118&'( #184"0")4%5*9 !. "/#$234"
!"#408"&'( 2*:"'$ !. $/8!2348
!"#!$!%&'( ;:7884 !. $/#%234"
!""0%84&+&'( <'=9! !. !/81234#
!"$14#"&+&'( >?*8?7 !. !/##2348
!"818.$&'( >,@=$' !. %/0%2348
!"".18%&'&'( A7=(! !. $/4#2348
!"80"#0&B&'( >,CD !. 0/"1234"
!"#!""0&'( "088"41)4!5*9 !. "/"%234"
!"8#!%"&+&'( E?6!, !. %/8!234"
!"8%%#4&'( F*C*7! !. #/1"234.
!"$8$%$&'&'( GA8:8'G !. !/0.234"
!"#$4"1&'( H',D?7 !. #/!8234"
!"##00"&B&'( 2CI@C! !. !/!"2348
!"#448!&'( >J" !. !/%42348
!"8%$0.&B&'( K'*,+ !. !/!8234"
!"##$%#&'&'( 5L+!% !. %/80234#
!"$%$%0&'( M'N71 !. 1/402348
!"".$4"&'( GO'@! !. !/112348
!"$8".%&'( H=*7( !. 8/!!2348
!"$"%8$&'&'( 56@8C !. 0/042348
!"#$48.&'( H'7P'!G !. 8/"8234%
!"$".18&'( 5Q:$ !. 8/#42348
!"8#1"0&'( RS' !. !/8%234"
!"!#1$8&'( 2*:# !. $/$02348
!"8"!!!&'( GT7-Q$ !. %/%0234"
!"#"1#.&'&'( U+,$$S! !. 8/#$234"
!""!.%%&+&'( GK(S++! !. !/002348
!"!1%!$&'( V6=# !. 8/.8234"
!"$4.10&'&'( WX-'? !. $/%0234"
!"!0"14&'( RQ?" !. $/!$234#
!"#$4#!&'( >,(=8 !. $/"1234#
!"!11%$&'&'( 57C. !. ./#1234"
!"!1$#.&'( H,(# !. 8/08234#
!"8!4#1&'&'( K=++$8 !. 1/#8234"
!"$8#%"&'&'( K'*,+ !1 !/$$2348
!"".%"1&'( <'Q$'! !1 $/1$234%
!""08%4&'( H+:$=?$ !1 !/4.234"
!"!%444&'&'( K=SB! !1 "/"4234"
!""11$4&B&'( K=9',' !1 %/.02348
!"$"444&'&'( 57+!! !1 $/0!234"
!"#!4.0&'&'( >=,Q! !1 8/".2341
!"$8".0&'( G<NS !1 $/#12348
!"!.4$#&'( Y-C-?$ !1 !/%%234"
!"$1!$%&'( A+7'!? !1 !/.12348
!"!0844&'( FC(! !1 !/"1234#
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!""#$"#%&' ()*+" !, -./0120"
!""#/#3%&' 456**! !, !.3#120"
!"$$-7#%8%&' 9&:3! !, ".,,120/
!"7$-/,%;%&' <=>&:? !, ".001207
!"77/$"%&' @AB&$ !, 3.!71207
!"!#3"0%&' C>+3 !, !.!01207
!"$3/,0%&' @5*- !, !.#$120/
!"30",#%&' D&+!*! !, -./"1207
!"$/0#7%8%&' 1=E7FG !, -.-3120"
!"7"707%&' 9&+?! !, !./-120"
!""000-%&' H*EI,# !, 3.3312!0
!"3-$--%&%&' !!!00!-J379=K !, 7.0#1207
!"7$-##%8%&' LK !, !.$3120"
!"!/0/0%&' (>F!:!$ !, 3.7-1207
!""#3,-%&' MI+F7 !, 3.#0120/
!"37,#$%&' 1A*6! !, !./31207
!"!/!,/%&' <NA>! !, ,.!/120$
!"!///#%&' ('F7$ !, !.0,1207
!"$3$!-%&%&' OE+7/ !, !.37120/
!"$$3$!%&' L'A&! !, !.3/1207
!"!-3-3%&' <'I&7 !, !.",120/
!"$07-"%&' CP*+?7 !, ".3$120"
!"77/"$%&' Q*F""&! !, !.70120"
!"$3--,%&' /#30"7!R309=K !, ".3-120"
!"3,3$0%&' M'+3&3 !, $.7!120"
!"7,07$%8%&' 96E!" !, ,.7#120#
!"3"7",%&' S++/F !, $.$-1207
!"/0/03%&' 4*F! !, !.03120/
!"3"7,7%&' MINF87 !, 3.$-1207
!"$3/$-%&' 4BK !/ /."-1207
!"37$7$%&' THU!000",,-" !/ #.7"120/
!"!/07-%8%&' U5I/! !/ !.7$120"
!"3#!/,%&%&' @+V*! !/ ".7"120$
!"3/37/%&%&' C*)* !/ 3.3/120"
!"!$-"-%&' U+BG !/ -.!,1207
!"7$,"$%&' $07!"7-C0,9=K !/ ,.0$1207
!"!$/#7%&' DN'! !/ !.0,120"
!""#!07%;%&' DP6P !/ 7.,$1207
!"3,!3-%&%&' <6I6+I !/ #./#1207
!"3-00$%&' @W&;! !/ ,.-,1207
!"7/$37%;%&' !#!0033J0-9=K !/ !.7#1207
!"3#,,/%&' Q*F!0&/ !/ #.#!120"
!"77/7"%&' LIE3>+3 !/ $."!1207
!"7"#/0%&' D&IA7 !/ 3.3"1207
!"$0/-0%&' 9&6>+3 !/ /./"120"
!"3#0#3%&' MF;*$ !/ 7.!"1207
!""#$,0%&' CNX !/ $.0#120"
!"3,#,$%&%&' 9+*7" !/ -.#,120$
!"#$%&%'('() *+,-!# !. !/"0120$
!"$$"$&'() 3-45! !. %/""120"
!"$"6"0'('() 37)( !. !/&$120$
!"!68"&'('() 9+(:; !. $/$6120$
!"!8.#6'<'() 3=;+8 !. !/8!120$
!"#&00#'() >4?! !. ./6!120"
!"##"86'('() @9-<$( !. 8/#%120"
!"!%&80'('() A;7!0 !. %/8$120$
!"$"%86'('() BC:4$ !. !/#8120$
!"$%.!0'('() 3+DE !. %/""120$
!"6!".#'('() FG4(+# !. &/8&1206
!"60&#6'('() 9-<#87 !. !/##120"
!"!&%8&'<'() *+,C#6 !. %/6&120$
!"6!0%0'() H<-! !. $/8&120$
!"6"&..'() F):(% !. #/$$120"
!""%!.#'() I;(C! !. 6/!%120$
!"#.88.'() J(<7 !. 6/0&1206
!"!.%88'('() K+-76! !. $/""120"
!"6!!0!'('() @9-<#% !. "/#6120"
!"6"88"'() LG-""6 !. 8/0%120$
!"$66#.'() *M+!(,-# !. 6/!$120"
!"66&8%'('() K()4# !. !/0&120%
!""&""6'='() KG(-!( !. $/$0120"
!""&!.8'() 1-N"/!7"( !. 6/."1206
!"!.0&0'() @OPQN !6 8/#0120"
!"6#!.$'() 1)<! !6 &/.#120"
!"$$&!.'() I(C-$ !6 !/$"1206
!"$8.0%'='() R?Q(S !6 #/8%120$
!"6##%!'() >M<# !6 #/6"120"
!""86!&'='() *-=# !6 !/."120$
!"$%!8.'='() !!!00$!A0.9,T !6 8/!0120$
!"6$0&6'() 9(N!0 !6 $/!$120"
!"#0"6&'() 9,--7D$ !6 %/66120"
!"$6%%%'() 1:G+ !6 #/"01206
!"$$&#0'() >5C("; !6 !/"0120%
!"66%#6'<'() U4=! !6 &/0.120"
!"#6.!"'='() UV3!000"6%." !6 #/""1208
!"$$8%!'('() 37P4!# !6 #/!!120$
!"6$$#!'() W4P;! !6 !/661206
!"#0!!.'<'() XM7-Q$ !6 "/6%120$
!"6#%88'() #8000#&K0&9,T !6 !/%!120$
!"$$.!.'('() #$!00#%V!!9,T !6 #/#&120"
!"6#$"&'='() FY#06@ !6 %/$&120"
!".080&'('() A()6 !6 #/#0120"
!"!%##$'() >5;!!( !6 $/0.120$
!"!808!'<'() 3D-"Z$ !6 &/06120$
!"!."8&'('() *C5C!"; !6 "/#6120"
!"660$&'('() >,4$N !6 6/"&120$
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!"##$%&'(')* +,*-! !# ./".012"
!"!3!"!')* 45*6 !# %/.2012"
!"%&2$"')* +)76% !# !/$"0128
!"8".%"'(')* 96:$ !# !/2"012.
!"%$8%&')* ;:<!= !# "/$!0128
!"%"3&%')* >7?733 !# !/&!0128
!"!32#"')')* 2.!222$@239AB !# "/#20128
!"8#!%%'(')* @C7*! !# 8/$!012"
!"%##%&')* D--(! !# "/%!012"
!"!$#"#')')* E*6.F!=! !# 8/$20128
!"8""%8')* GHI6! !# !/&&012.
!"%.8##')')* .882#3&0!39AB !# 8/&#0128
!"#!8&#')* %8!22#.D239AB !# !/%"0128
!"#82%$':')* JK6.#2 !# ./.$0128
!"#2$!$')* L66! !# 8/#&012"
!"%%&%8')* 06:&M !# $/2!0128
!"%833%'(')* NI=%#)# !# !/&%012"
!""$$2.')* N?I6 !# "/%&0123
!""2&!.'(')* @O(! !# 8/2#012"
!"%88".')* @?5:! !# ./!"0128
!"%.&2&')* +5)I:8 !# 3/!$012"
!"88&..'(')* D-O(! !# "/!8012&
!"#&.#$')* MDI)=$ !# !/380123
!"8"3$.')* P)76" !# !/8%0128
!".2..2'(')* 9?-! !# "/280128
!"#%2!.')* EIQ(#)6 !# $/8.012"
!"%%$2.')* ER=5% !# !/".0128
!""&"!.')* L56 !# "/$8012"
!"%83#"')* 4S*78 !# 8/%#0128
!"%3#."')* @A)6% !# #/&.0128
!"8"."&')')* T=7% !# $/2"0128
!""&"&"')* E7O! !# 8/.&0128
!"#%%23')* TA*?O% !" "/2#012"
!"88&2.'(')* T)I- !" !/"2012"
!"8"&$%'(')* 9RR6" !" "/!&0128
!"!&.$$':')* U?=V !" !/28012"
!"!3!%"')* @:*C !" !/"80128
!"#2."%')* 8!!222!4%29AB !" !/!2012"
!""&%2.')* D:7)% !" %/#%0128
!"#23%"')* @-=*CCR!) !" 8/"30128
!".2#"3')')* WC-6B !" #/$!0128
!"%&2&8')* %8!22"8;!29AB !" !/2!0128
!"#.382'(')* E=*I.) !" $/"8012.
!"!&#$!')* @C)X)"M !" 8/3.012.
!"#2$23')* N6=:% !" #/"$0128
!"%"!2.')* !%22228T2#9AB !" 3/2.0128
!"!.2#"')* 96:# !" %/%20128
!"8."8!')* !3222%#G2"9AB !" 8/3%012#
!"#"!"!$%& '()*!%# !" +,!-./01
!"!2103$%& 45367# !" !,31./01
!"+#!-2$%& 489! !" +,"2./01
!"+2-:3$6$%& ;6<=! !" ",3!./01
!"10:32$%& ><?@%=1 !" 2,2"./0-
!"11+02$%& A!#0002.+# !" ","1./0#
!"!-:"+$%& A%5B !" ",!-./0"
!"103"!$%& ;C)9= !" ",:3./0:
!"+"13"$%& D@%B6- !" +,+1./0"
!"+3"-2$6$%& EF%G%+ !" 1,!+./0#
!"!3131$%$%& '@?H !" 1,3!./0#
!"!2"::$%& A)F@+ !" !,02./0"
!"#"1:0$%& .F==" !" 1,13./0"
!"+2333$%& I)#?!" !" +,:#./0"
!"+1":2$6$%& J&5<2 !" +,-:./0"
!"+::"-$%$%& J%)7! !" 2,-3./02
!"+###+$%& ;C)9= !" +,01./0"
!"+:#23$6$%& ><?@%=+! !" -,2-./0"
!"":#2#$%& K%=! !" +,#+./0"
!"+10+:$%$%& 4=5+ !" +,":./0#
!"+"00:$%$%& L9=56+ !" 2,03./0-
!"1!12-$%$%& MN+0# !" 1,1"./0#
!"11-::$O$%& P8BCQ=# !" 1,#!./01
!"##-"!$%& AC#: !" !,#-./0#
!"1"32!$%& ;*FG! !" +,:!./0#
!"!:!#"$%& ;B)+1%"2 !" ","!./0#
!""12:"$6$%& RC%)+ !" ",-0./0#
!"!-!1-$%& >)&<!0 !" #,10./0#
!"+1"#2$O$%& SB<%#H !" ",3!./0#
!"#:":-$6$%& ITT# !" 3,0:./01
!"+2+!3$%& ;)=+ !" 2,!"./0#
!"":"2!$%$%& H4?8)- !" +,-0./0"
!"!22#2$%& HL?U9 !" 1,-3./0#
!"+#-:+$%& J89VB!9 !" !,2!./0-
!"!-1-#$%& +0!0#!!E0#LQV !" #,2#./0#
!"1"0-"$%$%& L6<)+ !" #,-!./0#
!"#-!3#$6$%& ;F<=9 !" !,-0./0"
!"+::+3$%& 2:+0"0!R0!LQV !" #,3"./0#
!"!3:#1$6$%& PBU)! !" !,"-./01
!"#":+#$O$%& J*U8W+ !" ",#1./0#
!"!1:3-$%$%& J@6&! !" 3,+1./0#
!"#"#0!$%& E##0010M+#LQV !" +,!1./01
!"#2:-"$O$%& ;B)+1%1 !" 3,12./0"
!"#-"10$O$%& +-00020.0+LQV !" :,1-./0#
!"+"2+:$%$%& !1000#+E!2LQV !" +,+3./0#
!""!302$O$%& ;*%=! !" 1,1"./02
!"1!#!0$%$%& A&6B !" +,!+./0#
!"!1-"!$%& 45U5!21 !" 1,:+./0#
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!"#$"%"&'( )*+,- !" ./"012%"
!"".#%#&'( 345'! !" 6/!.12%"
!"###0"&7&'( 87+49!! !0 $/:612%0
!"#"6".&;&'( <9=> !0 !/%612%0
!""6..0&'( ?(@0 !0 $/#012%"
!"0"!0A&'( 1"0%%A#1A!B,C !0 :/A"12%0
!"!:"$6&'&'( DEFA !0 !/##12%0
!"AA#A.&7&'( <'7GA !0 !/6"12%$
!"#A600&'( B'4@HIA !0 $/6#12%0
!"!.##"&'( <E"$ !0 A/":12%#
!"#!%".&'( JK'40! !0 0/6#12%0
!"!#$#!&'( L4!+40 !0 :/..12%"
!"0#6!!&'&'( M5K#% !0 !/#%12%0
!"!$#"%&'( 19I! !0 !/0"12%0
!"#".!:&7&'( ?NO4! !0 #/!612%0
!"!:.$!&'( <P;$'A !0 A/#:12%"
!"!$6!6&'( QR(N! !0 !/$612%"
!"A#:!:&'&'( <KEKA0 !0 0/":12%"
!""66AA&'( >S7T+: !0 !/#:12%0
!"AA#:6&'( )EH9! !0 !/:012%0
!"0":0$&;&'( U,50+ !0 !/..12%0
!"!$$!6&'( 1,I0@ !0 A/"612%0
!"A#"#6&'&'( VN+!% !0 "/$"12%"
!""$A0"&7&'( U5;: !0 A/:A12%0
!""6:.$&7&'( >B490:'9 !0 6/#%12%0
!"A%#!"&'( WTHT"$ !0 0/!612%0
!"!::::&'( UHN4,5HA !0 0/6!12%0
!"0."%!&;&'( S44AN#H !0 0/"#12%0
!"0"A60&'( X8<!%%%"".:6 !0 ./."12%0
!"0"6.:&'( YI4"AA2N7! !0 ./"%12%#
!"0""%0&'( U4NHEA !0 :/AA12%#
!"!#.%:&'( >WT7+"; !0 0/:612%:
!"!$:6"&'( WF=T4E0 !0 A/.A12%0
!"#!%$#&7&'( <(E74A !0 :/AA12%"
!"!#$%%&'&'( U7N0 !0 0/AA12%#
!""6#.%&'( <P9:'! !0 :/"012%#




!"A6A#.&'( S;E5 !0 #/%.12%"
!"06"A%&'( B+T0. !0 0/A!12%0
!"A6!$.&'( )E=IZA !0 0/$"12%"
!"0:0.%&'&'( <9KK! !0 A/":12%0
!""6.:$&'( ),475'40' !0 "/!:12%0
!"#:!$%&;&'( <'9N !0 !/0"12%"
!"00#:!&'( <H5(+A !0 ./A%12%"
!"#!A#"&'( [C+C'4 !0 ./0012%0
!"#$!##%&%&' ()*+! !# $,$-./01
!"22#!3%&' .45-6 !# 1,#3./0#
!"#1"-!%7%&' (87#6 !# !,#-./0#
!"!30!0%&' 9:4-#$ !# ",-#./0#
!"!3"10%&' (';8 !# 2,#-./0"
!"!10"3%&' <5=7 !# +,$!./0#
!""$-!#%&' >=7&! !# #,1-./0"
!"--"2-%&' ?&@# !# $,-!./02
!"##1!#%&' ($01!# !# 2,+1./0"
!"-#$0"%&%&' ABC! !# +,1$./0#
!"!+3!1%&%&' 6D4;!0 !# ",!-./0#
!"-#321%&%&' EF5G! !# !,2-./0#
!"-!$2$%&' >B&F!3 !# #,!+./0"
!"#"2"!%7%&' HIB*8;! !# -,+$./0"
!"!++31%&' >85B# !# !,23./0#
!"-23!$%&%&' AJ=;!&84 !# ",##./0#
!""100#%&%&' KL!8 !# !,12./0#
!"-"0!2%&' 6D&8+C4! !# !,30./0#
!"#+1$0%7%&' (=G'- !# ",1$./0"
!"-#!"1%&' MN4!& !# -,3+./0#
!"-3$$1%&' M4=&- !# 3,$3./0"
!"+022-%&' >;55#O! !- !,#1./0#
!"-"""#%&' PB@:*4#6 !- !,20./0#
!"-"#-"%&' .;5G! !- ",3#./0#
!"-$++-%&%&' PG47 !- 3,!"./0"
!""32--%;%&' E=N;- !- #,-0./02
!"-#!13%&%&' 6MFQN- !- 3,0#./0#
!"2$#"2%;%&' (GOQ5!! !- ",3#./0"
!""3$!1%7%&' (GO$&! !- !,$3./0"
!"!2$$1%&%&' P;4108! !- -,-1./0"
!"#2212%&' !$!00!!R!0DCN !- 2,0-./0#
!"-$"$1%&' 95*8! !- 3,-2./0#
!"!$110%&' S;"&"B !- !,2-./0#
!"-$$+$%&%&' 6R&T! !- !,13./0#
!""1#--%&' 6<'4"&! !- ",00./0+
!"!3$20%&' D8! !- -,2#./0#
!"!$2#+%&' P-/U26 !- #,11./0"
!"#2$$"%&' A';=! !- $,+1./0#
!"-#3$!%&' 6V&Q! !- #,-$./0#
!"!3#"1%&' <OB= !- #,#$./0"
!"#2$02%&' WC=3& !- !,"3./0"
!"!1+#1%&' .:=8- !- !,+$./0#
!"22+$$%&' XB*- !- $,$$./02
!"+0#+3%&' P84! !- $,!$./0#
!"20++"%&' Y&84& !- 2,#2./0"
!"-+311%&' D&8$8 !- -,--./0#
!"!232$%&' Z*)O !- !,-2./0#
!""32$"%;%&' S)5'! !- !,2$./0#
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!"#!$%"&'&'( )*(+# !# !,-./01.
!"#2%-$&'( 345$6 !# .,17/01"
!"""#2#&'( 89:5! !# !,!"/01$
!"!.27-&;&'( <=>?'# !# !,."/012
!"!7!$1&'&'( )?9;2 !# 2,!1/01$
!"$.7-#&'( %121"#1@1"AB: !# !,.7/01%
!"!72""&'( C'DE# !# .,2$/012
!"$"%$%&;&'( 34'B! !# #,7-/012
!"!7!7"&'( FG+4$ !# 7,#./01"
!"!7!$7&'( HI+ !# #,71/012
!"#%7"-&'( )+I2$'2 !# 7,."/012
!"#"27$&'( !-!112.J!.AB: !# ",.#/012
!"$$-#.&'( KG4+# !# !,."/012
!""-%#%&'( F!2'! !# 7,!./012
!"##"%$&'&'( LD54! !# .,1-/012
!"#-2."&'( 3+IM !# !,!./01"
!"2".1$&'( N(GE# !# ","-/01"
!"#-!-.&'( N=". !# ",!./01$




!"!7"1$&'( P54 !# #,-2/01"
!"!..7-&'( 84E+'- !# %,%-/012
!"#"!1"&'( )*?# !# %,-./01"
!"2"%7-&'&'( OI(92 !# #,"-/01"
!"2.7!$&;&'( HE;2.I !# ",#-/012
!"$"-$!&'( <9#I# !# 2,!2/01$
!"22$1.&'&'( LD54#6 !# ","%/012
!"$771%&'( N'D:#4! !# !,.#/01$
!"##7!%&'( 8E'E#' !# $,2#/012
!"#!2.$&'&'( )!11'7 !# !,#$/01$
!"#7#-$&'( C'D'# !# $,21/012
!"$!#!"&'( QG(G=# !# ",#-/01"
!"$1%!!&'( 8EBG !# !,$2/012
!"#2.".&'&'( 8=:! !# ",%"/012
!"$7#$1&R&'( S5TB !# !,%-/01"
!"#$$"$&R&'( L#0U! !# 7,-1/01"
!"2.$!!&R&'( N+II! !# 2,#2/012
!"7122#&'( 8+4 !# 7,##/0!!
!"#17!-&'( NEMG" !# $,11/01"
!""%11.&'( P(526 !# !,"%/012
!"#2$77&'&'( L;E!!1 !# !,2-/012
!"#%72.&'( ##!1"!%J1-AB: !# $,72/01"
!"$$7#.&'( NV+-'! !# 2,#7/012
!"2.271&'( 8I=W!% !# 7,-1/012
!"2$.2-&R&'( )M9?# !# %,2#/01$
!"2$"-"&'( )+I$'2 !# ",1%/012
!"".%22&'( QB?#7' !! #,!$/012
!"#$"!#%&%'( )*+++,+-+)./0 !! ,1"2-3+#
!")$*2+%'%'( 4565!,* !! 2122-3+#
!"!,#)2%'%'( 7(8,9+6 !! !1+)-3+#
!"$))!"%'( :0/; !! *1$<-3+"
!"!,+*)%'( =>#" !! !1#<-3+,
!"$*2)#%'( =?@,! !! )1)+-3+#
!"$$!),%&%'( )#!++)2A!!./0 !! 21")-3+#
!")*!#!%B%'( CD@@E$2 !! !12$-3+"
!""!+2!%'%'( !!!++#2F!)./0 !! $12*-3+#
!""2#+$%'( .'G, !! )1)<-3+"
!")2,+"%'( ),!+#+$H!#./0 !! !1<*-3+#
!")#*#)%'( 4@'5! !! !1!#-3+#
!"#"!2+%'( I6@5() !! "1,!-3+#
!"$+2<*%'( 7@JK'8$ !! <1,+-3+"
!"")#"+%&%'( =?@,! !! !1$"-3+#
!"#*+""%'%'( LG' !! $1,#-3+#
!",+!<)%'( ABG8;!' !! <12!-3+#
!""<##$%'( 4/58# !! )12<-3+"
!")#*)<%'%'( .MN!2! !! 21<,-3+"
!"#*)#2%&%'( O5># !! #12!-3+#
!"#<"$)%&%'( HM868 !! ,1!)-3+#
!"#,*#<%'( 7K(@!' !! !12$-3+$
!"$)2,,%'( O'@B !! !1<#-3+#
!"#!!**%'%'( C.8;!+' !! "1+)-3+#
!"##,$$%'( .MN!"! !! !1!<-3+#
!"#"<##%'( .E#J! !! !1*$-3+#
!"##$#"%'%'( =E() !! )1<$-3+#
!"!,)2)%'( PB5E# !! ,1<!-3+"
!"$"<<*%'( QB@G# !! )1+*-3+"
!"!,<+"%'( QGM;! !! $1)2-3+"
!"##""#%'%'( R5KEB!C !! !1#2-3+#
!"#***#%&%'( H>&!* !! "1*,-3+#
!"#<"$$%&%'( ='8S'!C !! !1*<-3+#
!"!2,,"%'( Q8>S !! <1#,-3+$
!""2,*#%'( P9@;# !! $12<-3+*
!")#,$!%'( TBE'! !! !1!2-3+#
!")*!$*%'( =E>E2$' !! !1$!-3+*
!"#2"+*%'( HB6; !! )1""-3+#
!"##<!"%'( 7T*"*,<< !! <1#+-3+#
!"##2,2%'( F(G># !! !1<,-3+"
!",+,<"%B%'( :9/; !! 21!2-3+#
!"$,+")%B%'( =@'58!; !! )1<,-3+"
!"!2!$)%'( OBG8! !! $1"#-3+#
!"#)!$2%'%'( 4@'88E) !! !1+<-3+$
!"$$2+!%&%'( 4GE> !! 21")-3+#
!""*22$%&%'( O6>>< !! <1),-3+,
!"#"<*,%&%'( -/N"6G8! !! #12#-3+"
!"##,,2%'( PM@E! !! $1+<-3+#
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!"##$!%&'&'( )*+!,,,"$,-% !! #.,!/0,"
!"!12!-&'( 1##,",$3!!456 !! ".,%/0,"
!"!7$72&'&'( 89:5; !! #.%%/0,#
!"-",#2&'( <=>=11 !! -.""/0,1
!""%1$,&'( ?@9>-># !! !.$-/0,"
!"##2#7&'( A@,-,-,1 !! ".!%/0,7
!"71!#7&B&'( C:D !! 7.-%/0,"
!"-#!-1&'( A(;!9# !! ".27/0,"
!"711,#&'( !7,,,,7E!"456 !! !.#7/0,#
!"-!,1-&B&'( +F(' !! 1.%!/0,7
!"!7$#"&'( 4'9$ !! 1.21/0,"
!"#2%#,&'( )*+1$7#11 !! 2.%7/0,"
!"-$%%"&'( +GF#'! !! !.1!/0,7
!"777--&'( AHIJ>K!7? !! !.$-/0,1
!"#",%"&'( 7$#,1,!L,1456 !! #.,%/0,7
!""$#"2&B&'( /;",, !! -.,"/0,#
!"!2"%1&'( LG:M! !! 7.!1/0,7
!"#7%$"&'( CH6'9- !! 1.$!/0,#
!"-,"27&'&'( N;B-1' !! $.,7/0,#
!""%117&'( O=P !! #.12/0,1
!"7!7,%&'( )'H;- !! !."!/0,#
!"##$-!&:&'( 4;B-! !! 1.##/0,"
!"-1%-2&'( @5=M! !! #.$7/0,"
!"-%"$!&'( QGH9B! !! %.-#/0,#
!"1,1%,&'&'( ?4;F-# !! !.!#/0,"
!"722%$&B&'( +M(# !! 7.#-/0,#
!"-#,""&'( CHGBM !! 1.,2/0,#
!"7#7%1&'( /D(;P! !! 1.$-/0,#
!"!$"1,&'( RS(=- !! -.!!/0,"
!"!7$7-&'( T+,#!!%! !! !."#/0,#
!""#$%$&:&'( +'B;!" !! !.-"/0,#
!"7-,2-&'( "1#!"-1U,7456 !, !.%2/0,7
!"1,1$!&'( 3;:! !, 1.#!/0,"
!"-"2%%&'( VWF5; !, #.,2/0,#
!"#17%1&:&'( 4;B!" !, 7.2-/0,"
!"1,171&'&'( ?QX-P! !, 1.$,/0,#
!"--11,&'( )*+!,,,"#-7$ !, 7.22/0,"
!"##7"2&:&'( 4;B-! !, 1.27/0,"
!""$%1-&:&'( <I9B- !, !.,1/0,2
!"7!2%%&B&'( +I=;"9? !, -.,7/0,"
!"-#!!#&'&'( @9>-P# !, !.71/0,#
!"!%#,,&'&'( V6D6- !, -.,#/0,"
!"7!,1%&B&'( 4;B-7 !, -."#/0,7
!"-!,-#&'( C56#M-' !, %.2,/0,#
!"!12#$&'( 3'9'H'; !, 1."#/0,7
!"-$,1!&'( 499;% !, -.,!/0,7
!"-#%#2&'&'( TY#? !, 1.1$/0,7
!"##2$1&'( 4>>;# !, !.-!/0,"
!"#$%"&'() *)+,-. !& !/&%01&.
!"#%2%#'() 3)(,#4 !& "/%$01&.
!".".5%'6'() 789#! !& !/&$01&"
!"#$!#"'('() :;<! !& !/2.01&.
!"#"5="'() >?@A,5 !& !/%!01&.
!"$&".&'() >7(8#B !& 5/"%01&.
!"#.%.%'9'() #"&&&&.:!"7C< !& #/$"01&"
!".=..$'6'() >DECB<;A" !& ./2#01&5
!"#.&.!'() F(A( !& !/!&01&5
!"!=!%5'() GH$( !& 5/=!01&.
!"#5#"!'('() I94! !& "/&!01&.
!"!$=$$'() FJ9B# !& !/"501&.
!"#$"%$'() K46,# !& !/.=01&.
!"!$!"5'() L+6!5 !& !/.&01&"
!"#%%=5'() MJ;C@" !& =/&$01&$
!"#=22!'9'() K98"5 !& =/#%01&.
!"5!5#!'6'() 0C-"+ !& ./=!01&5
!".$%%.'() F4)89# !& ./="01&"
!"!2&%2'() ?C@8. !& !/#"01&.
!"5$5%='6'() #&!&&&5N&%7C< !& 5/!#01&.
!"552=$'6'() L4C !& !/5%01&"
!"#.!25'() OC()! !& !/"%01&.
!"55&=#'() :A8.5& !& !/".01&.
!"5.&55'() PA@($, !& 5/&"01&.
!"..$=&'() 0@8# !& ./#201&5
!"5#2!%'() L!20E),=.=A !& $/"%01&.
!"5#2%5'() K(B( !& #/"#01&"
!"!="5!'('() D8C( !& $/!201&.
!".$!%!'() L,A-# !& !/2%01&5
!"!=2$"'() 38.,! !& !/!.01&.
!"#%#5#'() :+@8#4 !& !/#$01&.
!""2$=2'9'() P)65( !& #/#$01&.
!"..22!'6'() L4C !& =/#"01&.
!"#.25%'('() ?)B.. !& #/!$01&.
!"!$5&5'() QE"(! !& 5/%"01&.
!"!$""#'() RAE# !& "/2=01&"
!".$&#%'() ?@A@.. !& !/.=01&.
!"#$$!5'9'() Q,ES" !& !/2$01&"
!"55&!2'6'() :<(8" !& !/5=01&.
!"#%22%'() D+-. !& 2/!.01&"
!"5"2$.'() 0".&&#%T#!7C< !& !/..01&.
!"..=&#'() 0E@8! !& =/%#01&.
!""=%=='6'() LU@)! !& !/#=01&"
!""2%%2'('() VBC(,! !& #/#=01&.
!"."52='() G(E85 !& 2/$501&.
!"!%#"2'() :EB8 !& "/#&01&.
!"5!#&$'9'() D9B,48 !& "/==01&.
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!"#$!$$%&' ()*!+ !, "-!"./,"
!"!00!1%&' (234!5 !, 0-6,./,$
!"+7#""%8%&' 9:;8$ !, !-$7./,$
!""6",0%&' <&3# !, "-!6./,$
!"#7$6#%&%&' =*';$ !, !-""./,$
!"$"06+%>%&' ?44!;!$5 !, !-,1./,$
!""00,0%&%&' @3A# !, "-$0./,$
!"#$$"6%&' BC*>+ !, !-+7./,"
!"$+$11%&' #"!,,,#D##EFG !, 1-$0./,$
!"$"1$!%8%&' ?;H8! !, !-7+./,+
!""6!0!%&' IA*2 !, $-,#./,"
!"+!7##%&' J35;H! !, !-$0./,$
!""000#%&' K3A36$ !, "-,1./,$
!"!+16"%&%&' B4FL! !, 6-++./,"
!"$"!67%&' ML&N&"O !, 0-1"./,+
!"7,+"+%&' K2;&4$ !, 7-6!./,+
!"#6+16%&' 7$$,",1P!0EFG !, !-+0./,1
!"!7+"$%&' @QA#:# !, !-1$./,$
!"!00#+%&' P;R3 !, "-6#./,7
!"!6,71%&%&' E&5RAQ! !, +-77./,"
!"+,"0"%&%&' KSGF !, #-!$./,$
!"+#,+#%>%&' .FQ$NO !, #-!"./,$
!"!76+#%&' ='47T!H !, 6-0$./,$




!"$"$0$%&' ?N&# !, +-,6./,+
!"$10+,%&%&' (L54 !, $-6,./,7
!"#$""6%&%&' =*'L" !, +-60./,$
!"+"1#"%8%&' +1$,""7(!+EFG !, #-,7./,$
!"$$670%&%&' UARQ6 !, !-",./,$
!"+!1,$%>%&' =4;' !, 1-17./,$
!"#0"#$%&' ?*RQ$ !, !-$7./,$
!"#"$!!%&' ,1!,,,0V,0EFG !, !-$1./,$
!"#7+##%&' W&H25O !, $-+#./,$
!"$",$1%>%&' ?*&Q !, +-$,./,$
!"!66!"%>%&' JD(!,,,"17,! !, 0-#0./,"
!"+"001%&' ?&G# !, "-,1./,$
!"$7,16%>%&' X&45 !, !-"$./,"
!"+,$1#%&%&' E4:!0 !, !-+1./,$
!"+#$1!%&' BQ;>!! !, !-$!./,$
!"!0,71%&' (Y# !, "-0$./,$
!"+61"6%>%&' I&'" !, 7-!,./,+
!"+!!"7%&' ZQ4$07 !, #-0$./,"
!"$"!#,%&%&' UA'&4# 6 #-!+./,$
!"#70+#%8%&' @CT 6 +-"#./,7
!""0!77%&%&' ?>35! 6 #-,7./,$
!"#$+!!%&' =>Q!& 6 0-#0./,$
!""!#"$%&%'( )*+,,#!- # !./012+,
!"0/,/"%'( 3445 # #.-!12+,
!"!//,+%'( 67, # -.,-12+/
!"0$0/#%'( 8549!! # 0.$!12+"
!"!::$0%'( ;<=<!< # -./#12+,
!"-0,#:%'( >?=@! # -.$-12+/
!"!$,#"%'( A?5" # /.0-12+,
!",$/0:%9%'( BCD' # ".,:12+,
!"-0,,+%'%'( 3&4': # /.+!12+$
!"0,+::%'( EFD7, # 0.,$12+"
!"":$-:%'( G4<50 # !.!$12+,
!"0//$!%'%'( B<F,# # ,.!-12+,
!"0+,0/%9%'( *4'FH!? # /.+:12+,
!"0/$+-%9%'( 6'49 # 0.!"12+-
!"-,!00%'( "#0!-,,I!"BJK # 0.!!12+,
!"0,/"-%'%'( L7&- # 0.,"12+-
!",#"-/%&%'( ;(H/'H0 # 0.-#12+"
!"-/+$#%&%'( ;H@&! # /./,12+,
!"0::""%'%'( )=?'5! # 0."!12+,
!"-/+!#%'( *M5!#?0N # ".!$12+,
!"0/:0$%'( O(C7=! # :.+!12+,
!"":!-,%'( *D&-' # !.+!12+,
!"0/:0+%'( 0/!+-+$)!!BJK # #.!!12+"
!"!$-+:%'( BP5!#' # #.!+12+,
!""+!-!%9%'( 175! # !.:-12+"
!"0/":,%'( >4K4J4 # /.-012+,
!"0/:$$%'%'( ><4F! # ,.:"12+,
!"-0#:"%'( IQ*!+++"":"0 # /.-#12+-
!"--#/-%'( ;7'F(9" # !.+$12+,
!",-:$#%'( ;K(, # -.0+12+"
!",,"""%'( RFS=9!N # ,.+012+"
!""$$$/%&%'( B'</ # ,.+-12+,
!"0:#00%'( !0++++#Q00BJK # 0.-+12+#
!"0:!+,%'( ;7'F!+ # "."#12+,
!""#0:,%'%'( 3'HK!0 # 0.0#12+,
!"0+:-#%'( >KJ' # ,.0!12+/
!",/00/%'( E=@<! # :.##12+-
!"0"0--%'( 8TH(-C # #.0$12+"
!"!/++"%'( OMC'C # !.:#12+,
!"!$!/0%'( EF<JF! # ,.$#12+,
!",#:0"%'( *CFN # $./$12+,
!"0,-/$%'%'( >9F'$ # ,.,#12+,
!"":!+:%'( 8@4JP=! # !.:"12+,
!",,/!,%'( >'PK, # ,.$012+,
!"0"#!:%'( E<=!7!# # -.",12+,
!",$!#$%'( 8D4<90 # ,.//12+/
!"0"#+0%'( >?&7=! # /.:$12+/
!","+00%'( U<(<,, # ,.-"12+,
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!"#$""%&'( )*+,- . !/.012%"
!"##"3-&,&'( 45670 . -/.$12%0
!"##-0!&'( 896:! . #/$012%"
!"!3;$0&'( 19<"=# . !/#012%0
!"33!%!&'( >?!3;!-% . "/0012%-
!"0""$;&'( @(5:" . 3/0012%0
!"33!"3&'( AB:*!. . #/.!12%"
!"30%!3&'( ".00"%-C%0D9E . 0/0"12%0
!"#"#$.&'&'( FGHI$ . ./0#12%0
!"0$-"-&'( !!!%%!"J%;D9E . !/0#12%3
!"!;#0#&,&'( 896,! . !/$012%3
!"##3$!&'( >:'6(,3F . ./0"12%3
!"$%0"$&'( >+,' . ;/#%12%"
!"0"%"#&,&'( G(6+0 . -/$%12%0
!"!3$.#&,&'( C'KL . ./#;12%-
!"0$#..&'( MI, . 3/0"12%"
!"##$#%&,&'( AN'N#' . ./;!12%"
!"!3.%;&'( O,NHI! . "/;.12%"
!"#!;"!&'( P=<+0 . $/3;12%.
!"00.!%&'( QBB*B$ . ./%$12%0
!"!$3%$&'( A,6'$ . 0/3.12%0
!"3-#3#&L&'( AI:# . #/#!12%0
!"3-%."&'( 4*R . ;/$!12%"
!"##3%$&'&'( C,(S . 0/!-12%"
!"##;";&'&'( A'SNK! . #/3;12%"
!"!$"$;&'( >I:*!'! . -/3.12%;
!"3!%$3&'&'( ):L0. . 0/0.12%0
!"#3;!3&'&'( T66+ . !/#"12%0
!"3!#"-&'( G<,:! . $/;$12%0
!"3$0.%&'( ANN#B' . 0/.-12%0
!"#3!;0&'&'( DNI" . ;/0-12%-
!"!$#""&'&'( CKSN . $/%012%"
!"!;##.&,&'( U<5! . "/;%12%0
!"3";.%&'( >67( . #/0;12%0
!"!$-"%&'( C7I3'! . $/%#12%"
!"3!"!3&'( !;!%%!!@!%D9E . "/;%12%"
!"0-00.&,&'( AB,E3 . #/"#12%0
!"33.-3&L&'( Q<N0!0 . 0/$!12%"
!"!;$3#&'( CLBI. . $/%-12%"
!"0"#";&'( A+EB* . 0/0$12%"
!"0-"0-&L&'( )KNRN . ;/0$12%0
!"";0..&'( O'L!SN! . #/"!12%0
!"";0!-&'( O6R6!#; . -/%012%0
!"";#"%&'( GS(N,! . "/0;12%3
!"#3".#&'( V6N+!' . !/$312%"
!"";.0.&'( W,N#3 . !/3012%0
!"!3--;&'( G7+<"I# . ;/%012%$
!"#$--"&'( A'+N!# . -/##12%"
!"#$%"&'() *+,-./0 1 &23#4563
!"!&$6$'() 7/8! 1 92$#4563
!"%%&#&'() :;<(1 1 !2$$4563
!"#"69!'='() >?6!$%69 1 %21%4563
!""$!9"'() ?@A! 1 !2314563
!"!9#%!'() BC(AD8 1 !2!"4561
!""$#3"'() E,(FG& 1 92#34563
!"%$36$'() *G,;# 1 %2%%456%
!"#$$&!'() "&3!"##H6%I/J 1 $2&3456"
!"36!33'() KG-!8$G 1 $266456"
!"3$916'<'() KDLD"!G 1 #2614563
!"##%13'() M03=! 1 !21!456"
!"#!1$#'('() N,-%6 1 &2&64563
!"#&&"&'() 1!366!!O!%I/J 1 %2&"4563
!"%6$9"'() P().3 1 &23$456"
!"3%"!"'='() E-),! 1 "21!4563
!""$!%#'() QRS# 1 !2#6456&
!"3%6#$'() T8.9 $ !2&14563
!"&6#63'() Q)0.! $ "2"9456"
!"%11$6'<'() I(G3( $ !2#1456"
!"3"66%'() IGD=! $ 326#4563
!"%#!19'() *D-" $ $2#34563
!"3%#%3'() I(G!!G $ "2!%4563
!"339$"'() 1636&!#P!3I/J $ 12&#4563
!"!9&""'() *=0, $ #26"456&
!""$36"'('() I(G& $ 321#456"
!"!$6!&'() C@D# $ !2664563
!"#$#39'() #9666%1E#!I/JB $ 92#!4563
!"&6&$#'='() ?L(-(D!B $ !23%456"
!"339##'() MJ(0!3 $ 12#34569
!"!$#$#'<'() *L.0/,(!G $ %23945!6
!"%66$"'='() QU,=!(G0 $ !2$14563
!"#"6"!'='() ?!=B $ %2#9456&
!"33113'() "13!"6&C!&I/J $ 32#"456"
!"!%1$!'() :L.0@8# $ !23#4563
!"%%!&&'() M.A%G $ 32&$4563
!"!%1&!'() Q)D#- $ !2&"456"
!""913&'() #"!666&:!&I/J $ !2""4563
!"3"#$!'() E8(! $ 32#64563
!"%#63#'() C.J(.!( $ !23$4563
!"##%6$'() M)0&U!( $ &2%%4563
!"%!#6"'() *-(.(% $ !2!34563
!"!&191'() C;D0 $ 12634563
!"##&6!'() *L.0/,G1 $ %26"456&
!"#"%93'() KDL8% $ #2$34563
!"3%6%$'<'() *)<G03( $ !2%"4563
!"!$%&6'() C8V(! $ 92!34563
!"!%1&3'() :,.0V# $ %2"$456"
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!"#$"%$&'&'( )!#*+(,--!. $ $/$"*0%"
!""1$23&'( *"1%%#$4#!567 $ 2/28*0%"
!"##-"!&'( 9(:+; $ 3/!8*0%"
!"#3#12&'( <'=>(=# $ !/%1*0%-
!"--3!#&?&'( @>A"-' $ -/%%*0%1
!"#2388&'( @B:"8 $ 1/!!*0%1
!"!22-2&'( C=6A! $ "/3$*0%"
!"1-81#&?&'( D(:2E%AF $ !/8%*0%-
!"#$$8!&'( GHC!%%%"8""! $ #/!!*0%1
!"!-$83&'&'( 5:=:# $ !/$%*0%1
!""$13#&'( GHC!%%%"28"% $ #/8"*0%1
!"!2!2!&'( 5',#! $ #/!!*0%"
!"-!%#-&'( D+=! $ 1/18*0%1
!"#1%83&'&'( FIJ;;#% $ -/2%*0%1
!"12333&'( -%11"!"K%"567 $ "/#8*0%1
!"!2381&'( LM:#=! $ 1/$2*0%1
!"##8!"&'( F@N.#6 $ 2/!3*0%1
!"1"2#-&'( "31%"1#H#!567 $ 1/#!*0%1
!"11333&'( O=7 $ -/$#*0%"
!"-$--%&'( PQJ!, $ 1/$1*0%"
!"112%-&'( R>::-' $ !/%2*0%1
!"-2$3$&'( GHC!%%%"-3-$ $ -/2%*0%-
!"!33!8&B&'( I;.,8 $ #/$!*0%1
!"#"!-2&'( 5N=! $ 8/12*0%1
!"#$11-&'&'( OAS,! $ #/#"*0%1
!"!88-!&'( O(7!% $ 1/"8*0%-
!"-"381&'( DT86: $ 2/83*0%"
!"!3"31&'&'( I:,-# $ -/3!*0%"
!"1$323&?&'( )M?1% $ -/"-*0%1
!"!3!$!&'( US:1#2 $ "/$2*0%1
!"#118"&'( LAJ'2 $ 2/-8*0%1
!"#11"8&'( O.A#1' $ #/11*0%1
!"#1338&'( CB,.! $ "/8!*0%1
!"1-%$!&'( OQ:= $ !/$2*0%-
!""18#!&?&'( ON>J# $ 8/-3*0%2
!"#83"1&'( DAQ:# $ 1/-%*0%-
!"112#"&'( -$1%"1"9#!567 $ "/$3*0%"
!"!-8%#&'&'( C(N:!F $ 2/$2*0%1
!""8$%2&B&'( O+:71 $ #/31*0%$
!"#"%#"&'( PAS,# $ #/"2*0%-
!"123-"&'( V6:S! $ 8/2"*0%"
!"#288-&B&'( OA';:! $ -/"3*0%1
!"1!13%&'&'( <+6>=!' $ -/!!*0%"
!"-##$$&'( P(;+!% $ !/31*0%1
!"1188!&'( -81%""2C!-567 $ #/-2*0%1
!"#!1""&'&'( WXN $ 1/%!*0%2
!"1%-"#&'&'( FO=A#-'- $ 1/1!*0%1
!"!#$%#&'( )*+' # ",-#./0%
!"1-##-&'( 2345! # 1,"!./0-
!"$1!$1&'( 6578(! # ","9./0-
!"!#0:-&'( ;<=' # ",%$./0"
!"1":#!&'&'( >4?'$ # #,0$./0"
!":00-9&'( 65<3!' # :,00./0$
!"1%9%!&'( 6@3%- # 9,1!./0-
!"1#"09&'( A'(!- # -,"1./0-
!"$-$%1&'&'( >5B1 # $,:%./0"
!"10:##&'&'( C*3< # !,-$./0"
!"$1%9$&'( D3E! # #,:"./0-
!"$1$#%&'( 23(=1 # 1,"0./0-
!"1""$$&'( FB='4B! # -,"%./0$
!"!9911&4&'( 2(=85! # #,!0./0-
!"-#$:0&G&'( 63(" # !,$:./0-
!"1%0$-&'( 2H7-HB # 1,":./0"
!"1:9%1&'( C<31"@ # 1,0:./0-
!"11""1&'( C?I! # $,-"./0-
!"!:%--&'( J+58! # $,-!./0-
!"$19:0&'( C3K5- # !,-0./0"
!"$$:--&'( LEB:"% # #,00./0"
!"$1!1$&'( MN='B- # 9,:!./0-
!"1-$0$&'( M'*58 # !,9#./0"
!"$"%0!&'( "9-0$0-O!9P7+ # 1,-#./0-
!"-:!!-&'&'( C(!- # -,1"./0-
!"1!#!1&'( M'BHB # !,0:./0-
!"!99#"&4&'( LEB:"" # $,!0./0"
!"$1%!%&'( C531$'1" % $,$%./0-
!"11":%&'( >B(! % -,#9./0"
!"$"#99&'( OBB % $,!#./0"
!"$"%"0&'( J7H! % ",9#./0-
!""-"#:&'( 6Q*% % !,:1./0-
!"$"#09&'( A3Q'% % !,1!./0$
!"1:%%#&'( )'*! % -,%#./0-
!"-"#::&G&'( 6B(!' % 1,%!./0-
!"$1:"#&'( MH=*! % 1,9"./0-
!"$":"!&'( 6**HB! % %,#:./0-
!"1-:#"&'( R8=B+ % -,#9./0-
!"$9%!-&4&'( M?<?!:' % $,$0./0-
!""!":1&'( )Q3+" % !,1%./0-
!"$"!-:&'&'( "91!$1"S!%P7+ % $,"!./0-
!"$:"#0&'( D=K % !,00./0:
!"$$0:9&G&'( C531$'" % !,:$./0-
!"-%-90&G&'( C(G!' % -,!1./0"
!"-#0#!&'( TJ33 % 1,#$./0$
!"-"$$!&'( R8=BI51T % -,""./0$
!"$":"-&'( UH'B15 % %,"9./0-
!"$1$#"&'( !$000-1O1"P7+ % :,%-./0-
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!"!#$"%&'( )*+,- % !.-$/01"
!"!2"#3&'( 4567!"' % 8."%/01#
!""1--2&'( 9/:;;! % %.-"/01"
!"8-#%%&'( <=>;2 % !.!-/01%
!"83$#!&'( 8#!1118?8-@A= % -.#2/01-
!"$88$!&'( )>6' % -.%#/01-
!"8#22"&'( BC5;; % 2.!2/01"
!"-""%3&'( DE4!111"$%$- % !.2%/01-
!"8"-$$&'&'( FA:-> % #.##/01-
!"$"%-#&'( G:=H*$% % -.!%/01"
!"8$3!"&'&'( 4'57H5 % 8.#"/01"
!""2!12&'( FI7J8 % #.-$/01$
!"-!822&'&'( 8-!11!"K1!@A= % ".!$/01"
!"8-%8!&'( L;M! % 8."2/01-
!"$12#3&'( NO7HPJ! % %.%1/01-
!"8#$$3&Q&'( 1#!11!1R13@A=9 % !.%!/01"
!"$-#$!&'&'( RH;""59 % %.3"/01"
!"8"!"%&'( GCJ'! % 8."3/01-
!"!#"$8&'( E'( % 8.3#/01-
!"--$#%&'( SM;J % !.2%/01-
!""3-"1&'( LM6M-1' % %.2!/01$
!"83%38&'&'( NO7H7! % 8.#-/01-
!"-%811&'( <7CI8 % !.-2/01#
!"$8!$$&'&'( T*Q!% % $.%2/01-
!"-$$$!&'( <CI*- % $.-#/01$
!"#1--%&'( FC-=>;! % #.#1/01-
!"838$!&'( FM7C*! % -.!!/01-
!"8-1$3&'( 4';U'8 % %.22/01-
!"8--$1&'( FI7J$ % !.83/01-
!"!#31%&'( 9@;5-#' % 3.8%/01$
!"833$-&'( B(7C! % %.32/01-
!"$8323&'( V;J-# % $.""/01-
!"8""$8&'( F5(M % 8.!8/01-
!"$813-&'&'( BW'! % !.%2/01-
!"8$-83&'( R4113!#- % $.33/01$
!"$1#-3&'( B*7*$ % 2.2#/01"
!""38%8&'( R(X8 % $.!$/01$
!"$!2-!&Q&'( K80D % -.-!/01-
!"$$"2"&'( 4I5!'! % $.%1/01$
!"!%82#&'( GY!9 % 2.3"/01-
!"8#21"&J&'( T:'W7!19 % 3.$#/01"
!"!%$-1&'&'( FH;2 % #."$/01-
!"!2$-#&'&'( @65' % ".!!/01-
!"8-!%%&'&'( G>A! % #.1!/01-
!""3%#2&'( F57-$>! % $.#-/01-
!"838!1&J&'( 4C+= % $.2"/01"
!"8#"$2&J&'( GZ$"23%% % 2.#-/01-
!"!#2-2&'( B;'! % %.#2/01-
!""#$%#&'&'( )*+,! - ./!%0123
!"$2%3"&'( 45+6!'3 - "/#-01!!
!"%"#2%&'( 78('* - $/"#0123
!"$3.9"&'( :+(;!2 - "/290123
!"3"9-$&<&'( 7)=>,! - %/$"012"
!"!92"!&'( ?@A! - 9/92012%
!"!."2"&,&'( 7B*,!. - !/"%012"
!"$.%$"&'( 4C*;'$ - %/#-0123
!"$"3"3&'&'( 0D=!' - !/%.0123
!"!##9$&'( BEFG - "/%-012"
!"3.-.$&<&'( 0H*3 - -/"%0123
!"3.!-%&'( I(<C- - !/-$0123
!"$%33$&'( J=*!2. - !/.20123
!"33.#9&,&'( B*,9 - -/-30123
!"$39-.&'( "932"%3K$"BDL - "/$!0123
!"3%$$2&,&'( M;+"$,N$ - !/%.0123
!"3.##%&'&'( MEN>* - %/"-0123
!"3.$$2&'( J=*$#- - !/"90123
!"%3$99&'&'( 7OC* - 3/%#0123
!"%%!%9&'( I**H! - $/-!0123
!"3--!%&<&'( I*N<! - "/".0123
!""#.."&'&'( )*NA - !/.!012"
!"$##2#&'( O>D+LHN$ - #/"#012.
!"$#%2$&'( I+(>. - ./-"0123
!".2.##&,&'( PC+!!9Q - !/%!0123
!"!#!%.&'( :+CN" - "/."012"
!"33""%&<&'( RSA+,!7 - 3/!2012"
!"3"%!2&'( O'*,,$ - 3/%-0123
!"%!2-.&,&'( 0D=3S - -/990123
!"$33$!&'( T6';S - !/.!012"
!"!.#%%&'( 4',! - %/""012%
!"$-!$-&<&'( R,*'!Q - "/!"0123
!"!.3#%&'&'( T.*> - -/2%012%
!"$%$.-&'&'( ON'>! - -/2!012"
!"!--9!&'&'( J=SH - "/%20123
!"$#$$"&'( RC>*;H - 3/99012%
!"!#2..&'( MU$ - #/$9012.
!"%.$!3&<&'( V'>, - !/#.012%
!""9!9.&'&'( 7B*,$-' - %/%90123
!"3$!""&'&'( B+E6! - $/2.0123
!"39%%-&,&'( W;Q$ - !/#30123
!"3%""2&'( O;X;# - $/$%012"
!"3#9#"&<&'( O,SQ" - $/-#0123
!""#%2%&'( M!; - !/-#0123
!"!9-23&'( MFH%'3 - !/!20123
!"3%2-9&'( )=>,!# - ./#.0123
!"!%.-.&'&'( O,SQ% - !/-90123
!"$."$"&'( )5A(! - $/".012"
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!"#$%&'()(*+ ,*-). % /0""12&$
!"3/3"&()(*+ 4+5-/ % !0%$12&$
!""3//'(*+ 67-8" % $0#312&$
!""93#/(*+ :7;.! % !0&"12&$
!"!'"/'(*+ <;." % $0$"12&3
!"#3"%/(*+ =>?"*3 % '0!!12&%
!"$%3&$(*(*+ 6@>A; % !0%&12&"
!"!93&%()(*+ 6>@)# % !0#&12&$
!"##""'()(*+ B@;# % $0#912&"
!"!%%//(*+ =8.3. % 90"&12&"
!"#/%&'(*(*+ C)7$$ % !03312&$
!"#$!&"(*+ D-)! % 303#12&'
!""'&'&(*(*+ EF)! % #0$'12&$
!"$33!'(*+ GB*7!. % !0'312&$
!"#9"%$(*+ H77$@. % $0&&12&$
!"3"/'/(*+ <;.! % #09#12&$
!"$3//#(*+ IJ*7 % '09312&$
!""9%/#(*+ B*K!% % !0!312&$
!"#/#&3(*+ GH77!@. % !0"!12&$
!"##%!/(*(*+ L@7! % /0"$12&$
!"#"/9"(*+ B*.3@ % $0$#12&"
!"!/3/"(*+ 6>M% % "0/"12&3
!"#"!/3(*(*+ 6N*-7O; % $0$&12&$
!""'993(*+ P5F5"% % /0/!12&$
!"#&9&'(*(*+ !3&&&&$Q&$BOJG % !0//12&$
!"#%&9/(*+ 6?O+$ % "03/12&"
!"3'/%'()(*+ 48>!. % !0%!12&"
!"$9!!%(M(*+ P5F5"!. % $0%312&$
!"$/'&9(*+ RQ=!&&&""&3# % !0$912&$
!"#9!#3(*+ "'#!3&/S&$BOJ % %0%312&$
!"#93&/(*+ LA@ % "0&912&"
!"3!3%#(*(*+ 3#$&"&&<#"BOJG % 309#12&"
!"#/%#3()(*+ 1+)! % $0/912&$
!"#&9%3(*+ PTU! % $0'%12&"
!"!39%"(*+ G67-8! % 30!#12&3
!"$'$'9(M(*+ IF?U % /0"'12&"
!"!3''&(*+ VK*@# % %0/912&"
!"$"$'#(*+ C)7$" % %03312&$
!"3!!&'(*(*+ IFKK" % '03'12&$
!"#""/9()(*+ HN?K.! % '0%!12&$
!"!%"3"(*+ =W?". % #0/312&$
!"$"&$9(*+ X;*Y@!$ % !09312&$
!"#/93!(*(*+ I>Z % 90$%12&/
!"3#%"'(*+ H*7K! / #0!/12&$
!"$"$$/()(*+ B@>-! / #0'"12&"
!"$%$$9(M(*+ 1?7$ / !03/12&$
!""'3!/(*(*+ B[)$ / !0!$12&"
!"#%9%9(*+ &/!&&!&Q!#BOJ / 30&/12&3
!"#$%"$&'( )**+# , "-."/0."
!""$!"1&'&'( 2345% , %-,!/0.#
!"!%$$$&'( 678! , 9-!9/0.%
!"#$"1"&:&'( 67*4;<1 , 1-%!/0.,
!"19,%=&'( >*7?! , =-=!/0.#




!"#,$%#&'( H345! , 9-9"/0.#
!"1$,$!&'( )(4*+ , ,-=#/0."
!"#"9%#&:&'( EI*J! , #-,"/0.#
!"%"=.,&'( FK*'+ , 9-#1/0.#
!"#==.,&:&'( L>4@!" , "-$!/0."
!"%.,#=&'&'( M7?4! , !-#./0.#
!"19#..&'( D47NN!B , "-$%/0."
!"19==1&'( O4P( , $-$#/0.#
!"#,#.1&'( DBN!.'= , 1-"1/0."
!"1#,9,&'&'( )**!# , ,-"!/0.#
!"#%!"9&'( M(4!?1 , %-.%/0.%
!"!9"9,&'( QJJ! , !-$1/0.,
!"!,$1"&'( R*3# , !-"!/0.#
!"##,!!&@&'( R;<#! , ,-9=/0.#
!"%#=%1&'( >4B!= , =-9./0.#
!""$,19&@&'( D('*<= , !-!1/0."
!"1!$$9&'( LSP*#' , "-1,/0.#
!"1%.$$&'&'( M*J(B , 1-$"/0.,
!""=$#!&'( HT@N!B! , !-,9/0.#
!"!=!,,&'( )@34! , 1-99/0."
!"!="#%&'( U'*+7 , 1-9=/0.#
!"!,.1=&'( )<N<, , "-!1/0.#
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!"!$3%3')')* @>AB " %/0.12&6
!"0%6!$')* CD,0 " 6/#612&"
!"0!&#6')* <*EF. " #/"%12&0
!"!0$!3')* @5*6 " 6/0.12&#
!""#66!'(')* G8)H6 " 6/0"12&"
!"%$$$#')* I8=806 " 6/!$12&#
!"!$!.0')* J)>F*!& " $/!$12&#
!"%&.""')* KLE!$0 " !/3%12&"
!"".6!"')* 06#&"6%M&.:;- " 6/"$12&#
!"##3$&'(')* BG;N)! " 0/.#12&#
!"##."%')* OP?3 " !/&!12&3
!"#0.#&')* G5)E=, " %/&612&0
!"!3$.!')* MA8D " #/."12&#
!"%%06!')* IQD7% " %/.#12&#
!"#$0"3'(')* BG>5%0)0 " #/#$12&#
!"0!03.')* M,%5% " 6/3612&#
!"##0$$')* 93R7A!!3= " !/#$12&#
!"%%036')* M;D)F " 6/".12&#
!"#3%33'(')* ST@!&&&"6&%$ " #/!612&"
!"#6"6.'(')* BID(# " !/3.12&"
!"3&%#"')* RH,$! " %/$312&#
!"!$3!3')* O)U " !/"012&0
!"!0.""')* GH5! " 0/!612&#
!"#$#.6')')* :D8#. " %/".12&#
!"!06&0')* .!#&&!!V!0:;- " 0/"$12&#
!"%$603')* W)7HQEE*B " !/6012&#
!"!0$&3')* <>)* " %/0!12&"
!"%033&')* 4*DH# " "/#!12&"
!"0%""3')')* I8AD% " ./0012&"
!"!.30.'7')* @Q;5% " 0/6312&#
!"0#%!%')* KLE#$# " #/&&12&$
!"%%$!$')* M=HH. " "/&%12&#
!"%00#.')')* :*F# " #/."12&#
!"0&3.!')* @)7-;F% " !/.#12&"
!"%##0%')* @,;7E>H! " !/&612&3
!"#3."3'7')* JFX0B " #/!%12&#
!"!$"."')* 1DL% " %/3612&#
!"#0&!3')* I,)-% " %/6612&0
!"#$!!"'(')* 1L7 " %/0!12&0
!"#06.#')* WEQ!D " #/3!12&#
!"#36.0')* .3#&&0$V%#:;- " #/6!12&"
!"!6.#6')* 9)5*! " $/0.12&#
!"!#$%$&'( )*+,$ " -.$/01/-
!"$-/2-&'( )34+,! " %.5#01/-
!"-/$//&6&'( 7(82 " 9.2#01/"
!"2-!/#&'( :*;2* " 5./201/-
!"2""$/&'( <=>?$?@ " %.%/01!/
!"!$#$"&'( ABC>2D " !.#$01/-
!"$$2$"&'( "5--"2/<!!EF4 " %.$!01/-
!"!9"/-&'( GH/!#%!2 " -.5%01/$
!"!9#-/&'( "%-!"2#H!#EF4 " "./$01/-
!""929#&'( H'6=!2@ " #.-%01/%
!"!%#2/&'( ID>6% " !.#"01/"
!"!5$"#&'( JD=F2 " #.2/01/"
!"!#"/5&'( K- " ".$901/-
!"22559&'( A?,+!5 " 5.5501/$
!""##2$&'( H/-//-"0!"EF4 " !.2#01/$
!"2"%!9&'( @ID-*" " $.-901/-
!"2-"/5&'&'( 2$////-7!/EF4 " ".2!01/-
!"-5999&'&'( LD'($ " !.9%01/-
!"2%9"/&'( IF,(2 " $.%$01/"
!"2--9$&'( @J63'8 " #.$#01/$
!"22%"/&'( A?,+*9 " !./%01/#
!"2$"9$&'( MD=%2 " 5.%201/-
!"2959%&'( $5-/"/5G!9EF4 " !.%#01/-
!""#9"#&'( MDNO;!% " 5.-"01/-
!"2!/22&8&'( )?N=! " #.-201/-
!"!%52"&'( G2-/!!5P/#EF4 " -.2!01/-
!"!#//!&'&'( Q"R6S$-; " -.9"01/-
!"$2%59&'( MD=$!2 " !./#01/-
!"$%"%%&8&'( )(83!/ " $.##01/-




!"$/%2$&'( HBC$'2 " 5./501/-
!"%/$#"&'( K'(" " 2.!201/#
!"2#"/"&8&'( @03B!@ " #."%01/-
!"2%9!2&'( @EDT,2 " 2."201/-
!"$/9$/&'( IU?- " 9.5-01/"
!"$!$-%&'( 7V>! " -./#01/-
!"$!9#!&'( HSC"' " !.9"01/-
!"-9$/$&'( HCF?$ " $."#01/"
!"$52#"&'( MD=%9 " %.%%01/"
!"-!!!/&'( AC8,?2 " !."201/-
!"!#!/#&'( J=,$2C2 " "."!01/-
!""5%"5&'( 9!-///$L!"EF4 " !./901/"
!"!9/#/&'( HN6! " 9.//01/%
!""#5"!&8&'( I(-W'C% " 2.""01/-
!"!9"$#&'( EW3;D " !.5%01/5
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!"!#$%$&'( )*+,-$ " %./0123%
!"-#!$!&'( 4567! " 0.##123%
!"$$-#0&'( 897%# " #.-$123%
!"%#$/"&+&'( :;<=( " %.0-123>
!"!#3$>&'( ;5?6! " >.>3123"
!"%$>/%&'( @'AA " %.!0123%
!"%$#>#&'( BCD%* " !.!"123"
!"-"##3&'( E'A9! " %.$$123%
!"$3"!0&'&'( F<GH" " !.!-123%
!"%0%$"&+&'( EDD% " 0.#-123"
!"-"-"#&'( 17C! " /.">123%
!"$->%-&'( I'J!: " %.!"123#
!"$!%!!&'&'( I9<G,7! " "."0123%
!"!/%03&'( :KHG"-% " !./>1230
!"$-0"#&'( -"!3330L3%M<J " %./#123$
!"$-0$>&'( E76*NH " -.!>123%
!"$-//%&'( $"%3"!>O3/M<J " 0.0/123#
!"$$>!#&'( P?*79! " /.#/123%
!""0/0/&'&'( @Q,!* " ".$"123%
!"%%0$#&'( )'(! " ".">123%
!">3%""&'( -%!33%%)!"M<J " !."/123%
!"!$0#>&'&'( MG5-> " $.$>123%
!""3!$>&5&'( IR0$!$-% " !.##123"
!"!/%#>&'( !!!33!0@3%M<J " #.!-123$
!"$-3#-&'( @QC(! " $.#0123>
!"%%#0-&'( EA9D!- " -.0!123"
!"$>>-/&'( IDJ79"# " /.3%123>
!"-">3-&5&'( :S7CC" " -.!#123%
!"%%#30&'( B7G>0 " -.>>123%
!"%>$!"&'( TGC" " >./#123"
!"$!""3&'( EU,9A " 0.#3123>
!"$!#"#&'&'( I(=!- " /.#!123%
!"!03/-&5&'( V7<G!3 " /.#-123"
!"-"$>#&'( V5G'D- " !.-3123$
!"%""##&'( W6C': " !.$-123%
!"%%#$$&'( @<67! " -.$3123%
!"-%%//&'&'( F'H- " ".!!123%
!""0/%%&'( ;C9U*!# " >.$!123%
!"!$#>/&'( R(CU % %."0123%
!"-$%"3&'&'( ;(G7' % -.%>123%
!"%#->-&+&'( XC'5- % 0.#!123%
!"%"/$/&'( YUU % 0.-0123"
!"!>"$0&'( I7H- % %.#$123%
!"-"-%>&'( V*C!9!3* % ".!/123%
!"!0-!/&'( RA!$ % #.$0123%
!"-#/-0&5&'( ;<=Z % !.#>123#
!"$"/>$&'( POE>%"0"- % 0.>!123"
!"$>3!0&'( X79/ % !.%!123%
!"##$$%&'&() *+,(- . %/#.012"
!".#3$3&() 4)5.3, . "/22012.
!""3.2-&() 67)8-2 . 9/"%012.
!"-"!#"&(&() :;7(- . "/.2012.
!"#-9--&() <==!>.8 . "/-.012"
!"-%-!-&;&() ?@A@!%!( . %/".012.
!".-"!$&(&() ?;=(B- . $/"9012"
!""32-9&() ?C'. . -/23012"




!""!92-&'&() H4,7-9(" . $/2!0129
!"!322$&() !3!222$I!"FG5 . "/9#012.
!"!%93-&() J+'+! . !/3$012.
!""3.-#&() IK8!!% . "/#.012.
!"!%"%9&() LMN=! . -/#$012.
!".$!#-&() IA'.C . 9/"$012#
!"!$%!%&() 4)%O(,B(7- . ./9-012#
!"-3%3!&() P@%23 . #/-3012"
!"-.#.-&() FBQ"" . ./""012.
!".!2$9&() R!S)BQ- . #/%2012"
!""$!%2&() HT+B+ . "/%-012"
!"-%3-#&() J@B,. . !/#"012"
!".9%32&() ?BQ;Q!2 . -/..012"
!"#-..-&() R7873#( . -/##012.
!"--%-9&;&() 4U>++@. . ./.%012.
!"-..%-&() 4+>)! . !/-3012.
!".9!3$&() V=;!.8 . 9/39012.
!"!%#."&() E=Q- . 9/#3012.
!"#!%."&() -3!22#!J2-FG5 . -/9.01!!
!"#-.2"&(&() W>UOAQ# . !/#9012.
!"#!3-!&(&() 4=!22 . "/2-012"
!"#!%3.&'&() X-1E! . ./93012"
!"!%23"&() HYQ(B8# . -/2-012.
!".#.$2&(&() RA;. . ./!.012.
!""2-.$&() 0>77" . 9/92012#
!"."-..&() -%!22.2X2%FG5 . -/!-012.
!"!%93.&;&() J+'+! . -/99012"
!"..%-.&() YQ=.%$ . #/!.012.
!"-3"2!&() Y77U7. . !/33012.
!"%2-"3&() R='@- . ./-!012#




!".%.!#&() IK;). . -/$3012"
!".3#"#&() H4,7-#(# . ./$"012.
!".##"#&() *R2.--2. . $/##012.
!".99%"&() ?@A@!$2 . "/93012"
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!"#$%&&'(')* +,- % ./0&120"
!"%&$"&'3')* !!4000%5!#+6- % !/%01207
!"7$0"!')* 893!$ % &/%0120%
!"%$0$#')* :;<9! % &/7#120%
!"%00%0')* 7%%0"#$=!$+6- % !/70120%
!"#7$#$')* >(*?!@ % !/%412!!
!"#!70.')* ABC;.& % #/#0120.
!"#70#4')')* 5DE)*# % !/!.120%
!"#%#74')* FG"@ % &/!.120"
!""&40#')* H*<#% % !/!7120%
!"%7%""')* !!!00#4F07+6-@ % !/%"120"
!"!40.&')* I69 % #/$!120%
!"744!!')* JG;#B % 7/!"120%
!""&!40')* 5;KB%% % "/.0120%
!"77!&&')* 1KLD! % !/!!120"
!""&.&.')* 5E)K! % 7/##120%
!"%7"$%'(')* 5,E!G % %/"$120%
!"#4!$$'(')* JB?9 % #/4!120%
!"7##"#')* JMK77 % 4/".120"
!"#"#%4')* #%!00$$1!"+6- % %/7.120%
!"%$0#4')* N6<<! % ./%"120%
!"%4700')* 8<;9! % %/0.1207
!"#&%"#')* +<E;% % ./%&120"
!"7!74%')* O#2P! % &/"412!0
!""0##$')* QCK.$0 % !/7%120"
!""&%4&'(')* +KB## % 4/0$120$




!"""0.$')* QCK&! % !/".120"
!"770!&')* R?*-# % %/0"120%
!"#&$#0')* 19() % #/.01207
!"#4#"0')* 8*);G" % !/%%120"
!"%.!4$'3')* @+K(!$ % 7/7%120%
!"!$.07')* +KM % %/""120%
!""4474'3')* R<M!L % %/04120"
!"7".%!')* 5,E!0 % %/7"120%
!"#$44.')* @HL;) % !/$&1207
!"##&70')* =)DK9! % 4/!4120%
!"$0#"4')* R93# % !/$71207
!"!$%&.')* =6K"-#< % ./0#120"
!""4!&&')* 56G9 % 7/!"120"
!"#44"%')* J*D( % 7/..120$
!"%7!4$')* I*;-# % ./0&120$
!"7"$!!')')* J)B?! % %/$0120%
!"%"%07')* T#)C!B" % !/#7120"
!"#%&$7')* 8B<"")! % !/&.120"
!"!&#07')* HL(G! % #/.#120%
!""#$#%&'( )*+,$ - ./--012-
!"3"$%.&4&'( 567*! - "/-3012$
!"!%".8&'( 9:;7!"' - 3/!2012-
!"3#--8&'( !#!22-"<32=>? - 3/3#012"
!"3-!$!&'( @A'BC!! - 8/%"012-




!"!#33#&'( )E+! - ./$-012"
!"$%.2!&'( FAE!:? - -/3%012-
!"328$3&'( @(G-H - 3/!!012.
!"!%2.3&'( 0IC"/!:- - !/#%012"
!"3#!-"&'( 9JK% - 3/!8012$
!"!.%.#&'&'( L4*-C8 - !/!8012-
!"-."%#&'( MN>O! - #/!!012-
!"!#$!$&'( PQ3 - 3/2!012-
!"!.-%#&'( P;4*7! - "/.$012-
!"--8!3&'( MR$$$"." - 8/"3012$
!"!82!-&'( L4IC# - !/--012-
!"-%".!&G&'( )467;"' - 3/!"012"
!"!%-8!&4&'( SJ4N3 - ./"$012-
!"$$!"3&'( FJ74" - "/2-012"
!"$."82&G&'( HT+CC37H - -/#.012#
!"!8383&'( %!-222$)!"=>? - %/".012"
!"-!888&'&'( L6UA- - !/38012"
!"--.-%&'( $8-2$%-V!8=>? - 3/320128
!"3-!2-&'( =EG$ - 8/"#012-
!"$-22%&'( 9I6 - #/!"012-
!"-#""3&'( MD"$23-. - %/$.012"
!"$38--&'( W'A?3 - 3/$"012-
!"3.#2-&'( =C63. - $/880128
!""%33.&'( L>7! - ./.2012$
!"$"#!$&'( F;N('*3 - %/8.012-
!"!$8-#&'( TGA*7!3 - $/#8012"
!".2-%%&'( 97*7!!8 - !/$!012"
!"3#-.8&'( )*4(! - "/3"012-
!"$-!3%&'&'( =U4!3 - !/38012$
!"$"#$.&G&'( H=I:-$ - ./$!012-
!"-$$.#&'( M<!3%!3# - 8/2"012-
!"!8$.3&'( 0>E";CI! - #/88012-
!"-$--%&'( <7(*!$ - "/$3012-
!"-"2#!&'( 5X9!222"8%32 - 3/$8012-
!""#!$$&'( W*7*.>I - -/$"012-
!"-%2.#&'( 0N'I! - #/"8012-
!"!#.$!&'( FI'('. - !/23012-
!"3!2##&'( SI7" - 3/3%012-
!"3"2%%&'( 3-!22!.9!.=>? - ./3%012"
!".2$#2&'( W7AG - 3/-%012"
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!"##$%&'() *+,-.! / "0!1231/
!"/41&4'() 5678 / 404423!#
!"/$9&9'() :;+,<= / %0&"231/
!"/!&"#'('() >;/?!" / "049231#
!"9/!##'() *,@ / $04#231/
!"//#4/'() =>AB/%# / !0$9231/
!"/4$9#'C'() D)B%E1;= / !0&$231"
!"/"4"1'() F,- / !0!/231"
!"/#%1/'() *G8H! / %0/$231%
!"944$%'() IH6A,< / 90%$231/
!""$114'() JK<B/ / 40#"231/
!""""1$'() LB?/(< / 409#2314
!"#!11/'() M(B/7&@B9 / /0"&231/
!"9%$49'() N<OP;?! / #0&%231%
!"#1%!4'('() *B,,9( / 40!/231&
!"/#$!1'() N(H./ / /0%!231"
!"!%#$4'() Q<@.9 / !0/&231%
!""4$%1'() RCC;# / /0!!231#
!""14%1'() S-8( / !0#1231/
!"/&&!1'C'() !&1119!I99L@7 / "09$231/
!"/&#%/'() I?A91<! / !0%#231"
!""119!'() QB,91 / 904!231/
!""$/&!'() F(,.9 / $0""231"
!"/&#!9'C'() 2-G(!-B9 / /0"4231/
!"9$!/!'() T-89E9 / !0&%231"
!"#!9%!'.'() *)(B9 / &0$%231/
!"/!/"1'('() 9/!1119U9!L@7 / /04&231/
!"/#9"/'() >AB&"% / 90$4231/
!""$$44'() Q@V(B! / "0%!231/
!"!4/$$'() W;)H$ / /0$!231/
!""$/"/'.'() *@G/( / !0%1231$
!"#%&4$'() >AB"%9 / /09"231/
!"/"9%&'() S87! / 901#231"
!"/"&%#'() 2B/11 / "0%4231/
!"##9"&'() DV+)<! / 90&4231#
!"//$/%'() 1%!11!129!L@7 / 4019231/
!"/%"9%'() R;9H9( / /019231/
!"9#41$'() N(-B" / 909$231/
!"%1!$%'() R-,! / /0$#231/
!"!$1"#'() *<;9#(9/ / !0!1231"
!"/#9##'() I<CG-! / "0"9231#
!"/"1#4'() M)V,!9 / 40&%231/
!"9"!//'() JV8V$4 / !0&1231"
!"9%&%%'() %//1"1/W1&L@7 / !0&%23!9
!"#!1"!'() L+;79 / !0"%231/
!"94&!$'() 91!1/1$Q9!L@7 / /0/!231"
!"!&"##'() J6X/ / %0$1231#
!"###/4'() %//1"1/M9/L@7 / "019231/




!"!."$#&'( 6-8!" $ !/#4230"
!"$#"4!&'( 9:,;! $ ./.0230"
!"<!%#<&'( =,,+! $ %/.%230$
!"$<<<%&'( >?@1 $ "/11230$
!"40"!1&'( ABCD'$' $ #/.4230$
!"$".#1&'( 9EE!,!4F $ </.#230$
!"$<<1.&'( 98+'! $ 1/!"230$
!"$%4.$&'( 67E+! $ "/10230$
!"<0"$!&'&'( GC--" $ ./#%230$
!"$%0!1&H&'( BE,,4' $ "/##230"
!"$"41%&'( ))<$1.!. $ ./$.230$
!"41.#4&'( IE,!4< $ !/!#230"
!"4"1$<&'( 2CJ!'! $ !/#4230$
!"$"!0<&'( 2ED4'7E! $ $/00230"
!"!%$04&'( KC?; $ "/<!2301
!"<<#!.&H&'( LH-F $ !/0!230"
!"41.$$&'( M(E+! $ $/%<230$
!"$."41&'( N'O $ !/<0230$
!"$<%%#&'( 5O*F!7E! $ </!4230$
!"!.#"#&'( LJE.0" $ </%%230<
!"$<".0&'( =P5<".!<0 $ $/#!230$
!"<4$#.&'&'( )D@(;4 $ !/00230"
!""%<<0&'( >?@!O $ 1/#"230$
!"<!"%0&'( =?E;';! $ </!1230"
!""#"$$&'&'( 9O@;OC $ 4/.<230"
!"$10!!&'( 2;D@4 $ ./%"230$
!""%0.0&H&'( )EO--! $ !/00230<
!""#!!1&'( QF'! $ </##230"
!"4%0!#&'( $#$0"0#R4"67+ $ ./.1230$
!"<<0<<&'( "%$0<14R!%67+ $ #/4$230$
!"40#<<&'( 2;* $ !/<%230<
!"$.<.1&'( 4#!0"4.)0.67+ $ ./%"230$
!"<"10"&S&'( TSE'*!4 $ 4/1#230$
!"4#!4!&'( 41!0<4#U!!67+A $ #/"<230$
!"4""00&'&'( );-8!;!A $ 1/<1230$
!"!14#%&'( 9;@-! $ 4/$"230$
!"444!1&'( >7-4 $ 4/"%230$
!"$$.$1&'( KOJO! $ 4/!%230$
!"<1!"1&'( =P5!000".<$0 $ !/4<2301
!"<1<4!&'( G,<'4 $ $/!"230$
!"41#0!&'( BCE(# $ "/<4230$
!"<<%0!&'( 58E(! $ !/4.230<
!"4".14&'( 5!V(*J<A $ !/.1230#
!"4%.1"&'( !<0000<U!"67+ $ #/0"230$
!""#444&H&'( 5@H#' $ 1/0<230$
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!""#$"$%&' (&)" * !+,-./-*
!"*,##0%&' 12&304 * !+$*./-*
!"**,0,%&' .56)& * ,+#0./-*
!",,777%&' 893,$, * $+*#./-*
!"07$#!%&' :;<=7 * "+0*./-"
!""->*7%&' ?@!*!7,! * #+$-./-,
!",">!>%&' ?6=)50> * *+*0./-*
!""-#*#%&' ?@#,0-7" * !+$-./-"
!",#*,*%&' AB5! * 0+>"./-"
!"0**#$%&' CD&5> * >+7-./-*
!"0"7>!%&' :4E=F9! * "+-,./-*
!"!#>!"%&' GH<3# * *+0!./-*
!"0##7>%&' .IJ;*40 * >+$!./-"
!"0>$-0%&' KC))D0 * 0+#!./-"
!""0#--%I%&' ?#*--,$@0-LM= * !+00./-*
!"7-7!,%&' A',5;! * >+,#./-*
!"!>,7#%&' A;&45 * *+!"./-*
!"*"!*$%&' :&)3!! * 0+,"./-"
!"*>"0"%&' CN5E0 * !+77./-"
!"0"!!$%&' :)=&2! * $+#,./-*
!",*-0,%&' O&;)J50 * ,+7#./-,
!"00"7,%&%&' KAI6 * !+!7./-*
!"0,$>>%&%&' C4= * "+"!./-*
!"*"$,7%&' L69!>- * *+#,./-*
!"*7-7#%&' 82'2!- * #+!7./-*
!"*,7#0%&' P&)<0 * !+#7./-"
!"0#,0>%&' C6I> * #+>>./-*
!"*,"$0%&' CJ;<7 * 0+">./-*
!"0$*,$%<%&' L23D< * !+"#./-"
!"*,>#!%&' (&65! * 7+#,./-*
!"0#*,>%&' 07!--!$Q-*LM= * 7+*#./-*
!"0,"#0%<%&' ?6=DN0 * 0+7,./-*
!"*"7$!%&' C9)<0M3 * !+"#./-*
!"!,$7#%&%&' R&3 * $+0"./-*
!"*7$0"%I%&' K.)J!4K * 7+,"./-*
!"0>*,7%&' 0*!--*!?!#LM=K * 7+0!./-,
!"0,-$,%&' S(--0-,$ * ,+,0./-*
!",7-0>%&' L2D"! * ,+>*./-*
!"0"$7#%&' 00!--0*T-,LM= * 0+>-./-"
!""$-0*%&%&' .UF! * #+0,./-"
!"!7*,"%&' L2DI * ,+-,./-*
!"0*">0%&' CE3'0 * *+*0./-*
!"!$0->%&' 893*> * ,+"#./-,
!"*>$*-%&' T4'0,50 * ,+#0./->
!"0>,7#%&%&' @V#- * ,+*!./-*
!"0>*"$%I%&' 0#!--0!T-0LM= 0 $+"7./-*
!""$!,"%&' (J4!!&! 0 #+>!./-*
!"*#7#,%&' 8DND7 0 *+77./-*
!"#$%"&'() *+,- . !/0$123$
!"!4"4%'() 567"(# . !/%3123"
!""##&&'() 89(:!(; . 0/&0123#
!""4&%%'() <=6!%(! . #/.3123#
!"!$"!!'() >?):. . #/#&123#
!"#0""&'@'() ;AB6#&( . 4/$.123%
!"!&.&#'() C9," . ./"3123"
!"!$..3'() 5B7?! . #/3!123#
!"!&%$&'() <)DDEFB! . 4/3$123#
!"##$.$'() C6?7G" . !/%4123"
!"%%!40'() HGF:## . ./%3123#
!"!&%4!'() *I=9I . &/&&123#
!".#&3!'() <=(?J . "/0&123#
!".3".0'() C79IE# . $/30123"
!""#&4%'@'() C96F:& . %/%0123#
!"!0&"#'?'() <(G:! . #/4#123#
!"%3%#%'() KG)(B!.2! . ./%&123"
!"#&4#"'?'() C(7?FD# . "/&%123#
!"#4&$3'@'() 89(:!% . !/$&123#
!".""!%'?'() 5B=D! . %/$3123#
!".03..'() 897J(B!G! . %/!4123%
!".4%&#'() <ID. . #/#&123#
!"#4#"0'() L<3"#"&$ . 4/4.123%
!""4$0#'() >6)B9! . &/&3123#
!".04"!'() M-+N!3 . "/4%123"
!"%...#'?'() >7(B!" . $/"%123#
!"#4&$$'() CDG7. . !/&!123#
!"%3!""'() C6(.G! . "/.&123#
!"."."3'() 8GOB. . 0/&%123#
!""0#$.'('() MFD,! . %/#4123#
!"!$%!#'() P(:E. . 4/."123#
!"%40#3'() 8"+D) . &/$0123#
!"%!3"$'() ;QNB:! . "/!.123"
!".303#'() 5)$+(6D(7# . &/.3123"
!"#4&34'@'() RSI(E . #/3&123#
!"%!!4&'() 3$!33#&C3%AF, . %/!"123#
!"%.""3'() ;HDN?N!.; . $/#!123%
!".$3$#'('() >-: . "/%3123&
!""0.!#'() P(+-# . ./3!123#
!"#0$!4'() C9-!3( . "/"!123"
!"."%.%'() >GB . #/%0123#
!"%33$$'() TEG! . !/4$123#
!"!&!00'() H:-:!4#( . &/0!123#
!"#..#%'() 1B?U! . 4/%#123#
!""#&03'@'() "0#3"!"P..AF, . !/$#123&
!"%30.3'() <7DE. . 4/40123#
!"$3334'@'() ;1G=!6; . "/$"123#
!"#%00!'() VG#7. . &/"!123#
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!""#"$%&'( )"*'+($ , "-."/01$
!"%.2.!&'( #$$1!,13!!456 , .-$!/01%
!"%!%%1&'( /789$ , #-",/01"
!"%%$2#&'( :79'! , !-%,/01$
!""#;1"&'( <=>( , #-;,/01%
!"!22,!&'( ?+*+! , !-!,/01$
!"$.!2!&@&'( 497>A , ;-"1/01$
!"%%1"1&A&'( !!!112,B12456 , #-1%/01"
!"$$.21&'&'( 489CC$ , ,-%;/01$
!"$%;,$&@&'( /*D. , !-1%/01$
!"21%;"&'( 35A77C,' , #-%#/01$
!"%1#$%&'( /EFF% , 2-,;/01$
!"$;22.&'( %.$1"!1/!%456 , !-##/01$
!"";!%"&'( GCE*, , ,-"./012
!",#"2#&'( :#$11!$H!1456 , ;-2%/01$
!"$$...&'( ?$>9(+, , !-11/01,
!"%%",1&'( 4'C,$9 , %-,2/01$
!",#,;!&'( ,2!111;/!!456 , ,-1;/01$
!"$;;"$&@&'( IB(F8, , !-,$/01$
!"$"!,2&'( "#$1"1,3,"456 , 2-1!/01%
!"%21%1&'( J;1##; , !-."/01"
!""!#!!&@&'( K'E( , !-!!/01$




!",$$%$&'( JE5A7+C! , ,-;!/01"
!"%;$%;&'( <'=6, , $-#!/01$
!""1$;!&'( ,"!11;%B!.456 , 2-$$/01"
!"!2,%%&'( KP'" , 2-"#/01"
!",1#$1&A&'( J(=='+! , ;-1./01"
!",#%;!&'( :F'C# , ,-../01$
!"%#;1.&@&'( "#$$"12/,1456 , ,-%./01$
!"!.#%,&'( JQ7,P2 , ,-1#/01$
!"!;.#!&'( O8$*+, , "-#$/012
!"";!12&'( GRF'7! , %-.%/01"
!",#;2#&'( !!!11,1J1$456 , $-,2/0!,
!"$%%2!&'( /ES , 2-../01$
!"".%"1&'( M5*C$ , 2-.#/01$
!"$#22%&'( K7E,$ , $-.,/01$
!"$$"$$&'( BQA(, , %-%;/01%
!""!!!"&'( #$$1!%2<1;456 , %-,1/01$
!""1"%,&'( TE7, , ,-;$/01$
!"!;",;&'( U5S%9 , ,-#1/01$
!"%.$",&'( V6WS" , !-1;/01$
!",#!12&'( "#,!%1#X!.456 , "-,"/01$
!"%!1.1&'( KC5! , !-"./01$
!",$2!!&'( :+7+ , $-$!/01$
!"%1","&'&'( V+!;97 , !-%"/01$
!"#$#$!%&' ()*+, - ./0123$"
!""$0$1%4%&' 5&6*1 - 1/""23$.
!""7.01%&' 869:;-$ - #/#.23$1
!"1-.!<%&%&' =>?' - 0/"723$"
!"-7-1.%&' @&A>'A- - #/7123$"
!"#$-7-%&%&' B?&*6&! - -/"023$"
!""0<<0%&' BC*D" - 7/.$23$1




!"-<-7$%&' E*'0! - 0/1023$7
!"1".$<%&' =,H,A! - 1/1723$1
!""711"%&' 5+?,1 - 7/".23$1
!""0$1-%&' IJ+- - -/$123$1
!"-7!"<%&' @&D- - !/"723$7
!""7.1!%&' KH,*HA- - 0/-.23$"
!"1-!$"%&%&' IAA6 - -/!"23$.
!"!<!0$%&' 86DG< - 1/7#23$1
!"1.0""%&' I11$$$7=-1F+G - ./.#23$.
!"1"!.1%&' B:; - 1/-$23$1




!".#1<1%4%&' NF,D-$ - ./..23$1
!"-.100%&%&' 5,G! - !/-!23$"
!"1!.#!%&%&' L:41" - !/!123$1
!"!<$$7%&' O!* - "/0723$.
!".!17#%&' 8P?'- - -/-$23$"
!"1#$<!%&' I>G*9-# - -/."23$1
!".111$%&' O696006 - !/0023$1
!"1#7$#%&' F>C!## - 0/"023$"
!""7!1!%D%&' O9!9! - </."23$1
!"-010"%&' L"QRS$7.!H - 1/--23$"
!"10!"-%D%&' !<$$$-!E!"F+GN - !/!!23$1
!"".7!"%&' =*C! - !/$-23$.
!"-#711%&' M4D*! - 0/7723$1
!".-$#-%&' 8*,D&,- - #/0<23$1
!"1"1#!%&' B:1,41 - "/$123$1
!"-10$$%&' L&*D - -/1<23$1
!""-1<!%&' K?;*! - </!023$1
!"-$<0$%&' ID6A1 - 1/0"23!!
!"10-7!%4%&' NF,A1< - </..23$.
!""-$#1%&' I9&?'DA! - !/-"23$.
!"#$--0%&' KMO!$$$"<70$ - 7/#<23$"
!"-"0.$%&' (&,1G! - 7/$"23$1
!"-"70#%D%&' T;4R< - "/$!23$1
!"""1"1%&' I!1$$#"K!"F+G - !/#-23$1
!"100#!%&' Q>6- - #/7723$#
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!"#"#$%&'( )*+!,- - ./".012#
!"-#34-&'( )(5#26 - !/2-012"
!"%--$"&'( 7(89:! - 4/"$012"
!"32!23&'( ;<=>? - !/!!012$
!"%!!!%&'( 7>'@# - #/%-012#
!"-"!-#&'( A,B59- - %/"3012#
!"323-2&'( CD8%.- - !/33012#
!"-!%-$&'&'( EF=-- - 4/"#012#
!"!.2%"&'&'( 7(8?-! - $/!%012#
!"%-33.&'( -$!22!-G2#H>I - ./2!012#




!"-$24-&'&'( N*,88! - 4/"$012#
!"!$""3&'( OL,5!3'- - !/$$012#
!"-4"-$&'( P,F5"Q - "/!-012#
!"#$22$&'( GQ'# - %/!-012#
!"-"3#"&'( )5F',! - 3/""012#
!"%$!.4&R&'( S='+!'O - "/"%012"
!"#"4.!&'( S(83B2'- - ./2!012#
!"%-.3!&'( !-2222.T--H>I - %/24012"
!"-.-$"&'( E*6I,-6 - 4/!3012"
!"%#4#"&'( S(9R - !/2#012#
!"-2%%3&'( TR( - $/3%0123
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